data_2jy0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jy0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.52 0.676 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.58 175.48 12.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.903 -0.498 . . . . 0.0 110.469 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 60.29 71.46 0.57 Allowed 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.387 0.613 . . . . 0.0 111.24 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.01 -44.14 61.3 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.833 -0.542 . . . . 0.0 110.333 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.3 tpt -61.83 -30.9 71.14 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.704 -0.623 . . . . 0.0 109.953 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.12 -32.85 74.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.67 -0.644 . . . . 0.0 110.496 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.78 -26.23 54.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.654 -0.654 . . . . 0.0 110.64 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.7 t -66.08 166.66 11.28 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.51 -0.744 . . . . 0.0 111.0 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 56.56 29.25 15.19 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.056 -0.402 . . . . 0.0 111.945 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.8 56.45 0.23 Allowed Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 163.48 -61.21 0.26 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.12 98.41 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 122.058 -0.672 . . . . 0.0 109.918 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.0 t -59.77 -40.02 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -65.91 -39.12 90.29 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.87 -0.519 . . . . 0.0 109.845 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.39 -44.41 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.92 -37.62 94.51 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.7 tp -63.67 -43.42 96.76 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 122.074 -0.662 . . . . 0.0 110.016 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.0 t -60.28 -41.29 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tt -67.11 -41.86 85.5 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.882 -0.511 . . . . 0.0 110.089 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.03 -35.62 79.12 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.724 -0.61 . . . . 0.0 110.447 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.8 m -65.88 -36.82 84.48 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.3 -49.29 11.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.902 -0.499 . . . . 0.0 110.26 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.42 113.9 1.89 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.616 -0.678 . . . . 0.0 110.323 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HD2' ' CE2' ' A' ' 26' ' ' TYR . 50.0 Cg_endo -81.27 25.33 0.65 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.275 1.317 . . . . 0.0 113.369 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 55.04 71.52 0.53 Allowed 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.262 -0.899 . . . . 0.0 111.19 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CE2' ' HD2' ' A' ' 24' ' ' PRO . 55.9 m-85 -67.47 155.96 37.77 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.688 -0.633 . . . . 0.0 110.454 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 117.647 -1.168 . . . . 0.0 110.251 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mtp . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.246 0.546 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -97.21 133.57 41.67 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.652 -0.655 . . . . 0.0 110.597 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -161.37 53.76 0.27 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.731 0.777 . . . . 0.0 109.111 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.03 -15.31 8.78 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.679 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 66.4 mtm -132.77 -57.52 0.93 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.4 -0.812 . . . . 0.0 110.179 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.44 34.8 23.74 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 120.971 0.415 . . . . 0.0 111.181 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.72 -44.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.274 -0.892 . . . . 0.0 110.976 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -69.98 86.46 0.53 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.517 0.675 . . . . 0.0 110.274 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.65 -63.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.72 -51.47 0.24 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.4 -47.64 89.88 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.87 -43.36 99.01 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 117.972 0.886 . . . . 0.0 109.8 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.31 -36.56 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -72.35 -35.65 68.59 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.734 -0.603 . . . . 0.0 110.051 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.46 -46.37 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.89 -36.54 93.42 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.2 tp -63.16 -41.93 99.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.086 -0.655 . . . . 0.0 109.884 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.5 -40.76 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -37.1 84.94 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.722 -0.611 . . . . 0.0 109.876 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 tt -62.27 -41.1 98.18 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.591 -0.693 . . . . 0.0 109.556 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.0 m -75.05 -22.37 58.42 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.754 -0.591 . . . . 0.0 110.549 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tt -57.46 -47.47 81.76 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.707 -0.621 . . . . 0.0 111.262 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.84 104.84 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.236 0 CA-C-N 117.813 0.279 . . . . 0.0 111.151 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.86 149.96 83.19 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.983 1.122 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -104.5 -44.46 4.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.057 -0.402 . . . . 0.0 110.947 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -70.5 -44.87 66.72 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.683 -0.636 . . . . 0.0 110.499 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.6 tttt . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 118.582 -0.723 . . . . 0.0 110.082 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 mtm . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 120.691 0.281 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.37 -164.5 0.21 Allowed 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 120.957 0.408 . . . . 0.0 111.611 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.38 -74.23 0.62 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.267 -0.895 . . . . 0.0 110.416 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 52.35 28.46 5.77 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.3 mmt 49.78 65.26 1.47 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.598 -0.689 . . . . 0.0 111.347 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.53 13.11 32.31 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.535 -0.728 . . . . 0.0 112.351 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.07 -41.42 74.17 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.087 -1.008 . . . . 0.0 110.377 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -98.14 131.38 44.56 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 56.3 38.78 30.09 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 120.843 0.354 . . . . 0.0 111.107 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.3 -85.92 0.09 OUTLIER Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.49 -45.39 95.63 Favored Glycine 0 N--CA 1.501 2.968 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.44 -43.27 97.0 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.105 -0.644 . . . . 0.0 110.059 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.4 t -63.53 -40.9 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.99 -39.66 92.97 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.938 -0.476 . . . . 0.0 110.247 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.63 -46.33 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.7 -0.625 . . . . 0.0 109.317 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.97 -37.63 87.99 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.8 -45.15 94.0 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 122.188 -0.595 . . . . 0.0 110.171 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.32 -41.17 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 121.764 -0.585 . . . . 0.0 109.449 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.04 -36.73 84.96 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 122.163 -0.336 . . . . 0.0 110.327 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.67 -46.01 73.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.78 -0.575 . . . . 0.0 110.143 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.0 m -63.8 -42.41 97.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.736 -0.603 . . . . 0.0 109.62 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.8 -36.28 83.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.656 -0.652 . . . . 0.0 110.231 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.82 80.73 41.28 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.533 -0.729 . . . . 0.0 109.513 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.65 77.33 3.92 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.464 1.244 . . . . 0.0 109.999 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 26.9 m80 57.13 21.19 6.21 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 122.15 -0.344 . . . . 0.0 111.551 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -169.46 147.11 3.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.248 -0.907 . . . . 0.0 109.819 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.898 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.062 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -163.18 -59.61 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.734 -0.604 . . . . 0.0 111.743 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -116.31 -56.51 2.29 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.386 -0.821 . . . . 0.0 111.292 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 59.8 24.4 13.38 Favored 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 122.513 0.325 . . . . 0.0 111.728 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.6 ptm -165.54 -42.19 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.279 -0.888 . . . . 0.0 111.72 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.1 80.52 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.6 -0.688 . . . . 0.0 111.639 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.76 87.72 3.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.556 -0.715 . . . . 0.0 109.951 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.5 p -89.44 168.56 12.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.875 -0.515 . . . . 0.0 110.611 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 69.15 0.17 2.72 Favored 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.68 -64.81 0.73 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.49 -38.96 83.1 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.52 87.96 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 117.883 0.842 . . . . 0.0 110.67 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.74 -40.42 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -67.64 -40.76 84.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.728 -0.608 . . . . 0.0 109.893 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.23 -41.0 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.7 -0.625 . . . . 0.0 109.827 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.07 -39.52 94.73 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 tp -65.79 -41.33 92.08 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.887 -0.773 . . . . 0.0 110.275 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.48 -40.67 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 tp -66.9 -38.96 87.25 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.796 -0.565 . . . . 0.0 110.056 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 tt -59.88 -41.95 92.67 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.4 m -68.68 -30.87 69.63 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.757 -0.589 . . . . 0.0 109.655 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.4 tp -70.55 -32.39 69.79 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.776 -0.578 . . . . 0.0 110.892 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m 59.18 60.82 4.74 Favored Pre-proline 0 N--CA 1.505 2.29 0 O-C-N 122.064 -0.397 . . . . 0.0 111.606 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.45 139.18 31.15 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.406 1.214 . . . . 0.0 110.641 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -62.26 -30.12 70.89 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.881 -0.512 . . . . 0.0 111.005 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -112.02 149.58 31.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.564 -0.71 . . . . 0.0 109.805 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.144 0 CA-C-O 118.886 -0.578 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 N--CA 1.498 1.945 0 CA-C-O 120.98 0.419 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -109.05 28.25 8.67 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.723 -0.611 . . . . 0.0 110.889 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.51 55.03 0.55 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.205 -0.934 . . . . 0.0 110.328 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -118.39 38.46 3.72 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.238 -0.914 . . . . 0.0 110.814 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.4 -62.3 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.73 -0.607 . . . . 0.0 109.863 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.41 -31.06 71.59 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.992 -0.442 . . . . 0.0 111.192 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.04 90.18 1.59 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.472 -0.767 . . . . 0.0 109.647 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.5 t -159.02 -84.72 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.969 -0.457 . . . . 0.0 110.421 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.3 -39.63 4.65 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.46 -0.775 . . . . 0.0 110.657 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.615 ' HA2' ' HB2' ' A' ' 14' ' ' PHE . . . -121.26 13.99 9.5 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.44 -55.16 0.72 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.57 -46.8 4.64 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 117.723 0.762 . . . . 0.0 110.094 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.88 -41.93 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.987 -0.445 . . . . 0.0 111.024 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.615 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 46.6 t80 -63.58 -45.27 91.2 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.44 -0.788 . . . . 0.0 110.907 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.4 -42.77 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.833 -0.542 . . . . 0.0 110.169 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.31 -36.51 91.78 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.26 -36.74 74.63 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.622 -0.928 . . . . 0.0 110.75 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.15 -50.25 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.54 -0.725 . . . . 0.0 109.465 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -31.81 73.22 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.803 -0.561 . . . . 0.0 109.665 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.14 -46.67 87.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.0 m -67.96 -25.01 65.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.041 -0.412 . . . . 0.0 110.37 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tt -61.28 -55.48 31.36 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.776 -0.578 . . . . 0.0 110.843 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.1 m -145.18 75.43 13.9 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.452 -0.78 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -83.22 71.32 6.22 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.613 1.323 . . . . 0.0 110.426 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 50.52 32.71 6.94 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.915 -0.491 . . . . 0.0 111.068 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -161.81 156.83 23.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.566 -0.708 . . . . 0.0 110.114 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 117.571 -1.204 . . . . 0.0 110.177 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 mtm . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -140.15 107.99 5.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.94 -0.475 . . . . 0.0 110.193 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.89 147.46 5.77 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.865 -0.522 . . . . 0.0 110.311 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 54.91 26.3 7.72 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.122 0.487 . . . . 0.0 111.79 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.87 -60.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.323 -0.86 . . . . 0.0 109.537 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 49.37 62.5 2.59 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.481 0.657 . . . . 0.0 110.107 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 62.16 22.42 13.12 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.56 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 51.03 38.53 20.79 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.697 -0.627 . . . . 0.0 110.523 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.6 -45.14 0.12 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.343 -0.848 . . . . 0.0 111.741 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.9 -61.28 7.52 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.55 -37.0 93.45 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.59 -48.85 79.94 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 117.774 0.787 . . . . 0.0 110.423 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.21 -39.46 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.69 -0.631 . . . . 0.0 109.736 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -63.16 -45.52 91.46 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.786 -0.571 . . . . 0.0 110.06 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.41 -42.14 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.675 -0.64 . . . . 0.0 109.847 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.18 -39.82 98.39 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tt -64.68 -41.26 96.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.95 -0.735 . . . . 0.0 109.879 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.9 t -63.06 -34.75 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.36 -41.08 63.86 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 tp -71.34 -37.8 71.69 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.733 -0.605 . . . . 0.0 110.348 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.36 -24.07 67.15 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.435 -0.791 . . . . 0.0 111.057 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.85 -26.59 59.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.387 -0.821 . . . . 0.0 110.696 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.23 68.35 0.83 Allowed Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.89 -0.506 . . . . 0.0 111.287 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -83.12 106.18 1.38 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.222 1.281 . . . . 0.0 110.315 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -136.05 -51.25 0.71 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.629 -0.669 . . . . 0.0 111.119 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 57.92 75.3 0.39 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.473 0.654 . . . . 0.0 110.329 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 1.8 mmpt? . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.52 -0.738 . . . . 0.0 110.713 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 tmm? . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -131.63 -58.58 0.98 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.784 -0.573 . . . . 0.0 111.016 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.45 -79.84 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 122.836 0.454 . . . . 0.0 110.49 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.64 -42.93 81.48 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.195 -0.941 . . . . 0.0 109.421 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -71.03 -24.21 62.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.839 -0.538 . . . . 0.0 110.861 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.17 -18.0 24.11 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.517 -0.739 . . . . 0.0 111.857 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.06 -44.4 3.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.33 -0.856 . . . . 0.0 111.43 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 t -77.22 82.74 3.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.33 -0.856 . . . . 0.0 110.568 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.88 -64.74 0.28 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.797 -0.564 . . . . 0.0 110.191 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.42 -48.73 0.96 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.6 -47.64 82.93 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.42 92.62 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 117.717 0.759 . . . . 0.0 110.37 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.27 -39.34 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -64.31 -42.16 96.47 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.799 -0.563 . . . . 0.0 109.865 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.9 t -59.51 -39.66 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.57 -42.49 97.39 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -69.38 -41.73 76.09 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.989 -0.712 . . . . 0.0 109.632 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.5 t -60.46 -45.37 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.75 -38.42 90.93 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -42.51 98.51 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.747 -0.596 . . . . 0.0 110.004 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -64.85 -36.39 84.2 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.654 -0.654 . . . . 0.0 109.593 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.22 -49.14 53.19 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.688 -0.632 . . . . 0.0 109.823 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.6 p -130.95 89.25 43.22 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.875 -0.516 . . . . 0.0 109.657 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.25 144.13 55.72 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.477 1.251 . . . . 0.0 110.938 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -113.31 53.22 0.77 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.476 0.655 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -104.22 167.89 9.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.606 -0.684 . . . . 0.0 110.215 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 117.668 -1.158 . . . . 0.0 110.295 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.499 1.979 0 CA-C-O 121.009 0.433 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -103.64 -167.17 1.34 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.764 -0.585 . . . . 0.0 110.182 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -162.83 130.35 3.69 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.318 -0.863 . . . . 0.0 110.961 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 52.34 48.23 23.06 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 121.846 0.832 . . . . 0.0 111.617 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.71 -35.06 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.942 -0.474 . . . . 0.0 111.034 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.67 -60.35 2.61 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.628 -0.67 . . . . 0.0 110.859 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -161.03 31.28 0.14 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.377 -0.827 . . . . 0.0 112.649 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.0 p -127.84 35.6 4.46 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.929 -1.107 . . . . 0.0 111.497 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.44 7.71 45.82 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.544 -0.722 . . . . 0.0 110.619 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.47 -38.72 2.99 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.42 -50.82 10.88 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.83 98.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.947 -0.737 . . . . 0.0 109.928 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.31 -39.35 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.14 -40.19 94.06 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.883 -0.51 . . . . 0.0 109.941 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.66 -44.39 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.15 -37.43 94.54 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.05 -39.1 86.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.835 -0.803 . . . . 0.0 110.385 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.68 -40.25 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -38.66 87.2 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tp -72.82 -38.64 67.09 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.943 -0.473 . . . . 0.0 110.122 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.4 m -65.73 -25.02 67.1 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.709 -0.619 . . . . 0.0 110.413 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -63.84 -57.53 9.58 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.417 -0.802 . . . . 0.0 110.46 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 67.36 150.45 0.12 Allowed Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -72.45 157.17 53.48 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.301 1.334 . . . . 0.0 110.614 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 55.14 50.84 14.38 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.247 0.546 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -105.19 -18.44 14.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.62 -0.675 . . . . 0.0 111.992 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 3.6 tppt? . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.322 -0.861 . . . . 0.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttm . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -133.18 158.36 43.03 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.721 -0.612 . . . . 0.0 110.489 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.1 mtm-85 -74.55 -51.86 13.46 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.778 -0.577 . . . . 0.0 110.605 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 49.99 36.99 12.94 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.0 mtt 52.12 49.47 20.56 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.864 -0.523 . . . . 0.0 111.835 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.5 -41.31 12.12 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.479 -0.763 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.51 -58.75 2.0 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.412 -0.805 . . . . 0.0 110.969 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.2 m 50.11 41.95 24.36 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.051 -0.406 . . . . 0.0 111.283 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.14 58.37 5.62 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.33 0.586 . . . . 0.0 111.962 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.19 15.14 72.01 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -103.05 -30.59 5.37 Favored Glycine 0 N--CA 1.495 2.577 0 CA-C-N 118.54 1.17 . . . . 0.0 110.248 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.64 94.19 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 118.053 0.927 . . . . 0.0 110.598 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.72 -46.47 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.22 -49.71 66.33 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.735 -0.603 . . . . 0.0 109.717 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.28 -39.2 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.48 -43.94 98.31 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -43.23 99.3 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.822 -0.811 . . . . 0.0 109.871 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -59.92 -40.23 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.501 -0.749 . . . . 0.0 109.474 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.84 -37.73 67.35 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.949 -0.47 . . . . 0.0 110.576 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.54 -37.7 42.21 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.72 -0.613 . . . . 0.0 111.327 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.2 m -73.88 -4.35 34.45 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.533 -0.729 . . . . 0.0 112.289 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.59 -19.16 9.32 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 120.805 -1.185 . . . . 0.0 112.595 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.28 129.73 86.75 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.332 -0.855 . . . . 0.0 110.746 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.53 158.75 56.13 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.6 1.316 . . . . 0.0 110.175 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -104.87 51.51 0.76 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.497 0.665 . . . . 0.0 109.863 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -93.26 168.58 10.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.618 -0.676 . . . . 0.0 110.413 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 117.715 -1.136 . . . . 0.0 109.932 179.801 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -155.16 -45.87 0.08 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.932 -0.48 . . . . 0.0 111.443 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.6 mtt-85 60.69 69.21 0.7 Allowed 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.455 0.645 . . . . 0.0 110.796 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.07 -34.55 73.6 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.724 -0.61 . . . . 0.0 110.469 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.3 mtm -120.8 -70.73 0.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.573 -0.705 . . . . 0.0 109.321 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 40.89 51.98 3.22 Favored 'General case' 0 N--CA 1.506 2.358 0 C-N-CA 122.688 0.395 . . . . 0.0 111.438 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.438 ' O ' ' HA3' ' A' ' 11' ' ' GLY . . . 63.92 100.21 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.488 0.661 . . . . 0.0 109.885 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 m -96.11 -51.46 4.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.458 -0.776 . . . . 0.0 109.885 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.79 -49.53 77.14 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.72 31.61 8.18 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . -105.3 -45.07 1.39 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.27 -48.23 62.28 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 118.198 0.999 . . . . 0.0 111.298 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.48 -43.88 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.701 -0.625 . . . . 0.0 109.331 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -69.88 -39.02 76.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.873 -0.517 . . . . 0.0 110.313 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.55 -40.81 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.795 -0.566 . . . . 0.0 109.685 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.25 -45.63 96.1 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.39 -42.73 87.46 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.98 -0.718 . . . . 0.0 109.433 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.06 -42.06 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -39.99 95.85 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.798 -0.564 . . . . 0.0 109.819 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.24 -36.73 78.41 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.949 -0.47 . . . . 0.0 109.862 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.6 m -81.61 -45.84 15.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.647 -0.658 . . . . 0.0 109.526 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.65 -42.89 97.91 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 122.081 -0.387 . . . . 0.0 110.347 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.4 m -112.87 89.92 14.43 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.709 -0.619 . . . . 0.0 109.869 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.17 90.12 1.01 Allowed 'Trans proline' 0 N--CA 1.489 1.233 0 O-C-N 123.771 1.406 . . . . 0.0 110.081 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -128.26 31.74 4.99 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.756 -0.59 . . . . 0.0 111.068 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.02 87.78 2.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.3 -0.875 . . . . 0.0 109.622 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.998 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -133.06 118.73 19.12 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.935 -0.478 . . . . 0.0 110.425 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.5 mtt-85 -77.46 -31.85 54.03 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.931 -0.481 . . . . 0.0 111.401 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -55.87 -43.93 77.64 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.896 -0.502 . . . . 0.0 110.433 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -88.26 -73.85 0.48 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.629 -0.669 . . . . 0.0 109.202 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.67 18.51 3.72 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.22 2.63 5.18 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.914 -1.116 . . . . 0.0 112.168 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.9 m -106.12 33.86 3.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.933 -1.104 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.72 21.22 2.56 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.69 43.0 53.31 Favored Glycine 0 N--CA 1.502 3.05 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.08 -49.09 0.02 OUTLIER Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.49 -44.52 46.13 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-N 117.795 0.797 . . . . 0.0 111.244 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.8 t -56.27 -42.08 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.986 -0.446 . . . . 0.0 109.993 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -67.91 -41.35 82.78 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.762 -0.586 . . . . 0.0 109.863 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.17 -41.02 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.724 -0.61 . . . . 0.0 109.596 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.01 -37.96 94.88 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -41.47 89.92 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.965 -0.726 . . . . 0.0 110.25 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.73 -38.92 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.33 -39.65 94.32 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.83 -29.87 68.29 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.893 -0.504 . . . . 0.0 110.089 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 m -100.1 39.65 1.32 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.635 -0.666 . . . . 0.0 109.455 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tp -119.81 -78.73 0.59 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.147 -0.971 . . . . 0.0 109.893 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 p -167.62 139.46 2.55 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.387 -0.821 . . . . 0.0 110.853 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.52 89.89 1.24 Allowed 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.844 1.444 . . . . 0.0 110.157 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -64.67 -43.85 92.26 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.729 -0.607 . . . . 0.0 110.751 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -149.27 159.75 43.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.675 -0.641 . . . . 0.0 110.716 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 tptt . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.108 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 120.831 0.348 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.37 175.54 7.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.843 -0.536 . . . . 0.0 110.83 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.15 -167.9 2.58 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.99 19.06 5.57 Favored 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.1 tpt -129.37 -39.7 1.49 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.85 -1.156 . . . . 0.0 111.105 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.28 -36.9 33.45 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.784 -0.572 . . . . 0.0 112.318 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.53 -45.16 10.13 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.305 -0.872 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 p -66.01 -34.63 78.53 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.447 -0.783 . . . . 0.0 111.229 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.38 69.89 4.29 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.193 -0.942 . . . . 0.0 109.844 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.8 -65.48 0.51 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.08 87.07 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.04 -37.13 78.91 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 117.847 0.824 . . . . 0.0 110.68 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.1 t -66.01 -46.08 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.11 -48.7 67.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.635 -0.666 . . . . 0.0 109.807 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.32 -37.7 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.49 -40.32 98.53 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 tt -67.19 -46.08 74.98 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 122.012 -0.699 . . . . 0.0 109.664 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -62.17 -41.53 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tt -65.61 -40.21 92.38 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -37.29 78.95 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 122.02 -0.425 . . . . 0.0 110.187 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -72.86 -33.01 65.82 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.554 -0.716 . . . . 0.0 109.745 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.74 -63.0 1.21 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.61 -0.682 . . . . 0.0 109.72 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.9 m 55.17 93.59 0.05 OUTLIER Pre-proline 0 N--CA 1.504 2.233 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.21 82.5 2.03 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 O-C-N 123.425 1.224 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -106.18 -51.12 3.02 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -92.16 -45.25 8.36 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.8 pttt . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.813 179.593 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mmt . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 t70 65.18 -76.36 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 122.81 0.444 . . . . 0.0 111.176 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.63 66.94 9.9 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.372 -0.83 . . . . 0.0 109.542 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -158.06 -59.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.0 ptm -50.7 -29.13 10.5 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.09 -48.05 77.67 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.529 -0.732 . . . . 0.0 111.002 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.81 -54.77 2.32 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.598 -0.689 . . . . 0.0 110.479 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.42 -171.92 1.97 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.703 -0.623 . . . . 0.0 110.324 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 74.76 -52.36 0.68 Allowed 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.063 0.545 . . . . 0.0 112.081 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.68 -53.43 25.57 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.66 -40.94 99.44 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.0 -33.42 74.3 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.986 -0.714 . . . . 0.0 110.673 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 80.0 t -67.83 -45.91 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.461 -0.774 . . . . 0.0 109.273 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -69.23 -47.22 65.35 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.545 -0.722 . . . . 0.0 109.914 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.7 t -64.95 -43.24 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.52 -38.89 97.0 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -43.39 98.95 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 117.652 0.726 . . . . 0.0 109.679 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.55 -40.26 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.489 ' HA ' HD13 ' A' ' 22' ' ' LEU . 3.2 mm? -68.73 -42.08 78.12 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.876 -0.515 . . . . 0.0 109.813 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.2 tp -62.03 -35.65 79.21 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.047 -0.408 . . . . 0.0 110.403 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 54.8 m -68.87 -31.17 69.91 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.592 -0.692 . . . . 0.0 109.782 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 19' ' ' LEU . 17.0 mt -68.85 -55.64 10.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.637 -0.665 . . . . 0.0 110.171 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.68 99.88 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.251 0 O-C-N 122.236 -0.29 . . . . 0.0 111.394 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.22 60.78 7.53 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 O-C-N 123.368 1.194 . . . . 0.0 110.054 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.1 m80 56.37 40.77 29.64 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 121.309 0.576 . . . . 0.0 110.568 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.54 92.34 3.72 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 109.782 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.138 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ttt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.586 0.707 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -154.62 141.7 19.34 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.732 -0.605 . . . . 0.0 109.879 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -117.77 176.03 5.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.487 -0.758 . . . . 0.0 111.135 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 60.55 19.98 9.8 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.8 mtt -139.06 -64.58 0.5 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.78 88.27 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.0 -23.52 28.64 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.833 -0.542 . . . . 0.0 110.557 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -72.13 -49.41 36.18 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.249 -0.907 . . . . 0.0 109.865 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.18 -50.66 6.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.884 -0.51 . . . . 0.0 110.134 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.3 51.28 1.62 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.66 -86.94 0.06 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.28 -46.85 86.91 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 117.814 0.807 . . . . 0.0 111.309 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.46 -40.77 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -61.58 -51.26 69.25 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.893 -0.505 . . . . 0.0 109.753 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.21 -43.01 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.98 98.56 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -42.13 98.79 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 117.715 0.757 . . . . 0.0 110.313 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.37 -42.02 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.38 -41.29 69.85 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 tp -60.53 -33.57 72.85 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.946 -0.471 . . . . 0.0 110.922 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 m -62.24 -38.88 90.94 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.502 -0.749 . . . . 0.0 110.083 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.57 50.55 1.17 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.596 -0.69 . . . . 0.0 109.801 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 t -106.41 118.42 54.7 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.23 -0.919 . . . . 0.0 110.757 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -79.46 93.54 1.08 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.795 1.418 . . . . 0.0 109.747 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -113.49 25.68 11.07 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.508 -0.745 . . . . 0.0 111.507 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -99.38 78.85 2.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.064 -1.022 . . . . 0.0 109.606 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.1 tptt . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 117.293 -1.337 . . . . 0.0 110.841 -179.88 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtm . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 120.951 0.405 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.04 169.26 18.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.786 -0.571 . . . . 0.0 110.459 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -90.99 -90.16 0.16 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.633 -0.667 . . . . 0.0 110.209 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 48.83 32.5 3.74 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 118.871 0.759 . . . . 0.0 112.235 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.39 29.48 15.25 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.685 -0.635 . . . . 0.0 111.278 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.27 -57.48 2.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.362 -0.836 . . . . 0.0 109.894 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.73 87.86 3.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.624 -0.673 . . . . 0.0 109.505 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 m -123.02 124.71 43.73 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.42 -73.16 0.06 Allowed 'General case' 0 N--CA 1.506 2.358 0 C-N-CA 122.804 0.442 . . . . 0.0 110.455 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.16 -50.42 28.08 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.93 -35.24 89.2 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.47 -38.04 73.87 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 117.858 0.829 . . . . 0.0 110.448 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.54 -38.72 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -74.88 -32.02 61.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.684 -0.635 . . . . 0.0 110.112 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.84 -44.46 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.0 -38.65 94.31 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.36 -45.56 93.05 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 122.02 -0.694 . . . . 0.0 109.266 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.05 -38.63 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.548 ' HA ' HD11 ' A' ' 22' ' ' LEU . 13.5 tp -61.69 -27.01 68.39 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.702 -0.624 . . . . 0.0 109.95 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.48 -38.86 23.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.903 -0.498 . . . . 0.0 110.222 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.89 -15.72 61.58 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.657 -0.652 . . . . 0.0 111.912 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.548 HD11 ' HA ' ' A' ' 19' ' ' LEU . 11.8 mt -58.77 -55.07 39.85 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.458 -0.776 . . . . 0.0 110.898 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 m 62.09 90.9 0.08 OUTLIER Pre-proline 0 N--CA 1.503 2.195 0 C-N-CA 122.459 0.304 . . . . 0.0 110.618 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.75 -28.99 24.62 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 O-C-N 123.498 1.262 . . . . 0.0 111.516 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -129.65 -65.75 0.83 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -158.23 142.3 15.73 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 110.352 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.586 -0.721 . . . . 0.0 109.82 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.16 152.51 38.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.742 -0.599 . . . . 0.0 110.345 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -157.34 -174.54 4.94 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.712 -0.618 . . . . 0.0 110.311 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 59.13 22.93 11.13 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.856 -0.528 . . . . 0.0 111.976 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.78 -45.77 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.575 -0.703 . . . . 0.0 109.947 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.15 43.85 1.15 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.361 -0.837 . . . . 0.0 109.908 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -118.44 -53.47 2.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -108.36 -49.21 3.21 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.26 80.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.924 -0.485 . . . . 0.0 111.138 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.92 69.31 1.92 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.53 -86.8 0.06 OUTLIER Glycine 0 N--CA 1.498 2.786 0 CA-C-N 118.284 1.042 . . . . 0.0 111.058 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.45 79.93 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 122.104 -0.645 . . . . 0.0 111.267 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.02 -42.89 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -65.4 -40.89 93.99 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.112 -0.367 . . . . 0.0 110.062 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.5 t -60.58 -42.2 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 O-C-N 121.613 -0.68 . . . . 0.0 109.278 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.5 -40.35 96.14 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.0 mt -62.73 -46.59 87.36 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.034 -0.686 . . . . 0.0 109.756 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.2 t -52.79 -40.6 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.648 -0.658 . . . . 0.0 109.591 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.58 -46.6 21.71 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.977 -0.452 . . . . 0.0 109.865 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.49 90.73 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.849 -0.532 . . . . 0.0 109.669 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.7 m -66.91 -34.5 77.91 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -38.25 76.88 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.916 -0.49 . . . . 0.0 110.293 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.18 116.58 66.63 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.883 -0.51 . . . . 0.0 110.007 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.16 136.0 26.05 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.597 1.314 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -99.4 -55.66 2.62 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.699 -0.626 . . . . 0.0 109.878 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -134.67 102.28 5.23 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt . . . . . 0 N--CA 1.503 2.191 0 CA-C-O 117.272 -1.347 . . . . 0.0 110.569 -179.485 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.52 -60.85 0.1 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.878 -0.514 . . . . 0.0 110.903 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 56.8 68.23 0.89 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.182 0.515 . . . . 0.0 111.706 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -93.82 -60.33 1.78 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.253 -0.904 . . . . 0.0 109.779 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -145.4 67.81 1.22 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.778 0.799 . . . . 0.0 109.97 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.89 -45.1 8.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.705 -0.622 . . . . 0.0 109.725 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.88 112.95 2.96 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.005 -0.434 . . . . 0.0 109.938 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.445 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 0.4 OUTLIER 59.74 -162.46 0.25 Allowed 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.841 -0.537 . . . . 0.0 111.193 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.99 39.82 0.91 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.965 -1.084 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.2 38.12 88.89 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.6 -54.64 0.01 OUTLIER Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.27 -50.54 71.09 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 118.065 0.933 . . . . 0.0 111.007 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 8' ' ' SER . 12.1 t -65.74 -32.44 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.666 -0.646 . . . . 0.0 110.247 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -71.94 -42.37 66.7 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.53 -0.731 . . . . 0.0 110.235 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -56.65 -45.33 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.749 -0.594 . . . . 0.0 109.443 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.11 -33.86 88.38 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 tp -77.39 -35.81 54.02 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.68 -0.894 . . . . 0.0 110.171 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.41 -45.6 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.578 -0.701 . . . . 0.0 109.648 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -36.1 82.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.775 -0.578 . . . . 0.0 109.834 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tp -77.32 -35.5 54.8 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.74 -0.6 . . . . 0.0 110.344 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -64.5 -23.94 67.45 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.78 -0.575 . . . . 0.0 110.9 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -75.27 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.393 -0.817 . . . . 0.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.434 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 54.91 -172.55 0.01 OUTLIER Pre-proline 0 N--CA 1.507 2.386 0 CA-C-N 118.656 0.662 . . . . 0.0 111.004 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 23' ' ' SER . 50.6 Cg_endo -75.76 68.87 6.27 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.411 0.741 . . . . 0.0 110.729 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -109.32 -50.88 2.94 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.34 -0.85 . . . . 0.0 110.261 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -83.47 75.28 10.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.61 -0.682 . . . . 0.0 109.762 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 117.268 -1.349 . . . . 0.0 111.373 -179.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mtp . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 t70 66.66 -65.65 0.2 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 122.963 0.505 . . . . 0.0 111.766 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.97 -6.28 48.77 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.408 -0.808 . . . . 0.0 111.388 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.15 -45.35 87.56 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.293 -0.88 . . . . 0.0 109.912 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.02 -32.31 63.3 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.829 -0.544 . . . . 0.0 109.846 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.85 -28.92 69.19 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.903 -0.498 . . . . 0.0 111.016 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.19 80.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.657 -0.652 . . . . 0.0 110.209 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 m -94.43 28.42 2.59 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.537 -0.727 . . . . 0.0 110.95 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.66 -39.46 91.41 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.155 -0.965 . . . . 0.0 110.45 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.42 85.24 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.13 -40.88 98.48 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.61 91.53 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 117.795 0.798 . . . . 0.0 110.054 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.29 -40.78 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.21 -40.23 93.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.961 -0.462 . . . . 0.0 109.957 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.9 t -62.19 -43.77 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.02 -37.34 94.13 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.9 -44.29 93.44 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.967 -0.725 . . . . 0.0 110.012 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.6 t -58.67 -43.63 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.92 -39.44 93.53 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -41.78 95.41 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.9 -0.5 . . . . 0.0 109.99 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 49.5 m -69.31 -29.16 66.95 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.66 -0.65 . . . . 0.0 110.526 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.62 -29.02 62.11 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.471 -0.768 . . . . 0.0 110.563 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.36 73.69 0.53 Allowed Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.927 -0.483 . . . . 0.0 110.708 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.82 69.5 6.86 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.464 1.244 . . . . 0.0 109.974 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -118.41 -35.3 3.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.758 -0.589 . . . . 0.0 111.054 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 61.16 -168.19 0.18 Allowed 'General case' 0 N--CA 1.505 2.314 0 CA-C-N 118.2 0.455 . . . . 0.0 110.693 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.379 0 C-N-CA 123.082 0.553 . . . . 0.0 111.286 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ptp . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.073 0.463 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -133.38 -54.82 0.9 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.65 -0.656 . . . . 0.0 110.334 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -72.49 106.19 4.48 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.478 -0.764 . . . . 0.0 109.224 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -96.03 -55.49 2.95 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.999 -0.438 . . . . 0.0 109.984 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -42.52 17.31 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.528 -0.732 . . . . 0.0 110.089 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.48 82.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.799 -0.563 . . . . 0.0 111.139 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.63 23.81 3.37 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.498 -0.751 . . . . 0.0 111.745 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.4 t -87.3 61.68 6.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.07 -1.019 . . . . 0.0 109.958 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 14' ' ' PHE . . . 39.75 83.82 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 122.927 0.491 . . . . 0.0 111.177 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.58 -65.42 4.02 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 149.94 51.74 0.02 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 75.45 -47.96 0.61 Allowed 'General case' 0 N--CA 1.511 2.591 0 CA-C-N 117.886 0.843 . . . . 0.0 110.688 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.2 -44.9 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.477 ' HB3' ' O ' ' A' ' 9' ' ' ALA . 12.8 t80 -75.67 -32.43 60.15 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.137 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 9' ' ' ALA . 72.6 t -60.45 -44.43 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.661 -0.65 . . . . 0.0 110.049 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.02 97.88 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.76 -44.97 79.99 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.809 -0.818 . . . . 0.0 110.111 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.96 -42.0 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.02 -33.27 70.55 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.921 -0.487 . . . . 0.0 109.7 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tt -71.39 -44.8 64.27 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.9 -0.5 . . . . 0.0 109.826 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.0 m -75.11 -29.59 60.62 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.668 -0.645 . . . . 0.0 110.889 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.08 62.35 0.88 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.888 0.852 . . . . 0.0 108.99 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.0 t -117.07 78.07 9.57 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.786 -0.571 . . . . 0.0 110.561 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -86.11 70.51 4.48 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 121.256 1.304 . . . . 0.0 109.475 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 57.52 57.65 4.22 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.649 0.738 . . . . 0.0 109.982 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -121.35 162.18 20.79 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.464 -0.773 . . . . 0.0 110.965 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt . . . . . 0 N--CA 1.499 2.007 0 CA-C-O 117.701 -1.143 . . . . 0.0 110.115 179.761 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -110.57 38.72 2.39 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.537 0.684 . . . . 0.0 110.463 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.51 -47.28 2.45 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.47 ' HB3' ' HE3' ' A' ' 5' ' ' MET . 0.3 OUTLIER -92.34 -38.14 12.21 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.47 ' HE3' ' HB3' ' A' ' 4' ' ' GLU . 2.9 mtm -92.04 19.0 7.2 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.64 -0.662 . . . . 0.0 111.771 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.7 -66.9 0.87 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.152 -0.968 . . . . 0.0 109.118 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.79 21.37 0.79 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.729 -0.607 . . . . 0.0 111.494 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 p -107.24 -50.57 3.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.329 -0.857 . . . . 0.0 110.377 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.83 73.1 5.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.175 -0.953 . . . . 0.0 110.009 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.36 -82.3 0.05 OUTLIER Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.872 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.14 -47.89 84.11 Favored Glycine 0 N--CA 1.503 3.156 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.51 75.95 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.049 -0.677 . . . . 0.0 110.654 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.58 -44.97 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.76 -0.588 . . . . 0.0 109.743 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.74 -48.41 66.53 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.65 -0.656 . . . . 0.0 110.424 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.3 t -67.33 -40.13 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.776 -0.577 . . . . 0.0 109.79 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.55 99.24 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -45.22 94.36 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 117.752 0.776 . . . . 0.0 109.825 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.98 -41.76 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tp -65.57 -33.29 75.56 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.61 -0.681 . . . . 0.0 109.665 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -36.52 74.04 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.567 -0.708 . . . . 0.0 110.326 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.69 -24.12 63.54 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.347 -0.845 . . . . 0.0 111.367 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.47 -32.83 8.35 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.363 -0.835 . . . . 0.0 111.008 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.67 167.24 0.12 Allowed Pre-proline 0 N--CA 1.504 2.262 0 C-N-CA 122.749 0.42 . . . . 0.0 111.276 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.76 63.46 4.55 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.202 1.268 . . . . 0.0 109.556 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 52.12 46.16 27.1 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.291 0.567 . . . . 0.0 110.637 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -126.92 124.95 40.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.414 -0.803 . . . . 0.0 110.854 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 tptp . . . . . 0 N--CA 1.505 2.292 0 CA-C-O 119.028 -0.51 . . . . 0.0 111.2 179.909 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 120.639 0.257 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -89.84 -47.59 7.79 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.242 -0.912 . . . . 0.0 109.459 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -103.17 -14.98 16.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.746 -0.596 . . . . 0.0 111.07 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.7 -48.06 42.07 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.361 -0.837 . . . . 0.0 110.99 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.6 ttm -76.59 -45.4 30.47 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.716 -0.615 . . . . 0.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.59 36.03 19.56 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.966 -0.459 . . . . 0.0 111.883 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 51.79 44.57 29.21 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.709 -0.619 . . . . 0.0 112.546 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -92.85 0.66 57.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.45 -0.781 . . . . 0.0 111.167 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 14' ' ' PHE . . . 52.94 56.57 7.38 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.375 -0.828 . . . . 0.0 109.266 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' CB ' ' A' ' 14' ' ' PHE . . . 80.35 -63.18 4.2 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.63 50.39 0.03 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 75.48 -48.44 0.61 Allowed 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 123.494 0.718 . . . . 0.0 110.27 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.41 -45.38 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.837 -0.539 . . . . 0.0 109.571 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CB ' ' HA3' ' A' ' 10' ' ' GLY . 20.7 t80 -67.0 -35.15 79.31 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.109 -0.369 . . . . 0.0 110.842 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.43 -46.63 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.46 -37.94 86.19 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -43.29 96.92 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 122.021 -0.694 . . . . 0.0 109.751 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -59.7 -40.75 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.81 -42.96 97.57 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.9 tt -59.58 -45.69 91.13 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.925 -0.484 . . . . 0.0 109.985 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.5 m -64.22 -34.04 77.18 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.899 -0.501 . . . . 0.0 109.929 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -33.76 76.28 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.702 -0.624 . . . . 0.0 109.652 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -82.06 118.85 73.56 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.47 132.54 22.4 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.232 1.288 . . . . 0.0 111.445 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -143.91 64.4 1.32 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.557 -0.714 . . . . 0.0 110.679 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -103.93 70.2 0.99 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.199 -0.938 . . . . 0.0 110.697 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.224 0 O-C-N 121.453 -0.78 . . . . 0.0 111.255 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 120.886 0.374 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -105.38 148.74 26.78 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.729 -0.607 . . . . 0.0 110.042 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 58.88 -94.61 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 122.477 0.311 . . . . 0.0 111.336 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 55.67 18.34 2.79 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-N 118.984 0.811 . . . . 0.0 112.793 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.79 -60.43 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.079 -1.013 . . . . 0.0 109.391 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 57.03 33.58 23.57 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.193 0.52 . . . . 0.0 111.057 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' HA ' HG11 ' A' ' 15' ' ' VAL . . . -152.2 -76.64 0.13 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.527 -0.733 . . . . 0.0 109.358 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.6 m 57.33 -76.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.58 -40.84 28.73 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.679 -0.638 . . . . 0.0 112.638 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 14' ' ' PHE . . . -89.75 34.48 4.04 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 52.88 30.19 36.2 Favored Glycine 0 N--CA 1.497 2.738 0 CA-C-N 118.52 1.16 . . . . 0.0 110.483 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.42 ' HA ' ' CB ' ' A' ' 7' ' ' ALA . . . 53.94 26.94 6.73 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 118.045 0.923 . . . . 0.0 110.935 -179.205 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.1 t -142.56 -60.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.449 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 51.9 t80 -55.05 -32.8 62.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 7' ' ' ALA . 17.8 t -56.36 -43.23 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.93 -40.59 97.31 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -40.92 98.13 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.93 -0.747 . . . . 0.0 109.602 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.27 -40.48 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -63.31 -40.69 98.03 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 tt -63.55 -36.65 84.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.038 -0.414 . . . . 0.0 110.111 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.5 m -68.08 -32.23 72.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.515 -0.741 . . . . 0.0 109.943 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -79.11 -63.94 1.3 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.631 -0.668 . . . . 0.0 110.142 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 p -165.9 95.11 0.8 Allowed Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.674 -0.642 . . . . 0.0 110.848 -179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -84.53 96.46 0.69 Allowed 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 121.293 1.329 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -109.55 -35.96 6.09 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.396 -0.815 . . . . 0.0 111.102 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.57 147.31 50.92 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.504 -0.748 . . . . 0.0 110.619 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 117.724 -1.131 . . . . 0.0 110.39 -179.931 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptp . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 120.707 0.289 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -79.39 161.71 26.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.533 -0.729 . . . . 0.0 110.611 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.8 ttm-85 51.78 47.8 24.08 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.086 0.47 . . . . 0.0 111.473 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.92 -39.54 14.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.453 -0.779 . . . . 0.0 109.853 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 11.9 ttm -106.62 -21.1 13.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.789 -0.569 . . . . 0.0 110.854 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.35 -50.48 63.4 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.202 -0.936 . . . . 0.0 110.727 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.33 74.64 1.12 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.625 0.726 . . . . 0.0 109.741 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.8 p -121.86 26.23 8.75 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.769 -0.582 . . . . 0.0 111.475 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.09 -60.91 0.57 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.333 -0.854 . . . . 0.0 110.035 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.19 -43.65 1.85 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.06 -47.78 89.1 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.05 90.75 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 118.024 0.912 . . . . 0.0 110.221 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.6 -39.37 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -63.96 -43.43 95.8 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.859 -0.525 . . . . 0.0 110.229 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.5 t -60.76 -42.47 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.87 -39.76 97.69 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -42.36 96.49 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.085 -0.656 . . . . 0.0 110.228 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.06 -40.08 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.24 -45.15 74.02 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -40.73 89.4 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.949 -0.47 . . . . 0.0 110.496 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -66.05 -37.89 86.99 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.751 -0.593 . . . . 0.0 109.619 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.91 -41.76 96.77 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.738 -0.601 . . . . 0.0 110.041 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 p -77.25 155.24 82.16 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.727 -0.608 . . . . 0.0 109.446 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.72 79.75 1.86 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.752 1.396 . . . . 0.0 111.023 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -86.01 -29.12 23.73 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.665 -0.647 . . . . 0.0 111.535 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 59.12 79.65 0.22 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.914 -0.491 . . . . 0.0 109.849 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.13 0 C-N-CA 122.856 0.462 . . . . 0.0 110.584 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ttp . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -133.97 28.28 3.84 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.878 -0.514 . . . . 0.0 111.548 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.64 56.48 7.57 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.668 -0.645 . . . . 0.0 112.318 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -137.66 -45.69 0.54 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.288 -0.882 . . . . 0.0 111.377 179.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.91 -11.02 20.1 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.282 -0.886 . . . . 0.0 112.233 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.84 -28.03 67.2 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.078 -1.014 . . . . 0.0 111.871 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.86 -62.11 1.95 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.345 -0.847 . . . . 0.0 110.83 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 m 54.05 -164.64 0.1 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.667 -0.646 . . . . 0.0 110.801 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 14' ' ' PHE . . . -90.9 89.43 7.45 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.919 -1.113 . . . . 0.0 109.282 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.616 ' HA3' ' CB ' ' A' ' 14' ' ' PHE . . . 106.69 -11.82 42.22 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.146 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.48 34.01 4.9 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 119.301 1.551 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 73.8 -46.49 0.63 Allowed 'General case' 0 N--CA 1.506 2.364 0 CA-C-N 118.084 0.942 . . . . 0.0 110.887 -179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.86 -48.46 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-O 121.331 0.586 . . . . 0.0 109.57 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.616 ' CB ' ' HA3' ' A' ' 10' ' ' GLY . 47.4 t80 -60.51 -39.27 87.18 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.6 -44.51 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.684 -0.635 . . . . 0.0 109.539 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.49 -38.84 96.95 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tt -64.5 -43.86 92.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.939 -0.742 . . . . 0.0 110.018 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.2 -38.2 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 mt -62.58 -40.62 97.48 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tp -63.07 -25.77 68.53 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 122.129 -0.357 . . . . 0.0 111.191 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.8 m -102.51 -11.12 18.78 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -0.759 . . . . 0.0 111.719 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.61 -44.31 2.55 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.829 -1.169 . . . . 0.0 111.944 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.1 t -89.68 113.01 55.17 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.224 -0.922 . . . . 0.0 111.304 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -77.31 92.1 1.14 Allowed 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.56 1.295 . . . . 0.0 110.266 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -83.11 -49.71 9.23 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.721 -0.612 . . . . 0.0 109.762 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -125.76 69.8 1.19 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 117.543 -1.218 . . . . 0.0 110.58 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.9 ttp . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.01 33.28 4.95 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.927 -0.483 . . . . 0.0 110.944 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -77.96 89.63 4.14 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.438 -0.789 . . . . 0.0 109.769 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -137.83 -63.94 0.56 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.847 -0.533 . . . . 0.0 110.219 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -117.26 25.18 10.64 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.59 -0.693 . . . . 0.0 111.115 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.23 -43.59 7.29 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.29 -0.881 . . . . 0.0 109.563 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.32 -35.93 66.13 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.963 -0.461 . . . . 0.0 109.961 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.1 m -98.73 47.52 0.98 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.716 -0.615 . . . . 0.0 110.312 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.21 -26.23 13.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.34 -0.85 . . . . 0.0 111.236 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.542 ' CA ' ' HB3' ' A' ' 14' ' ' PHE . . . -89.43 31.87 4.98 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.272 -0.892 . . . . 0.0 111.126 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.9 29.82 27.99 Favored Glycine 0 N--CA 1.497 2.762 0 CA-C-N 118.637 1.219 . . . . 0.0 111.544 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.36 14.68 3.87 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 118.463 1.132 . . . . 0.0 111.546 -179.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.7 t -128.29 -58.07 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.542 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 31.7 t80 -55.59 -37.12 67.66 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.271 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.61 -43.56 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.59 -37.18 93.35 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mp -63.86 -39.92 95.35 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.904 -0.763 . . . . 0.0 109.975 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.6 t -61.33 -41.23 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -37.61 85.59 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -40.94 82.98 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.13 -0.356 . . . . 0.0 110.213 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -65.28 -25.14 67.51 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.826 -0.546 . . . . 0.0 110.874 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.87 -60.77 3.14 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.551 -0.718 . . . . 0.0 110.495 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.76 96.86 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.229 0 C-N-CA 122.442 0.297 . . . . 0.0 111.537 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.38 134.91 23.52 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.345 1.364 . . . . 0.0 111.2 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -82.1 -46.71 13.49 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.711 -0.618 . . . . 0.0 111.04 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 t80 56.3 45.07 23.66 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.071 0.462 . . . . 0.0 110.83 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.505 2.304 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.458 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpt . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.42 0.628 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -156.71 146.23 20.64 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.799 -0.563 . . . . 0.0 110.258 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.47 43.29 0.19 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.561 -0.712 . . . . 0.0 110.939 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -132.26 -58.03 0.95 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.35 -0.844 . . . . 0.0 110.58 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.5 ttt -114.1 36.05 3.88 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.559 -0.713 . . . . 0.0 110.95 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.02 -39.16 88.71 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.482 -0.761 . . . . 0.0 110.944 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.41 -99.81 0.09 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.564 -0.71 . . . . 0.0 109.247 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.54 17.68 1.73 Allowed 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 119.334 0.97 . . . . 0.0 112.749 179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.7 -42.83 40.06 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.041 -1.037 . . . . 0.0 109.124 179.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.27 27.96 16.95 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 179.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.64 -42.79 1.2 Allowed Glycine 0 N--CA 1.496 2.657 0 CA-C-N 118.463 1.132 . . . . 0.0 110.408 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.73 -54.35 47.24 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-N 117.875 0.838 . . . . 0.0 111.15 -179.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.7 t -57.54 -37.9 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.756 -0.59 . . . . 0.0 110.181 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.5 -45.57 86.73 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.88 -0.513 . . . . 0.0 110.3 179.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.13 -38.6 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.673 -0.642 . . . . 0.0 109.935 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.54 -43.33 99.44 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.27 -45.95 75.11 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.4 t -61.93 -36.13 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.412 -0.805 . . . . 0.0 109.197 179.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.14 -33.67 61.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.608 -0.683 . . . . 0.0 110.661 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.93 -38.37 21.13 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.292 -0.88 . . . . 0.0 110.691 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -87.29 -50.97 6.22 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.635 -0.666 . . . . 0.0 111.026 -179.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.8 -47.1 8.88 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.609 -0.682 . . . . 0.0 110.315 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.6 m 69.2 130.51 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.269 0 C-N-CA 123.301 0.64 . . . . 0.0 111.403 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.39 -16.61 19.27 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.344 1.181 . . . . 0.0 112.24 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.8 m80 55.23 45.71 25.21 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.192 0.52 . . . . 0.0 111.278 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -141.69 140.78 33.27 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.392 -0.818 . . . . 0.0 110.201 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 tptt . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.856 179.827 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -135.55 -57.38 0.79 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.764 -0.585 . . . . 0.0 111.586 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -138.89 -135.84 0.13 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.448 -0.782 . . . . 0.0 109.934 -179.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 60.22 75.6 0.4 Allowed 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 118.84 0.745 . . . . 0.0 109.471 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.3 tpp 56.19 30.3 16.29 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.42 -179.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 49.89 36.51 11.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 122.016 -0.428 . . . . 0.0 111.167 -179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 54.35 29.33 10.69 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.964 -0.46 . . . . 0.0 112.091 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.7 m -82.52 81.62 8.26 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 0.0 109.975 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.83 -65.99 0.13 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.504 -0.748 . . . . 0.0 111.034 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.78 -27.28 6.75 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.09 -53.95 42.13 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.3 -26.38 62.95 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 118.183 0.992 . . . . 0.0 111.811 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.96 -37.58 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.333 -0.854 . . . . 0.0 110.566 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -105.48 -52.81 2.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.397 -0.814 . . . . 0.0 110.182 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.02 -47.23 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.4 -40.13 97.17 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.54 -43.12 98.03 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.164 -0.61 . . . . 0.0 110.195 179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.95 -40.42 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.69 -0.631 . . . . 0.0 109.544 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 tt -68.8 -30.67 69.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.737 -0.602 . . . . 0.0 110.585 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 tp -76.71 -31.62 57.3 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.393 -0.817 . . . . 0.0 111.032 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.4 m -65.43 -40.21 93.05 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.586 -0.696 . . . . 0.0 111.416 -179.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.36 -7.11 13.98 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.361 -0.837 . . . . 0.0 112.425 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.88 163.04 0.13 Allowed Pre-proline 0 N--CA 1.504 2.239 0 CA-C-N 118.717 0.69 . . . . 0.0 111.487 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.45 68.44 8.31 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.554 1.291 . . . . 0.0 110.031 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 56.43 49.16 15.46 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.235 0.541 . . . . 0.0 110.719 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -96.16 -50.71 4.71 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.526 -0.734 . . . . 0.0 110.117 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.388 179.994 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttp . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 120.811 0.338 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -150.84 172.43 15.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.839 -0.538 . . . . 0.0 110.833 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -106.78 34.46 3.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.493 -0.755 . . . . 0.0 110.931 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.19 -40.93 78.38 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.543 -0.723 . . . . 0.0 110.0 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.97 37.65 0.8 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.86 -0.525 . . . . 0.0 109.742 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.92 -53.68 4.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.605 -0.685 . . . . 0.0 109.571 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.67 116.89 3.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.811 -0.556 . . . . 0.0 110.033 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.2 t -128.47 38.56 3.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.723 -0.611 . . . . 0.0 110.244 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 50.08 63.59 2.13 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.802 -0.561 . . . . 0.0 110.34 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' A' ' 14' ' ' PHE . . . 56.38 31.05 59.36 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.44 27.98 64.15 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 53.95 26.96 6.78 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 118.362 1.081 . . . . 0.0 110.786 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.1 t -139.81 -57.46 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 25.0 t80 -56.18 -32.06 63.99 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.166 179.36 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 t -56.13 -44.22 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.71 -36.03 74.71 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -63.66 -44.52 93.55 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 117.854 0.827 . . . . 0.0 110.008 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.3 t -60.48 -42.26 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.53 -35.03 79.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.914 -0.491 . . . . 0.0 109.87 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.66 -45.71 74.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.113 -0.367 . . . . 0.0 110.359 179.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.5 m -67.43 -23.47 65.54 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.763 -0.586 . . . . 0.0 110.956 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.55 -53.99 46.45 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.448 -0.783 . . . . 0.0 110.753 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 t -152.1 77.66 6.79 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.633 -0.667 . . . . 0.0 110.628 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.77 71.88 6.81 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.528 1.278 . . . . 0.0 110.356 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.45 65.81 1.4 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.675 0.75 . . . . 0.0 110.702 -179.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -86.27 -38.55 17.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.693 -0.63 . . . . 0.0 110.295 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.796 -0.565 . . . . 0.0 110.925 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.43 -50.73 72.8 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.86 -0.525 . . . . 0.0 111.365 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.11 -34.37 68.56 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.954 -0.466 . . . . 0.0 110.881 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -53.4 -55.59 23.81 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -85.05 -31.47 23.4 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.617 -0.677 . . . . 0.0 110.47 179.396 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.6 31.31 9.87 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 51.89 39.94 26.96 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.625 -0.672 . . . . 0.0 112.8 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.3 t -83.74 -59.17 2.51 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.298 -0.876 . . . . 0.0 110.795 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.11 -53.73 8.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.61 -0.681 . . . . 0.0 109.816 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.1 71.75 1.89 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.21 -77.77 0.16 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.31 -48.79 80.29 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 122.046 -0.679 . . . . 0.0 111.48 -179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.48 -39.23 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.739 -0.601 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -65.74 -40.67 92.37 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.833 -0.542 . . . . 0.0 110.084 179.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.6 t -62.06 -39.47 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.651 -0.655 . . . . 0.0 109.79 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.84 95.53 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.34 -43.03 87.25 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.917 -0.755 . . . . 0.0 110.316 179.685 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.3 t -58.95 -39.71 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.88 -39.88 91.08 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.841 -0.537 . . . . 0.0 109.731 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 tt -60.12 -45.05 94.29 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.562 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 12.6 m -68.83 -36.17 77.87 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.831 -0.543 . . . . 0.0 110.012 179.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.36 -40.45 82.29 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.974 -0.454 . . . . 0.0 109.936 179.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.44 144.17 52.87 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.676 -0.64 . . . . 0.0 109.413 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.94 87.34 0.71 Allowed 'Trans proline' 0 N--CA 1.492 1.419 0 O-C-N 123.624 1.328 . . . . 0.0 110.531 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -149.07 60.73 1.05 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.663 -0.648 . . . . 0.0 110.456 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.562 ' CE1' ' HA ' ' A' ' 21' ' ' THR . 11.0 m-85 -132.7 130.45 40.07 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.351 -0.843 . . . . 0.0 110.183 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.819 -0.55 . . . . 0.0 111.506 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptt? . . . . . 0 N--CA 1.5 2.041 0 CA-C-O 120.359 0.123 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 61.57 107.84 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.262 0.553 . . . . 0.0 111.471 179.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.03 91.82 3.74 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.23 -0.918 . . . . 0.0 111.144 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 47.36 49.16 15.95 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-O 121.091 0.472 . . . . 0.0 111.013 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.7 mmm 61.18 38.63 16.65 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.092 0.472 . . . . 0.0 110.762 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.4 75.11 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.37 -0.831 . . . . 0.0 110.76 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.476 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . . . -167.48 80.07 0.19 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.468 0.651 . . . . 0.0 110.517 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.0 p -130.42 121.37 25.77 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.472 -0.767 . . . . 0.0 109.757 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.53 -69.35 0.12 Allowed 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.413 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.57 17.73 58.48 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.065 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 7' ' ' ALA . . . -65.14 -50.98 54.4 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.21 80.51 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.196 -0.59 . . . . 0.0 109.814 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.57 -40.97 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.378 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -63.99 -38.75 92.22 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.929 -0.482 . . . . 0.0 110.152 179.479 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.1 t -58.82 -43.65 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.9 -37.77 93.6 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.179 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.89 -41.99 95.15 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.007 -0.702 . . . . 0.0 109.821 179.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.8 t -59.94 -39.8 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.54 -43.44 89.97 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.09 -34.55 76.62 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.951 -0.468 . . . . 0.0 109.918 179.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -68.74 -38.11 79.91 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.9 tt -60.1 -45.44 92.94 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.874 -0.516 . . . . 0.0 109.977 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.88 159.01 83.98 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.613 -0.679 . . . . 0.0 109.757 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.34 56.41 3.25 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.532 1.28 . . . . 0.0 111.975 -179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -136.26 25.01 3.24 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.366 -0.833 . . . . 0.0 110.13 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -128.43 168.91 14.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.381 -0.824 . . . . 0.0 110.446 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.083 0 CA-C-O 117.598 -1.191 . . . . 0.0 111.33 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpp? . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 120.68 0.276 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 50.34 40.98 23.92 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.498 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 mmt85 58.13 19.33 5.98 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -88.85 -54.64 4.04 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.126 -0.984 . . . . 0.0 109.035 179.605 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.8 mtt -87.04 12.49 11.23 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.877 -0.515 . . . . 0.0 111.24 179.552 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.29 -47.27 7.28 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.206 -0.934 . . . . 0.0 109.926 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.69 -25.6 14.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.83 -0.544 . . . . 0.0 111.251 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -86.34 22.93 1.69 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.275 -0.891 . . . . 0.0 112.072 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.73 21.05 13.01 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.871 -1.143 . . . . 0.0 111.707 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.481 ' CA ' ' HB3' ' A' ' 14' ' ' PHE . . . -105.95 20.37 36.2 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.942 -1.099 . . . . 0.0 111.472 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.77 28.47 60.36 Favored Glycine 0 N--CA 1.497 2.719 0 CA-C-N 118.421 1.111 . . . . 0.0 112.015 179.675 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.7 12.79 3.89 Favored 'General case' 0 N--CA 1.508 2.425 0 CA-C-N 118.688 1.244 . . . . 0.0 111.989 -179.502 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 89.0 t -126.65 -56.5 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 179.62 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.481 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 29.7 t80 -59.76 -38.27 81.33 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.256 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.58 -45.92 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.912 -0.493 . . . . 0.0 109.713 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.96 -39.65 97.5 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.685 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 tp -67.84 -40.52 83.69 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 117.946 0.873 . . . . 0.0 110.804 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.22 -42.64 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 tt -69.67 -36.28 75.9 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.315 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.46 -42.11 75.33 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 122.242 -0.286 . . . . 0.0 110.606 179.75 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.7 m -71.84 -17.61 62.13 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.744 -0.598 . . . . 0.0 111.291 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -16.3 59.94 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.105 -0.997 . . . . 0.0 111.731 179.908 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.2 m 56.83 70.19 1.49 Allowed Pre-proline 0 N--CA 1.504 2.253 0 CA-C-N 118.704 0.684 . . . . 0.0 110.766 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.17 107.0 1.65 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.704 1.371 . . . . 0.0 109.929 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -125.71 -42.61 1.91 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.748 -0.595 . . . . 0.0 111.448 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 57.29 63.81 1.78 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.384 0.611 . . . . 0.0 110.105 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.7 mttt . . . . . 0 N--CA 1.499 1.99 0 CA-C-O 117.734 -1.126 . . . . 0.0 110.414 -179.808 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 ttp . . . . . 0 N--CA 1.501 2.082 0 CA-C-O 121.342 0.592 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -157.21 -87.61 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.748 -0.595 . . . . 0.0 109.698 -179.952 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -81.07 -32.08 34.13 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.067 -1.021 . . . . 0.0 110.051 179.592 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.61 -28.14 44.39 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 179.857 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -36.19 83.15 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.34 -0.85 . . . . 0.0 110.015 179.673 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.14 -41.26 67.34 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.229 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.98 -8.16 59.65 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.829 -0.545 . . . . 0.0 110.944 179.319 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.514 ' C ' ' HB2' ' A' ' 14' ' ' PHE . 48.0 m 57.6 56.95 4.57 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.652 . . . . 0.0 110.987 -179.878 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . . . 41.45 60.72 2.03 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.583 0.706 . . . . 0.0 111.785 179.79 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.64 21.43 79.42 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.748 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.55 36.82 72.43 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.825 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.28 -59.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 117.876 0.838 . . . . 0.0 110.352 -179.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 9' ' ' ALA . 91.5 t -55.07 -31.53 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.818 -0.551 . . . . 0.0 110.471 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.514 ' HB2' ' C ' ' A' ' 8' ' ' SER . 4.5 t80 -70.92 -42.83 69.37 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.587 -0.696 . . . . 0.0 109.492 179.346 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.09 -44.1 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.625 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.86 -39.46 98.04 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.614 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.31 -41.39 89.8 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.957 -0.731 . . . . 0.0 110.163 179.659 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.81 -40.34 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.67 -40.88 93.76 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.407 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tt -69.19 -43.93 73.17 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.453 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.4 m -75.29 -11.8 60.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.986 -0.446 . . . . 0.0 111.687 179.988 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.25 48.19 0.88 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.005 -1.059 . . . . 0.0 110.284 179.934 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.09 100.6 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.319 0 O-C-N 121.881 -0.512 . . . . 0.0 111.938 179.737 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.08 179.97 4.9 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.176 1.25 . . . . 0.0 110.68 179.64 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -144.2 41.15 1.37 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.291 -0.881 . . . . 0.0 111.459 -179.839 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -83.14 114.52 21.39 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.099 -1.001 . . . . 0.0 109.435 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.451 -179.636 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tpt . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.415 0.626 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -72.78 164.06 27.15 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.174 0.511 . . . . 0.0 110.403 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.72 -103.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.532 -0.73 . . . . 0.0 109.977 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.47 32.65 16.58 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 119.714 1.143 . . . . 0.0 111.39 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.7 ptm -168.53 -45.84 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.484 -0.76 . . . . 0.0 111.088 179.598 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.56 -53.41 4.32 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.429 -0.794 . . . . 0.0 110.172 179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.26 75.5 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.849 -0.532 . . . . 0.0 110.747 179.772 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.9 p -75.79 -20.26 58.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.585 -0.697 . . . . 0.0 111.235 179.576 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.87 47.45 0.75 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.271 -0.893 . . . . 0.0 110.829 179.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.82 -0.72 56.32 Favored Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.268 -0.895 . . . . 0.0 110.876 179.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -5.88 76.07 Favored Glycine 0 N--CA 1.498 2.786 0 CA-C-N 119.089 1.444 . . . . 0.0 111.531 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.58 -49.53 2.01 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.0 1.4 . . . . 0.0 108.948 179.673 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.42 -52.52 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.628 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -47.59 73.67 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.607 -0.683 . . . . 0.0 110.453 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.82 -39.12 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.947 -0.47 . . . . 0.0 109.926 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.0 -43.16 91.89 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.54 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.77 -43.29 96.85 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 117.601 0.701 . . . . 0.0 110.605 179.764 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.2 t -60.17 -42.77 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.581 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tp -65.41 -39.24 91.91 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.168 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.64 -52.68 64.45 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.438 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.2 m -61.22 -34.04 74.47 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.99 -0.444 . . . . 0.0 110.37 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.67 -39.24 93.34 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.832 -0.543 . . . . 0.0 109.721 179.591 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.6 m -73.15 157.68 88.01 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.875 -0.516 . . . . 0.0 109.987 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.55 93.01 0.5 Allowed 'Trans proline' 0 N--CA 1.492 1.434 0 O-C-N 123.896 1.471 . . . . 0.0 111.465 -179.717 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -57.58 -42.0 82.27 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.861 -0.524 . . . . 0.0 110.834 179.764 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -97.12 107.49 20.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.509 -0.744 . . . . 0.0 109.677 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 117.591 -1.195 . . . . 0.0 110.931 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 120.51 0.195 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 62.74 170.69 0.14 Allowed 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.905 0.86 . . . . 0.0 112.378 179.845 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.73 -52.56 0.75 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.642 -0.662 . . . . 0.0 109.485 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.87 -35.3 79.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.829 -0.544 . . . . 0.0 109.774 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.98 14.54 26.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.558 -0.714 . . . . 0.0 111.084 179.55 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.08 -3.34 21.66 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.226 -0.921 . . . . 0.0 112.054 -179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.33 -47.99 4.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.917 -1.114 . . . . 0.0 110.053 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -65.75 -28.35 68.98 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.761 -0.587 . . . . 0.0 111.395 179.791 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.08 -44.75 79.27 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.219 -0.926 . . . . 0.0 110.514 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.27 49.52 2.69 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.888 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -106.12 -77.23 1.08 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 179.725 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.07 98.6 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.196 -0.591 . . . . 0.0 109.775 179.449 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.65 -41.05 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.392 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -66.2 -41.16 90.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.902 -0.499 . . . . 0.0 109.97 179.534 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.3 t -57.84 -43.13 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.649 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.73 -40.14 90.03 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.4 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 mt -61.08 -38.78 87.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.874 -0.78 . . . . 0.0 110.094 179.637 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.2 -40.99 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.522 -0.737 . . . . 0.0 109.127 179.636 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tt -70.4 -42.28 71.89 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.378 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -35.34 78.41 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.818 -0.551 . . . . 0.0 109.531 179.431 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -103.1 34.99 2.67 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.718 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 23' ' ' SER . 0.6 OUTLIER -81.12 -24.39 37.7 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.385 -0.822 . . . . 0.0 111.603 -179.973 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 17.0 m 70.14 160.78 0.15 Allowed Pre-proline 0 N--CA 1.507 2.408 0 CA-C-N 118.202 0.455 . . . . 0.0 111.411 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 50.0 Cg_endo -73.37 -173.15 1.21 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 O-C-N 123.478 1.251 . . . . 0.0 111.065 179.964 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 60.21 57.85 2.81 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.564 0.697 . . . . 0.0 110.744 -179.963 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -134.75 130.11 35.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.436 -0.79 . . . . 0.0 110.634 179.953 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 120.697 0.284 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 55.21 41.93 31.0 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.176 0.512 . . . . 0.0 111.847 179.901 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.3 114.65 28.51 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.384 -0.823 . . . . 0.0 110.347 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -145.32 -76.32 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 11.8 mtm -126.78 48.07 2.23 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.13 -0.982 . . . . 0.0 110.218 179.616 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.78 -37.88 8.1 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.526 -0.734 . . . . 0.0 110.565 179.92 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.479 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . . . -132.13 67.89 1.51 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.31 -0.869 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.98 -15.31 15.15 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.793 -0.567 . . . . 0.0 112.305 179.926 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.54 56.59 1.82 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.882 -1.136 . . . . 0.0 108.721 179.573 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.66 14.65 49.3 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.405 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.479 ' HA2' ' CB ' ' A' ' 7' ' ' ALA . . . 57.03 37.52 79.95 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.73 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.46 -60.31 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.193 -0.593 . . . . 0.0 110.77 -179.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.86 -37.58 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 O-C-N 121.749 -0.594 . . . . 0.0 110.278 -179.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -62.36 -48.64 78.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.95 -0.469 . . . . 0.0 110.271 179.497 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.5 -43.85 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.965 -0.46 . . . . 0.0 110.349 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.15 -40.5 99.04 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.704 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -43.24 96.75 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.014 -0.698 . . . . 0.0 110.27 179.763 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.51 -42.54 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.735 -0.603 . . . . 0.0 109.668 179.702 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.6 -34.63 77.4 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.867 -0.52 . . . . 0.0 110.228 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tp -70.07 -46.3 65.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.781 -0.574 . . . . 0.0 110.226 179.752 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.9 m -67.96 -29.54 68.61 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.979 -0.451 . . . . 0.0 110.897 179.878 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.68 -61.77 1.89 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.593 -0.692 . . . . 0.0 110.434 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.56 109.71 1.34 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.59 -0.693 . . . . 0.0 109.941 -179.976 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.59 144.14 59.44 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 O-C-N 123.577 1.304 . . . . 0.0 110.673 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -107.71 49.38 0.81 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.752 -0.593 . . . . 0.0 110.475 -179.985 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -88.51 143.18 27.13 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.482 -0.761 . . . . 0.0 109.994 179.724 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 118.677 -0.678 . . . . 0.0 110.41 179.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.22 -32.46 15.77 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.069 -0.394 . . . . 0.0 110.786 179.961 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.1 mtm105 -102.73 39.71 1.49 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.279 -0.888 . . . . 0.0 110.137 179.635 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -37.14 85.11 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.906 -0.496 . . . . 0.0 110.045 179.664 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.1 ttp -110.77 25.42 11.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.732 -0.605 . . . . 0.0 110.061 179.356 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.07 -55.86 3.18 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.228 -0.92 . . . . 0.0 110.476 179.848 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.28 17.33 2.77 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.624 -0.672 . . . . 0.0 112.455 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m 50.0 39.67 19.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.325 -0.859 . . . . 0.0 111.633 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.513 ' CB ' ' HB ' ' A' ' 13' ' ' VAL . . . 48.74 63.9 1.92 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.8 0.81 . . . . 0.0 110.449 -179.787 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.45 20.22 77.14 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.573 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.59 42.18 66.24 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.39 -54.85 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 O-C-N 122.14 -0.624 . . . . 0.0 109.959 -179.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 9' ' ' ALA . 55.7 t -57.4 -34.75 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.778 -0.576 . . . . 0.0 110.243 179.821 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.06 -50.66 71.08 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.564 -0.71 . . . . 0.0 109.6 179.555 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.1 t -59.57 -37.78 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.618 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.09 99.71 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.722 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.23 -42.24 75.93 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.871 -0.781 . . . . 0.0 110.253 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.55 -38.92 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.454 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.45 -36.48 81.28 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.086 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 tt -61.31 -33.07 72.99 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.643 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.4 m -99.9 29.86 3.99 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.717 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 63.68 83.72 0.16 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.05 0.929 . . . . 0.0 111.598 179.794 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.8 t -71.91 141.74 84.71 Favored Pre-proline 0 N--CA 1.501 2.114 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.605 179.816 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -77.19 87.47 1.5 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.562 1.296 . . . . 0.0 110.283 179.846 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.33 -43.65 12.72 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.679 -0.638 . . . . 0.0 110.262 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.3 59.59 0.68 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.701 -0.624 . . . . 0.0 109.793 179.801 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 117.753 -1.118 . . . . 0.0 110.418 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 2.002 0 CA-C-O 120.875 0.369 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.71 174.37 10.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.874 -0.516 . . . . 0.0 110.56 -179.902 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.84 94.72 4.97 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.48 -0.763 . . . . 0.0 110.625 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -89.13 -58.23 2.61 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.471 -0.768 . . . . 0.0 109.831 179.763 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -39.14 57.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 110.366 179.686 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 47.57 43.26 15.95 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 122.016 -0.428 . . . . 0.0 111.96 179.741 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 58.98 89.04 0.06 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.578 0.704 . . . . 0.0 109.792 -179.646 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.434 ' C ' ' HB2' ' A' ' 14' ' ' PHE . 1.5 m -93.96 23.64 4.77 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.63 -0.669 . . . . 0.0 112.061 -179.488 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 43.16 69.06 0.43 Allowed 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.711 0.767 . . . . 0.0 110.79 179.848 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.62 17.04 72.51 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.15 33.27 60.86 Favored Glycine 0 N--CA 1.498 2.832 0 CA-C-N 118.545 1.173 . . . . 0.0 110.423 -179.626 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.26 -57.22 0.11 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.902 -0.763 . . . . 0.0 109.104 -179.982 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.5 t -57.13 -36.58 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.544 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.434 ' HB2' ' C ' ' A' ' 8' ' ' SER . 5.6 t80 -84.33 -35.02 23.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.486 -0.759 . . . . 0.0 109.806 179.429 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -57.68 -42.14 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.957 -0.464 . . . . 0.0 110.095 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.22 -43.61 96.8 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.687 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -40.75 95.64 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.886 -0.773 . . . . 0.0 110.632 179.786 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.18 -44.39 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.519 -0.738 . . . . 0.0 109.165 179.559 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 tp -65.94 -38.02 87.55 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.298 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -41.34 90.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.3 m -74.0 -31.59 63.02 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.691 -0.631 . . . . 0.0 110.118 179.574 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.94 -36.26 80.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.737 -0.602 . . . . 0.0 110.987 179.972 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.1 p -125.57 73.71 68.88 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.382 -0.824 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -89.99 52.54 1.3 Allowed 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.166 1.244 . . . . 0.0 110.852 179.764 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -162.46 77.57 0.48 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.917 -1.114 . . . . 0.0 110.953 179.982 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 54.49 67.46 1.01 Allowed 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.203 0.525 . . . . 0.0 110.735 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.14 -179.65 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 121.52 0.676 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.7 132.97 37.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.476 -0.765 . . . . 0.0 110.641 -179.795 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -109.93 -8.14 14.9 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.147 -0.346 . . . . 0.0 111.714 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -84.27 -49.65 8.58 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.303 -0.873 . . . . 0.0 109.832 -179.875 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -74.38 -40.86 61.82 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.828 -0.545 . . . . 0.0 110.023 179.692 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 51.67 39.03 24.31 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 122.101 -0.374 . . . . 0.0 111.94 179.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 52.9 83.9 0.06 Allowed 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.55 0.69 . . . . 0.0 111.388 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 m -58.85 -33.63 70.66 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.614 -0.679 . . . . 0.0 111.316 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.91 59.03 2.3 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.551 -0.718 . . . . 0.0 110.093 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.95 -70.31 0.31 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.79 -41.76 67.3 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.63 89.77 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.168 0.984 . . . . 0.0 110.171 179.694 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.48 -39.78 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.497 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -64.7 -43.16 94.39 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.756 -0.59 . . . . 0.0 109.473 179.304 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.46 -42.2 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 121.82 -0.55 . . . . 0.0 109.616 179.652 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.31 97.32 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.7 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 tt -64.63 -44.38 90.69 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 122.081 -0.658 . . . . 0.0 109.972 179.586 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.86 -39.71 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.553 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.42 -37.65 88.27 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.103 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.76 -26.65 67.07 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.68 -0.637 . . . . 0.0 110.292 179.396 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -67.54 -41.28 84.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.461 -0.775 . . . . 0.0 111.0 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.4 tp -104.88 -35.7 7.62 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.57 -0.706 . . . . 0.0 111.954 -179.727 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 m -106.42 95.86 12.55 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 -179.777 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -71.84 178.42 5.85 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 O-C-N 123.561 1.296 . . . . 0.0 111.111 179.786 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -152.07 42.3 0.68 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.576 -0.702 . . . . 0.0 110.896 -179.713 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -110.79 139.51 46.02 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.152 -0.967 . . . . 0.0 110.926 -179.907 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.842 179.911 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -130.7 105.29 7.71 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.434 0.635 . . . . 0.0 110.213 -179.515 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -119.19 -168.06 1.5 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.275 -0.891 . . . . 0.0 110.217 -179.885 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 53.58 45.78 27.41 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.913 -0.492 . . . . 0.0 111.22 179.956 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.2 mpp? 53.52 75.51 0.26 Allowed 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.528 0.68 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.7 39.25 1.14 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.679 -0.638 . . . . 0.0 111.054 179.855 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 55.21 96.74 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.539 0.685 . . . . 0.0 111.982 179.715 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.06 27.1 5.16 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.337 -0.852 . . . . 0.0 111.074 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.23 13.89 19.27 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.248 -0.908 . . . . 0.0 111.505 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 14' ' ' PHE . . . -106.84 34.07 5.97 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.911 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.0 31.45 55.85 Favored Glycine 0 N--CA 1.496 2.685 0 CA-C-N 118.184 0.992 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 53.47 29.08 8.42 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-N 118.368 1.084 . . . . 0.0 111.006 -179.455 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -143.37 -58.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.837 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.471 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 26.9 t80 -60.7 -28.09 68.38 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.49 179.354 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -54.67 -48.5 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.742 -0.599 . . . . 0.0 109.7 179.601 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.5 -39.44 96.85 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.71 -41.59 95.56 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 117.616 0.708 . . . . 0.0 109.989 179.572 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.9 t -62.07 -42.83 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.532 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -30.05 71.21 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.88 -0.512 . . . . 0.0 109.965 179.359 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.56 -46.59 46.49 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.6 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.1 m -67.56 -37.19 82.31 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.61 -0.681 . . . . 0.0 109.7 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.16 47.6 0.87 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.636 -0.665 . . . . 0.0 109.821 179.568 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.5 p -92.47 138.88 23.8 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.301 -0.875 . . . . 0.0 109.985 179.772 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.34 130.95 20.79 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.604 1.318 . . . . 0.0 110.156 179.783 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -146.72 69.65 1.19 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.689 -0.632 . . . . 0.0 110.583 -179.854 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -56.97 -38.48 73.06 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.655 -0.653 . . . . 0.0 110.469 179.835 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mttp . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.643 179.618 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.5 ttm . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.06 -139.38 0.9 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.249 -0.282 . . . . 0.0 110.691 179.947 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -135.7 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.085 -1.01 . . . . 0.0 110.219 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 63.72 10.13 4.87 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.199 -0.938 . . . . 0.0 112.236 -179.731 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.7 ttt -146.99 16.47 1.21 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.106 -0.996 . . . . 0.0 111.385 179.794 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.09 25.57 5.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.976 -1.077 . . . . 0.0 111.038 179.746 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.68 26.19 8.86 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.301 -0.874 . . . . 0.0 110.705 179.924 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.575 ' HB3' ' CB ' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -67.54 108.38 2.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.522 -0.737 . . . . 0.0 109.751 179.99 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . . . 46.77 62.03 2.54 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.658 0.742 . . . . 0.0 109.847 -179.324 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.61 19.31 77.8 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.086 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.62 39.9 76.94 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.562 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.91 -59.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 117.821 0.81 . . . . 0.0 110.931 -179.847 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.31 -28.8 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 121.678 -0.639 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.575 ' CB ' ' HB3' ' A' ' 8' ' ' SER . 26.6 t80 -65.2 -44.22 89.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.526 -0.734 . . . . 0.0 109.42 179.444 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.3 t -65.71 -44.93 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.471 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.63 -39.29 97.71 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.451 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.71 -45.3 93.37 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.098 -0.648 . . . . 0.0 109.729 179.591 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.52 -41.48 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.392 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.456 ' HA ' HD11 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -65.76 -36.76 84.48 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.0 -0.437 . . . . 0.0 110.311 179.449 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.9 tp -63.98 -37.13 86.27 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.69 -0.631 . . . . 0.0 109.769 179.601 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.5 m -68.56 -37.42 79.9 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.114 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 19' ' ' LEU . 35.8 mt -67.46 -38.11 83.94 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.371 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.7 m -63.97 161.26 40.2 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.921 -0.487 . . . . 0.0 109.979 179.731 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.79 73.32 1.39 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 O-C-N 123.869 1.457 . . . . 0.0 111.321 -179.851 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -127.65 -56.42 1.3 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.892 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -92.7 111.98 23.77 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.468 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? . . . . . 0 N--CA 1.498 1.95 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.66 -179.759 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.52 0.676 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.58 175.48 12.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.903 -0.498 . . . . 0.0 110.469 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 60.29 71.46 0.57 Allowed 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.387 0.613 . . . . 0.0 111.24 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.01 -44.14 61.3 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.833 -0.542 . . . . 0.0 110.333 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.3 tpt -61.83 -30.9 71.14 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.704 -0.623 . . . . 0.0 109.953 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.12 -32.85 74.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.67 -0.644 . . . . 0.0 110.496 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.78 -26.23 54.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.654 -0.654 . . . . 0.0 110.64 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.7 t -66.08 166.66 11.28 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.51 -0.744 . . . . 0.0 111.0 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 56.56 29.25 15.19 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.056 -0.402 . . . . 0.0 111.945 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.8 56.45 0.23 Allowed Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 163.48 -61.21 0.26 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.12 98.41 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 122.058 -0.672 . . . . 0.0 109.918 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.0 t -59.77 -40.02 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -65.91 -39.12 90.29 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.87 -0.519 . . . . 0.0 109.845 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 11' ' ' GLY . 84.4 t -60.39 -44.41 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.92 -37.62 94.51 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.7 tp -63.67 -43.42 96.76 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 122.074 -0.662 . . . . 0.0 110.016 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.0 t -60.28 -41.29 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tt -67.11 -41.86 85.5 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.882 -0.511 . . . . 0.0 110.089 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.03 -35.62 79.12 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.724 -0.61 . . . . 0.0 110.447 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.8 m -65.88 -36.82 84.48 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.3 -49.29 11.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.902 -0.499 . . . . 0.0 110.26 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.42 113.9 1.89 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.616 -0.678 . . . . 0.0 110.323 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HD2' ' CE2' ' A' ' 26' ' ' TYR . 50.0 Cg_endo -81.27 25.33 0.65 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.275 1.317 . . . . 0.0 113.369 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 55.04 71.52 0.53 Allowed 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.262 -0.899 . . . . 0.0 111.19 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.427 ' CE2' ' HD2' ' A' ' 24' ' ' PRO . 55.9 m-85 -67.47 155.96 37.77 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.688 -0.633 . . . . 0.0 110.454 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 117.647 -1.168 . . . . 0.0 110.251 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mtp . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.246 0.546 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -97.21 133.57 41.67 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.652 -0.655 . . . . 0.0 110.597 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -161.37 53.76 0.27 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.731 0.777 . . . . 0.0 109.111 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.03 -15.31 8.78 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.679 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 66.4 mtm -132.77 -57.52 0.93 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.4 -0.812 . . . . 0.0 110.179 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.44 34.8 23.74 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 120.971 0.415 . . . . 0.0 111.181 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.72 -44.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.274 -0.892 . . . . 0.0 110.976 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -69.98 86.46 0.53 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.517 0.675 . . . . 0.0 110.274 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.65 -63.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.72 -51.47 0.24 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -59.4 -47.64 89.88 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.87 -43.36 99.01 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 117.972 0.886 . . . . 0.0 109.8 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.31 -36.56 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -72.35 -35.65 68.59 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.734 -0.603 . . . . 0.0 110.051 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 11' ' ' GLY . 64.3 t -59.46 -46.37 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.89 -36.54 93.42 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.2 tp -63.16 -41.93 99.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.086 -0.655 . . . . 0.0 109.884 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.5 -40.76 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -37.1 84.94 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.722 -0.611 . . . . 0.0 109.876 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 tt -62.27 -41.1 98.18 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.591 -0.693 . . . . 0.0 109.556 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.0 m -75.05 -22.37 58.42 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.754 -0.591 . . . . 0.0 110.549 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tt -57.46 -47.47 81.76 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.707 -0.621 . . . . 0.0 111.262 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.84 104.84 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.236 0 CA-C-N 117.813 0.279 . . . . 0.0 111.151 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.86 149.96 83.19 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.983 1.122 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -104.5 -44.46 4.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.057 -0.402 . . . . 0.0 110.947 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -70.5 -44.87 66.72 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.683 -0.636 . . . . 0.0 110.499 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.6 tttt . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 118.582 -0.723 . . . . 0.0 110.082 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 mtm . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 120.691 0.281 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.37 -164.5 0.21 Allowed 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 120.957 0.408 . . . . 0.0 111.611 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.38 -74.23 0.62 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.267 -0.895 . . . . 0.0 110.416 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 52.35 28.46 5.77 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.3 mmt 49.78 65.26 1.47 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.598 -0.689 . . . . 0.0 111.347 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.53 13.11 32.31 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.535 -0.728 . . . . 0.0 112.351 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.07 -41.42 74.17 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.087 -1.008 . . . . 0.0 110.377 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -98.14 131.38 44.56 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 56.3 38.78 30.09 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 120.843 0.354 . . . . 0.0 111.107 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.3 -85.92 0.09 OUTLIER Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -59.49 -45.39 95.63 Favored Glycine 0 N--CA 1.501 2.968 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.44 -43.27 97.0 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.105 -0.644 . . . . 0.0 110.059 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.4 t -63.53 -40.9 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.99 -39.66 92.97 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.938 -0.476 . . . . 0.0 110.247 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 11' ' ' GLY . 95.2 t -61.63 -46.33 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.7 -0.625 . . . . 0.0 109.317 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.97 -37.63 87.99 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.8 -45.15 94.0 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 122.188 -0.595 . . . . 0.0 110.171 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.32 -41.17 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 121.764 -0.585 . . . . 0.0 109.449 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.04 -36.73 84.96 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 122.163 -0.336 . . . . 0.0 110.327 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.67 -46.01 73.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.78 -0.575 . . . . 0.0 110.143 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.0 m -63.8 -42.41 97.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.736 -0.603 . . . . 0.0 109.62 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.8 -36.28 83.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.656 -0.652 . . . . 0.0 110.231 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.82 80.73 41.28 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.533 -0.729 . . . . 0.0 109.513 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.65 77.33 3.92 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.464 1.244 . . . . 0.0 109.999 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 26.9 m80 57.13 21.19 6.21 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 122.15 -0.344 . . . . 0.0 111.551 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -169.46 147.11 3.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.248 -0.907 . . . . 0.0 109.819 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.898 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.062 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -163.18 -59.61 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.734 -0.604 . . . . 0.0 111.743 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -116.31 -56.51 2.29 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.386 -0.821 . . . . 0.0 111.292 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 59.8 24.4 13.38 Favored 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 122.513 0.325 . . . . 0.0 111.728 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.6 ptm -165.54 -42.19 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.279 -0.888 . . . . 0.0 111.72 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.1 80.52 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.6 -0.688 . . . . 0.0 111.639 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.76 87.72 3.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.556 -0.715 . . . . 0.0 109.951 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 30.5 p -89.44 168.56 12.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.875 -0.515 . . . . 0.0 110.611 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 8' ' ' SER . . . 69.15 0.17 2.72 Favored 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.68 -64.81 0.73 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -56.49 -38.96 83.1 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.52 87.96 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 117.883 0.842 . . . . 0.0 110.67 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.74 -40.42 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 18' ' ' VAL . 32.6 t80 -67.64 -40.76 84.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.728 -0.608 . . . . 0.0 109.893 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 11' ' ' GLY . 76.7 t -60.23 -41.0 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.7 -0.625 . . . . 0.0 109.827 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.07 -39.52 94.73 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 tp -65.79 -41.33 92.08 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.887 -0.773 . . . . 0.0 110.275 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 14' ' ' PHE . 99.3 t -62.48 -40.67 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 tp -66.9 -38.96 87.25 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.796 -0.565 . . . . 0.0 110.056 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 tt -59.88 -41.95 92.67 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.4 m -68.68 -30.87 69.63 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.757 -0.589 . . . . 0.0 109.655 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.4 tp -70.55 -32.39 69.79 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.776 -0.578 . . . . 0.0 110.892 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m 59.18 60.82 4.74 Favored Pre-proline 0 N--CA 1.505 2.29 0 O-C-N 122.064 -0.397 . . . . 0.0 111.606 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.45 139.18 31.15 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.406 1.214 . . . . 0.0 110.641 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -62.26 -30.12 70.89 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.881 -0.512 . . . . 0.0 111.005 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -112.02 149.58 31.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.564 -0.71 . . . . 0.0 109.805 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.144 0 CA-C-O 118.886 -0.578 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 N--CA 1.498 1.945 0 CA-C-O 120.98 0.419 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -109.05 28.25 8.67 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.723 -0.611 . . . . 0.0 110.889 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.51 55.03 0.55 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.205 -0.934 . . . . 0.0 110.328 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -118.39 38.46 3.72 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.238 -0.914 . . . . 0.0 110.814 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.4 -62.3 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.73 -0.607 . . . . 0.0 109.863 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.41 -31.06 71.59 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.992 -0.442 . . . . 0.0 111.192 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.04 90.18 1.59 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.472 -0.767 . . . . 0.0 109.647 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.5 t -159.02 -84.72 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.969 -0.457 . . . . 0.0 110.421 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.3 -39.63 4.65 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.46 -0.775 . . . . 0.0 110.657 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.644 ' HA2' ' HB2' ' A' ' 14' ' ' PHE . . . -121.26 13.99 9.5 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.44 -55.16 0.72 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.57 -46.8 4.64 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 117.723 0.762 . . . . 0.0 110.094 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.88 -41.93 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.987 -0.445 . . . . 0.0 111.024 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.644 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 46.6 t80 -63.58 -45.27 91.2 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.44 -0.788 . . . . 0.0 110.907 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.4 -42.77 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.833 -0.542 . . . . 0.0 110.169 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.31 -36.51 91.78 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.26 -36.74 74.63 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.622 -0.928 . . . . 0.0 110.75 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.15 -50.25 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.54 -0.725 . . . . 0.0 109.465 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -31.81 73.22 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.803 -0.561 . . . . 0.0 109.665 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.14 -46.67 87.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.0 m -67.96 -25.01 65.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.041 -0.412 . . . . 0.0 110.37 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tt -61.28 -55.48 31.36 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.776 -0.578 . . . . 0.0 110.843 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.1 m -145.18 75.43 13.9 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.452 -0.78 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -83.22 71.32 6.22 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.613 1.323 . . . . 0.0 110.426 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 50.52 32.71 6.94 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.915 -0.491 . . . . 0.0 111.068 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -161.81 156.83 23.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.566 -0.708 . . . . 0.0 110.114 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 117.571 -1.204 . . . . 0.0 110.177 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 mtm . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -140.15 107.99 5.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.94 -0.475 . . . . 0.0 110.193 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.89 147.46 5.77 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.865 -0.522 . . . . 0.0 110.311 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 54.91 26.3 7.72 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.122 0.487 . . . . 0.0 111.79 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.87 -60.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.323 -0.86 . . . . 0.0 109.537 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 49.37 62.5 2.59 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.481 0.657 . . . . 0.0 110.107 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 62.16 22.42 13.12 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.56 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 51.03 38.53 20.79 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.697 -0.627 . . . . 0.0 110.523 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.6 -45.14 0.12 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.343 -0.848 . . . . 0.0 111.741 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.9 -61.28 7.52 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.55 -37.0 93.45 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.59 -48.85 79.94 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 117.774 0.787 . . . . 0.0 110.423 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.21 -39.46 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.69 -0.631 . . . . 0.0 109.736 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -63.16 -45.52 91.46 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.786 -0.571 . . . . 0.0 110.06 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.41 -42.14 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.675 -0.64 . . . . 0.0 109.847 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.18 -39.82 98.39 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tt -64.68 -41.26 96.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.95 -0.735 . . . . 0.0 109.879 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 21' ' ' THR . 50.9 t -63.06 -34.75 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -73.36 -41.08 63.86 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 tp -71.34 -37.8 71.69 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.733 -0.605 . . . . 0.0 110.348 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -65.36 -24.07 67.15 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.435 -0.791 . . . . 0.0 111.057 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.85 -26.59 59.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.387 -0.821 . . . . 0.0 110.696 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.23 68.35 0.83 Allowed Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.89 -0.506 . . . . 0.0 111.287 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -83.12 106.18 1.38 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.222 1.281 . . . . 0.0 110.315 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -136.05 -51.25 0.71 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.629 -0.669 . . . . 0.0 111.119 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 57.92 75.3 0.39 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.473 0.654 . . . . 0.0 110.329 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 1.8 mmpt? . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.52 -0.738 . . . . 0.0 110.713 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 tmm? . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -131.63 -58.58 0.98 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.784 -0.573 . . . . 0.0 111.016 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.45 -79.84 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 122.836 0.454 . . . . 0.0 110.49 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.64 -42.93 81.48 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.195 -0.941 . . . . 0.0 109.421 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -71.03 -24.21 62.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.839 -0.538 . . . . 0.0 110.861 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.17 -18.0 24.11 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.517 -0.739 . . . . 0.0 111.857 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.06 -44.4 3.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.33 -0.856 . . . . 0.0 111.43 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 t -77.22 82.74 3.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.33 -0.856 . . . . 0.0 110.568 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.88 -64.74 0.28 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.797 -0.564 . . . . 0.0 110.191 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.42 -48.73 0.96 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -56.6 -47.64 82.93 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.42 92.62 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 117.717 0.759 . . . . 0.0 110.37 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.27 -39.34 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -64.31 -42.16 96.47 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.799 -0.563 . . . . 0.0 109.865 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 11' ' ' GLY . 73.9 t -59.51 -39.66 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.57 -42.49 97.39 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -69.38 -41.73 76.09 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.989 -0.712 . . . . 0.0 109.632 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.5 t -60.46 -45.37 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.75 -38.42 90.93 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -42.51 98.51 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.747 -0.596 . . . . 0.0 110.004 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -64.85 -36.39 84.2 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.654 -0.654 . . . . 0.0 109.593 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 22' ' ' LEU . 2.5 mm? -70.22 -49.14 53.19 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.688 -0.632 . . . . 0.0 109.823 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.6 p -130.95 89.25 43.22 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.875 -0.516 . . . . 0.0 109.657 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.25 144.13 55.72 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.477 1.251 . . . . 0.0 110.938 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -113.31 53.22 0.77 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.476 0.655 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -104.22 167.89 9.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.606 -0.684 . . . . 0.0 110.215 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 117.668 -1.158 . . . . 0.0 110.295 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.499 1.979 0 CA-C-O 121.009 0.433 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 21.7 m-20 -103.64 -167.17 1.34 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.764 -0.585 . . . . 0.0 110.182 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -162.83 130.35 3.69 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.318 -0.863 . . . . 0.0 110.961 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 52.34 48.23 23.06 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 121.846 0.832 . . . . 0.0 111.617 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.71 -35.06 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.942 -0.474 . . . . 0.0 111.034 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 2' ' ' ASP . . . -67.67 -60.35 2.61 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.628 -0.67 . . . . 0.0 110.859 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -161.03 31.28 0.14 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.377 -0.827 . . . . 0.0 112.649 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.0 p -127.84 35.6 4.46 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.929 -1.107 . . . . 0.0 111.497 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.44 7.71 45.82 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.544 -0.722 . . . . 0.0 110.619 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.47 -38.72 2.99 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -73.42 -50.82 10.88 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.83 98.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.947 -0.737 . . . . 0.0 109.928 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.31 -39.35 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.14 -40.19 94.06 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.883 -0.51 . . . . 0.0 109.941 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 11' ' ' GLY . 97.1 t -59.66 -44.39 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.15 -37.43 94.54 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.05 -39.1 86.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.835 -0.803 . . . . 0.0 110.385 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.68 -40.25 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -38.66 87.2 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tp -72.82 -38.64 67.09 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.943 -0.473 . . . . 0.0 110.122 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.4 m -65.73 -25.02 67.1 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.709 -0.619 . . . . 0.0 110.413 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.484 HD11 ' CE1' ' A' ' 26' ' ' TYR . 1.4 tm? -63.84 -57.53 9.58 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.417 -0.802 . . . . 0.0 110.46 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 67.36 150.45 0.12 Allowed Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -72.45 157.17 53.48 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.301 1.334 . . . . 0.0 110.614 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 55.14 50.84 14.38 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.247 0.546 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' CE1' HD11 ' A' ' 22' ' ' LEU . 2.4 p90 -105.19 -18.44 14.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.62 -0.675 . . . . 0.0 111.992 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 3.6 tppt? . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.322 -0.861 . . . . 0.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttm . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -133.18 158.36 43.03 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.721 -0.612 . . . . 0.0 110.489 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.1 mtm-85 -74.55 -51.86 13.46 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.778 -0.577 . . . . 0.0 110.605 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 49.99 36.99 12.94 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.0 mtt 52.12 49.47 20.56 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.864 -0.523 . . . . 0.0 111.835 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.5 -41.31 12.12 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.479 -0.763 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.51 -58.75 2.0 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.412 -0.805 . . . . 0.0 110.969 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.2 m 50.11 41.95 24.36 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.051 -0.406 . . . . 0.0 111.283 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.14 58.37 5.62 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.33 0.586 . . . . 0.0 111.962 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.19 15.14 72.01 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -103.05 -30.59 5.37 Favored Glycine 0 N--CA 1.495 2.577 0 CA-C-N 118.54 1.17 . . . . 0.0 110.248 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.64 94.19 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 118.053 0.927 . . . . 0.0 110.598 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.72 -46.47 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.22 -49.71 66.33 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.735 -0.603 . . . . 0.0 109.717 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.28 -39.2 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.48 -43.94 98.31 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -43.23 99.3 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.822 -0.811 . . . . 0.0 109.871 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -59.92 -40.23 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.501 -0.749 . . . . 0.0 109.474 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.576 ' O ' HD12 ' A' ' 22' ' ' LEU . 6.6 tt -72.84 -37.73 67.35 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.949 -0.47 . . . . 0.0 110.576 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.54 -37.7 42.21 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.72 -0.613 . . . . 0.0 111.327 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.2 m -73.88 -4.35 34.45 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.533 -0.729 . . . . 0.0 112.289 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -55.59 -19.16 9.32 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 120.805 -1.185 . . . . 0.0 112.595 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.745 ' N ' HD13 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -59.28 129.73 86.75 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.332 -0.855 . . . . 0.0 110.746 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.53 158.75 56.13 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.6 1.316 . . . . 0.0 110.175 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -104.87 51.51 0.76 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.497 0.665 . . . . 0.0 109.863 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -93.26 168.58 10.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.618 -0.676 . . . . 0.0 110.413 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 117.715 -1.136 . . . . 0.0 109.932 179.801 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -155.16 -45.87 0.08 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.932 -0.48 . . . . 0.0 111.443 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.6 mtt-85 60.69 69.21 0.7 Allowed 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.455 0.645 . . . . 0.0 110.796 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.07 -34.55 73.6 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.724 -0.61 . . . . 0.0 110.469 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.3 mtm -120.8 -70.73 0.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.573 -0.705 . . . . 0.0 109.321 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 7' ' ' ALA . . . 40.89 51.98 3.22 Favored 'General case' 0 N--CA 1.506 2.358 0 C-N-CA 122.688 0.395 . . . . 0.0 111.438 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.458 ' O ' ' HA3' ' A' ' 11' ' ' GLY . . . 63.92 100.21 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.488 0.661 . . . . 0.0 109.885 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 m -96.11 -51.46 4.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.458 -0.776 . . . . 0.0 109.885 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.79 -49.53 77.14 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.72 31.61 8.18 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -105.3 -45.07 1.39 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.27 -48.23 62.28 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 118.198 0.999 . . . . 0.0 111.298 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.48 -43.88 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.701 -0.625 . . . . 0.0 109.331 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -69.88 -39.02 76.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.873 -0.517 . . . . 0.0 110.313 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 11' ' ' GLY . 41.2 t -58.55 -40.81 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.795 -0.566 . . . . 0.0 109.685 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.25 -45.63 96.1 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.39 -42.73 87.46 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.98 -0.718 . . . . 0.0 109.433 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.06 -42.06 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -39.99 95.85 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.798 -0.564 . . . . 0.0 109.819 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.24 -36.73 78.41 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.949 -0.47 . . . . 0.0 109.862 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.6 m -81.61 -45.84 15.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.647 -0.658 . . . . 0.0 109.526 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.65 -42.89 97.91 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 122.081 -0.387 . . . . 0.0 110.347 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.4 m -112.87 89.92 14.43 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.709 -0.619 . . . . 0.0 109.869 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.17 90.12 1.01 Allowed 'Trans proline' 0 N--CA 1.489 1.233 0 O-C-N 123.771 1.406 . . . . 0.0 110.081 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -128.26 31.74 4.99 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.756 -0.59 . . . . 0.0 111.068 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.02 87.78 2.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.3 -0.875 . . . . 0.0 109.622 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.998 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -133.06 118.73 19.12 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.935 -0.478 . . . . 0.0 110.425 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.5 mtt-85 -77.46 -31.85 54.03 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.931 -0.481 . . . . 0.0 111.401 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -55.87 -43.93 77.64 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.896 -0.502 . . . . 0.0 110.433 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -88.26 -73.85 0.48 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.629 -0.669 . . . . 0.0 109.202 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.67 18.51 3.72 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.22 2.63 5.18 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.914 -1.116 . . . . 0.0 112.168 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.613 ' CB ' HG23 ' A' ' 13' ' ' VAL . 56.9 m -106.12 33.86 3.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.933 -1.104 . . . . 0.0 110.901 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.72 21.22 2.56 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.69 43.0 53.31 Favored Glycine 0 N--CA 1.502 3.05 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.08 -49.09 0.02 OUTLIER Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.49 -44.52 46.13 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-N 117.795 0.797 . . . . 0.0 111.244 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.613 HG23 ' CB ' ' A' ' 8' ' ' SER . 19.8 t -56.27 -42.08 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.986 -0.446 . . . . 0.0 109.993 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -67.91 -41.35 82.78 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.762 -0.586 . . . . 0.0 109.863 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.17 -41.02 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.724 -0.61 . . . . 0.0 109.596 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.01 -37.96 94.88 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -41.47 89.92 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.965 -0.726 . . . . 0.0 110.25 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.73 -38.92 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.33 -39.65 94.32 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.83 -29.87 68.29 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.893 -0.504 . . . . 0.0 110.089 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 m -100.1 39.65 1.32 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.635 -0.666 . . . . 0.0 109.455 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tp -119.81 -78.73 0.59 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.147 -0.971 . . . . 0.0 109.893 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 p -167.62 139.46 2.55 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.387 -0.821 . . . . 0.0 110.853 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.52 89.89 1.24 Allowed 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.844 1.444 . . . . 0.0 110.157 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -64.67 -43.85 92.26 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.729 -0.607 . . . . 0.0 110.751 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -149.27 159.75 43.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.675 -0.641 . . . . 0.0 110.716 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 tptt . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.108 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 120.831 0.348 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.37 175.54 7.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.843 -0.536 . . . . 0.0 110.83 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.15 -167.9 2.58 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.99 19.06 5.57 Favored 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.1 tpt -129.37 -39.7 1.49 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.85 -1.156 . . . . 0.0 111.105 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.28 -36.9 33.45 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.784 -0.572 . . . . 0.0 112.318 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.53 -45.16 10.13 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.305 -0.872 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 p -66.01 -34.63 78.53 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.447 -0.783 . . . . 0.0 111.229 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.38 69.89 4.29 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.193 -0.942 . . . . 0.0 109.844 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.8 -65.48 0.51 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.08 87.07 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.04 -37.13 78.91 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 117.847 0.824 . . . . 0.0 110.68 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.1 t -66.01 -46.08 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.11 -48.7 67.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.635 -0.666 . . . . 0.0 109.807 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.32 -37.7 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.49 -40.32 98.53 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 tt -67.19 -46.08 74.98 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 122.012 -0.699 . . . . 0.0 109.664 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -62.17 -41.53 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tt -65.61 -40.21 92.38 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -37.29 78.95 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 122.02 -0.425 . . . . 0.0 110.187 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -72.86 -33.01 65.82 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.554 -0.716 . . . . 0.0 109.745 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.74 -63.0 1.21 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.61 -0.682 . . . . 0.0 109.72 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.9 m 55.17 93.59 0.05 OUTLIER Pre-proline 0 N--CA 1.504 2.233 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.21 82.5 2.03 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 O-C-N 123.425 1.224 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -106.18 -51.12 3.02 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -92.16 -45.25 8.36 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.8 pttt . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.813 179.593 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mmt . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 t70 65.18 -76.36 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 122.81 0.444 . . . . 0.0 111.176 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.63 66.94 9.9 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.372 -0.83 . . . . 0.0 109.542 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -158.06 -59.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.0 ptm -50.7 -29.13 10.5 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.09 -48.05 77.67 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.529 -0.732 . . . . 0.0 111.002 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.81 -54.77 2.32 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.598 -0.689 . . . . 0.0 110.479 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -76.42 -171.92 1.97 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.703 -0.623 . . . . 0.0 110.324 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 8' ' ' SER . . . 74.76 -52.36 0.68 Allowed 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.063 0.545 . . . . 0.0 112.081 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.68 -53.43 25.57 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.66 -40.94 99.44 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.0 -33.42 74.3 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.986 -0.714 . . . . 0.0 110.673 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 9' ' ' ALA . 80.0 t -67.83 -45.91 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.461 -0.774 . . . . 0.0 109.273 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -69.23 -47.22 65.35 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.545 -0.722 . . . . 0.0 109.914 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.7 t -64.95 -43.24 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.52 -38.89 97.0 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -43.39 98.95 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 117.652 0.726 . . . . 0.0 109.679 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.55 -40.26 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.506 ' HA ' HD12 ' A' ' 22' ' ' LEU . 3.2 mm? -68.73 -42.08 78.12 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.876 -0.515 . . . . 0.0 109.813 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 20' ' ' LEU . 13.2 tp -62.03 -35.65 79.21 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.047 -0.408 . . . . 0.0 110.403 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 54.8 m -68.87 -31.17 69.91 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.592 -0.692 . . . . 0.0 109.782 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 19' ' ' LEU . 17.0 mt -68.85 -55.64 10.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.637 -0.665 . . . . 0.0 110.171 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.68 99.88 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.251 0 O-C-N 122.236 -0.29 . . . . 0.0 111.394 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.22 60.78 7.53 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 O-C-N 123.368 1.194 . . . . 0.0 110.054 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.1 m80 56.37 40.77 29.64 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 121.309 0.576 . . . . 0.0 110.568 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.54 92.34 3.72 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 109.782 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.138 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ttt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.586 0.707 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -154.62 141.7 19.34 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.732 -0.605 . . . . 0.0 109.879 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -117.77 176.03 5.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.487 -0.758 . . . . 0.0 111.135 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 60.55 19.98 9.8 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.8 mtt -139.06 -64.58 0.5 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.78 88.27 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.0 -23.52 28.64 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.833 -0.542 . . . . 0.0 110.557 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -72.13 -49.41 36.18 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.249 -0.907 . . . . 0.0 109.865 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.18 -50.66 6.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.884 -0.51 . . . . 0.0 110.134 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.3 51.28 1.62 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.66 -86.94 0.06 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.28 -46.85 86.91 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 117.814 0.807 . . . . 0.0 111.309 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.46 -40.77 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -61.58 -51.26 69.25 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.893 -0.505 . . . . 0.0 109.753 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.21 -43.01 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.98 98.56 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -42.13 98.79 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 117.715 0.757 . . . . 0.0 110.313 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.37 -42.02 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.38 -41.29 69.85 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 tp -60.53 -33.57 72.85 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.946 -0.471 . . . . 0.0 110.922 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 m -62.24 -38.88 90.94 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.502 -0.749 . . . . 0.0 110.083 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.57 50.55 1.17 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.596 -0.69 . . . . 0.0 109.801 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 t -106.41 118.42 54.7 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.23 -0.919 . . . . 0.0 110.757 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -79.46 93.54 1.08 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.795 1.418 . . . . 0.0 109.747 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -113.49 25.68 11.07 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.508 -0.745 . . . . 0.0 111.507 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -99.38 78.85 2.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.064 -1.022 . . . . 0.0 109.606 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.1 tptt . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 117.293 -1.337 . . . . 0.0 110.841 -179.88 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtm . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 120.951 0.405 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.04 169.26 18.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.786 -0.571 . . . . 0.0 110.459 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -90.99 -90.16 0.16 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.633 -0.667 . . . . 0.0 110.209 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 48.83 32.5 3.74 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 118.871 0.759 . . . . 0.0 112.235 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.39 29.48 15.25 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.685 -0.635 . . . . 0.0 111.278 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.27 -57.48 2.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.362 -0.836 . . . . 0.0 109.894 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.423 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . . . -102.73 87.86 3.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.624 -0.673 . . . . 0.0 109.505 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 m -123.02 124.71 43.73 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.546 ' O ' HG23 ' A' ' 13' ' ' VAL . . . 65.42 -73.16 0.06 Allowed 'General case' 0 N--CA 1.506 2.358 0 C-N-CA 122.804 0.442 . . . . 0.0 110.455 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.16 -50.42 28.08 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 7' ' ' ALA . . . -66.93 -35.24 89.2 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.47 -38.04 73.87 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 117.858 0.829 . . . . 0.0 110.448 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 9' ' ' ALA . 84.5 t -59.54 -38.72 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -74.88 -32.02 61.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.684 -0.635 . . . . 0.0 110.112 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.84 -44.46 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.0 -38.65 94.31 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.36 -45.56 93.05 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 122.02 -0.694 . . . . 0.0 109.266 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.05 -38.63 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.867 ' HA ' HD12 ' A' ' 22' ' ' LEU . 13.5 tp -61.69 -27.01 68.39 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.702 -0.624 . . . . 0.0 109.95 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.48 -38.86 23.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.903 -0.498 . . . . 0.0 110.222 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.89 -15.72 61.58 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.657 -0.652 . . . . 0.0 111.912 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.867 HD12 ' HA ' ' A' ' 19' ' ' LEU . 11.8 mt -58.77 -55.07 39.85 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.458 -0.776 . . . . 0.0 110.898 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 m 62.09 90.9 0.08 OUTLIER Pre-proline 0 N--CA 1.503 2.195 0 C-N-CA 122.459 0.304 . . . . 0.0 110.618 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.75 -28.99 24.62 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 O-C-N 123.498 1.262 . . . . 0.0 111.516 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -129.65 -65.75 0.83 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -158.23 142.3 15.73 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 110.352 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.586 -0.721 . . . . 0.0 109.82 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.16 152.51 38.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.742 -0.599 . . . . 0.0 110.345 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -157.34 -174.54 4.94 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.712 -0.618 . . . . 0.0 110.311 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 59.13 22.93 11.13 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.856 -0.528 . . . . 0.0 111.976 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.78 -45.77 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.575 -0.703 . . . . 0.0 109.947 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.15 43.85 1.15 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.361 -0.837 . . . . 0.0 109.908 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -118.44 -53.47 2.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -108.36 -49.21 3.21 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.26 80.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.924 -0.485 . . . . 0.0 111.138 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.92 69.31 1.92 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.53 -86.8 0.06 OUTLIER Glycine 0 N--CA 1.498 2.786 0 CA-C-N 118.284 1.042 . . . . 0.0 111.058 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.45 79.93 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 122.104 -0.645 . . . . 0.0 111.267 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.02 -42.89 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -65.4 -40.89 93.99 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.112 -0.367 . . . . 0.0 110.062 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.5 t -60.58 -42.2 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 O-C-N 121.613 -0.68 . . . . 0.0 109.278 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.5 -40.35 96.14 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.0 mt -62.73 -46.59 87.36 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.034 -0.686 . . . . 0.0 109.756 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.2 t -52.79 -40.6 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.648 -0.658 . . . . 0.0 109.591 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.58 -46.6 21.71 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.977 -0.452 . . . . 0.0 109.865 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.49 90.73 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.849 -0.532 . . . . 0.0 109.669 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.7 m -66.91 -34.5 77.91 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -38.25 76.88 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.916 -0.49 . . . . 0.0 110.293 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.18 116.58 66.63 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.883 -0.51 . . . . 0.0 110.007 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.16 136.0 26.05 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.597 1.314 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -99.4 -55.66 2.62 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.699 -0.626 . . . . 0.0 109.878 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -134.67 102.28 5.23 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt . . . . . 0 N--CA 1.503 2.191 0 CA-C-O 117.272 -1.347 . . . . 0.0 110.569 -179.485 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.52 -60.85 0.1 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.878 -0.514 . . . . 0.0 110.903 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 56.8 68.23 0.89 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.182 0.515 . . . . 0.0 111.706 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -93.82 -60.33 1.78 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.253 -0.904 . . . . 0.0 109.779 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -145.4 67.81 1.22 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.778 0.799 . . . . 0.0 109.97 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.89 -45.1 8.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.705 -0.622 . . . . 0.0 109.725 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 13' ' ' VAL . . . -156.88 112.95 2.96 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.005 -0.434 . . . . 0.0 109.938 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.541 ' HB2' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER 59.74 -162.46 0.25 Allowed 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.841 -0.537 . . . . 0.0 111.193 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.99 39.82 0.91 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.965 -1.084 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.2 38.12 88.89 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.6 -54.64 0.01 OUTLIER Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.27 -50.54 71.09 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 118.065 0.933 . . . . 0.0 111.007 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.61 HG21 ' HB1' ' A' ' 7' ' ' ALA . 12.1 t -65.74 -32.44 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.666 -0.646 . . . . 0.0 110.247 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -71.94 -42.37 66.7 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.53 -0.731 . . . . 0.0 110.235 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -56.65 -45.33 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.749 -0.594 . . . . 0.0 109.443 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.11 -33.86 88.38 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 tp -77.39 -35.81 54.02 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.68 -0.894 . . . . 0.0 110.171 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.41 -45.6 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.578 -0.701 . . . . 0.0 109.648 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -36.1 82.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.775 -0.578 . . . . 0.0 109.834 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tp -77.32 -35.5 54.8 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.74 -0.6 . . . . 0.0 110.344 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -64.5 -23.94 67.45 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.78 -0.575 . . . . 0.0 110.9 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -75.27 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.393 -0.817 . . . . 0.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.452 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 54.91 -172.55 0.01 OUTLIER Pre-proline 0 N--CA 1.507 2.386 0 CA-C-N 118.656 0.662 . . . . 0.0 111.004 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 23' ' ' SER . 50.6 Cg_endo -75.76 68.87 6.27 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.411 0.741 . . . . 0.0 110.729 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -109.32 -50.88 2.94 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.34 -0.85 . . . . 0.0 110.261 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -83.47 75.28 10.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.61 -0.682 . . . . 0.0 109.762 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 117.268 -1.349 . . . . 0.0 111.373 -179.972 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mtp . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 t70 66.66 -65.65 0.2 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 122.963 0.505 . . . . 0.0 111.766 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.97 -6.28 48.77 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.408 -0.808 . . . . 0.0 111.388 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.15 -45.35 87.56 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.293 -0.88 . . . . 0.0 109.912 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.02 -32.31 63.3 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.829 -0.544 . . . . 0.0 109.846 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.85 -28.92 69.19 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.903 -0.498 . . . . 0.0 111.016 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.19 80.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.657 -0.652 . . . . 0.0 110.209 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 m -94.43 28.42 2.59 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.537 -0.727 . . . . 0.0 110.95 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 13' ' ' VAL . . . -65.66 -39.46 91.41 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.155 -0.965 . . . . 0.0 110.45 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.42 85.24 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -64.13 -40.88 98.48 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.61 91.53 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 117.795 0.798 . . . . 0.0 110.054 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 9' ' ' ALA . 77.7 t -61.29 -40.78 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.21 -40.23 93.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.961 -0.462 . . . . 0.0 109.957 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 11' ' ' GLY . 90.9 t -62.19 -43.77 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.02 -37.34 94.13 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.9 -44.29 93.44 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.967 -0.725 . . . . 0.0 110.012 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.6 t -58.67 -43.63 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.92 -39.44 93.53 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.47 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -60.59 -41.78 95.41 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.9 -0.5 . . . . 0.0 109.99 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 49.5 m -69.31 -29.16 66.95 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.66 -0.65 . . . . 0.0 110.526 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.62 -29.02 62.11 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.471 -0.768 . . . . 0.0 110.563 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.36 73.69 0.53 Allowed Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.927 -0.483 . . . . 0.0 110.708 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.82 69.5 6.86 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.464 1.244 . . . . 0.0 109.974 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -118.41 -35.3 3.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.758 -0.589 . . . . 0.0 111.054 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 61.16 -168.19 0.18 Allowed 'General case' 0 N--CA 1.505 2.314 0 CA-C-N 118.2 0.455 . . . . 0.0 110.693 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.379 0 C-N-CA 123.082 0.553 . . . . 0.0 111.286 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ptp . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.073 0.463 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -133.38 -54.82 0.9 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.65 -0.656 . . . . 0.0 110.334 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 16.5 mtm105 -72.49 106.19 4.48 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.478 -0.764 . . . . 0.0 109.224 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -96.03 -55.49 2.95 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.999 -0.438 . . . . 0.0 109.984 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -42.52 17.31 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.528 -0.732 . . . . 0.0 110.089 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.48 82.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.799 -0.563 . . . . 0.0 111.139 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 3' ' ' ARG . . . -91.63 23.81 3.37 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.498 -0.751 . . . . 0.0 111.745 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.4 t -87.3 61.68 6.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.07 -1.019 . . . . 0.0 109.958 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 15' ' ' VAL . . . 39.75 83.82 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 122.927 0.491 . . . . 0.0 111.177 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.58 -65.42 4.02 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 12' ' ' ALA . . . 149.94 51.74 0.02 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . 75.45 -47.96 0.61 Allowed 'General case' 0 N--CA 1.511 2.591 0 CA-C-N 117.886 0.843 . . . . 0.0 110.688 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.2 -44.9 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 9' ' ' ALA . 12.8 t80 -75.67 -32.43 60.15 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.137 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.81 HG22 ' HB3' ' A' ' 9' ' ' ALA . 72.6 t -60.45 -44.43 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.661 -0.65 . . . . 0.0 110.049 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.02 97.88 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.76 -44.97 79.99 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.809 -0.818 . . . . 0.0 110.111 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.96 -42.0 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.02 -33.27 70.55 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.921 -0.487 . . . . 0.0 109.7 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tt -71.39 -44.8 64.27 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.9 -0.5 . . . . 0.0 109.826 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.0 m -75.11 -29.59 60.62 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.668 -0.645 . . . . 0.0 110.889 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.08 62.35 0.88 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.888 0.852 . . . . 0.0 108.99 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.0 t -117.07 78.07 9.57 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.786 -0.571 . . . . 0.0 110.561 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -86.11 70.51 4.48 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 121.256 1.304 . . . . 0.0 109.475 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 57.52 57.65 4.22 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.649 0.738 . . . . 0.0 109.982 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -121.35 162.18 20.79 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.464 -0.773 . . . . 0.0 110.965 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt . . . . . 0 N--CA 1.499 2.007 0 CA-C-O 117.701 -1.143 . . . . 0.0 110.115 179.761 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -110.57 38.72 2.39 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.537 0.684 . . . . 0.0 110.463 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.51 -47.28 2.45 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 0.3 OUTLIER -92.34 -38.14 12.21 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.475 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.9 mtm -92.04 19.0 7.2 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.64 -0.662 . . . . 0.0 111.771 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.7 -66.9 0.87 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.152 -0.968 . . . . 0.0 109.118 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.79 21.37 0.79 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.729 -0.607 . . . . 0.0 111.494 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 4' ' ' GLU . 6.1 p -107.24 -50.57 3.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.329 -0.857 . . . . 0.0 110.377 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.83 73.1 5.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.175 -0.953 . . . . 0.0 110.009 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.36 -82.3 0.05 OUTLIER Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.872 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.14 -47.89 84.11 Favored Glycine 0 N--CA 1.503 3.156 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.51 75.95 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.049 -0.677 . . . . 0.0 110.654 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.58 -44.97 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.76 -0.588 . . . . 0.0 109.743 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.74 -48.41 66.53 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.65 -0.656 . . . . 0.0 110.424 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.3 t -67.33 -40.13 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.776 -0.577 . . . . 0.0 109.79 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.55 99.24 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -45.22 94.36 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 117.752 0.776 . . . . 0.0 109.825 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.522 ' O ' HG22 ' A' ' 21' ' ' THR . 66.5 t -63.98 -41.76 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tp -65.57 -33.29 75.56 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.61 -0.681 . . . . 0.0 109.665 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -36.52 74.04 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.567 -0.708 . . . . 0.0 110.326 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -69.69 -24.12 63.54 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.347 -0.845 . . . . 0.0 111.367 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.47 -32.83 8.35 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.363 -0.835 . . . . 0.0 111.008 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.67 167.24 0.12 Allowed Pre-proline 0 N--CA 1.504 2.262 0 C-N-CA 122.749 0.42 . . . . 0.0 111.276 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.76 63.46 4.55 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.202 1.268 . . . . 0.0 109.556 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 52.12 46.16 27.1 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.291 0.567 . . . . 0.0 110.637 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -126.92 124.95 40.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.414 -0.803 . . . . 0.0 110.854 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 tptp . . . . . 0 N--CA 1.505 2.292 0 CA-C-O 119.028 -0.51 . . . . 0.0 111.2 179.909 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 120.639 0.257 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -89.84 -47.59 7.79 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.242 -0.912 . . . . 0.0 109.459 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -103.17 -14.98 16.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.746 -0.596 . . . . 0.0 111.07 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.7 -48.06 42.07 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.361 -0.837 . . . . 0.0 110.99 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.6 ttm -76.59 -45.4 30.47 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.716 -0.615 . . . . 0.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.59 36.03 19.56 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.966 -0.459 . . . . 0.0 111.883 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 51.79 44.57 29.21 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.709 -0.619 . . . . 0.0 112.546 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -92.85 0.66 57.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.45 -0.781 . . . . 0.0 111.167 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 14' ' ' PHE . . . 52.94 56.57 7.38 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.375 -0.828 . . . . 0.0 109.266 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 14' ' ' PHE . . . 80.35 -63.18 4.2 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.548 ' O ' ' HB3' ' A' ' 12' ' ' ALA . . . 146.63 50.39 0.03 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . 75.48 -48.44 0.61 Allowed 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 123.494 0.718 . . . . 0.0 110.27 -179.292 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.41 -45.38 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.837 -0.539 . . . . 0.0 109.571 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.46 ' CB ' ' HA3' ' A' ' 10' ' ' GLY . 20.7 t80 -67.0 -35.15 79.31 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.109 -0.369 . . . . 0.0 110.842 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.43 -46.63 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.46 -37.94 86.19 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -43.29 96.92 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 122.021 -0.694 . . . . 0.0 109.751 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -59.7 -40.75 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.389 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.81 -42.96 97.57 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.9 tt -59.58 -45.69 91.13 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.925 -0.484 . . . . 0.0 109.985 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.5 m -64.22 -34.04 77.18 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.899 -0.501 . . . . 0.0 109.929 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -63.52 -33.76 76.28 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.702 -0.624 . . . . 0.0 109.652 179.348 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -82.06 118.85 73.56 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.47 132.54 22.4 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.232 1.288 . . . . 0.0 111.445 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -143.91 64.4 1.32 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.557 -0.714 . . . . 0.0 110.679 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -103.93 70.2 0.99 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.199 -0.938 . . . . 0.0 110.697 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.224 0 O-C-N 121.453 -0.78 . . . . 0.0 111.255 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 120.886 0.374 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -105.38 148.74 26.78 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.729 -0.607 . . . . 0.0 110.042 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 58.88 -94.61 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 122.477 0.311 . . . . 0.0 111.336 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 55.67 18.34 2.79 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-N 118.984 0.811 . . . . 0.0 112.793 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.79 -60.43 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.079 -1.013 . . . . 0.0 109.391 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 57.03 33.58 23.57 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.193 0.52 . . . . 0.0 111.057 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.613 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -152.2 -76.64 0.13 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.527 -0.733 . . . . 0.0 109.358 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.6 m 57.33 -76.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.58 -40.84 28.73 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.679 -0.638 . . . . 0.0 112.638 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA3' HG23 ' A' ' 15' ' ' VAL . . . -89.75 34.48 4.04 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 52.88 30.19 36.2 Favored Glycine 0 N--CA 1.497 2.738 0 CA-C-N 118.52 1.16 . . . . 0.0 110.483 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.417 ' HA ' ' CB ' ' A' ' 7' ' ' ALA . . . 53.94 26.94 6.73 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 118.045 0.923 . . . . 0.0 110.935 -179.205 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.1 t -142.56 -60.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.463 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 51.9 t80 -55.05 -32.8 62.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.613 HG21 ' CA ' ' A' ' 7' ' ' ALA . 17.8 t -56.36 -43.23 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.93 -40.59 97.31 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -40.92 98.13 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.93 -0.747 . . . . 0.0 109.602 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 14' ' ' PHE . 71.9 t -60.27 -40.48 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.421 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 19' ' ' LEU . 2.0 mm? -63.31 -40.69 98.03 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 tt -63.55 -36.65 84.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.038 -0.414 . . . . 0.0 110.111 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.5 m -68.08 -32.23 72.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.515 -0.741 . . . . 0.0 109.943 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -79.11 -63.94 1.3 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.631 -0.668 . . . . 0.0 110.142 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 p -165.9 95.11 0.8 Allowed Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.674 -0.642 . . . . 0.0 110.848 -179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -84.53 96.46 0.69 Allowed 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 121.293 1.329 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -109.55 -35.96 6.09 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.396 -0.815 . . . . 0.0 111.102 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.57 147.31 50.92 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.504 -0.748 . . . . 0.0 110.619 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 117.724 -1.131 . . . . 0.0 110.39 -179.931 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptp . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 120.707 0.289 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -79.39 161.71 26.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.533 -0.729 . . . . 0.0 110.611 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.8 ttm-85 51.78 47.8 24.08 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.086 0.47 . . . . 0.0 111.473 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.92 -39.54 14.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.453 -0.779 . . . . 0.0 109.853 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 11.9 ttm -106.62 -21.1 13.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.789 -0.569 . . . . 0.0 110.854 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.35 -50.48 63.4 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.202 -0.936 . . . . 0.0 110.727 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.33 74.64 1.12 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.625 0.726 . . . . 0.0 109.741 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.8 p -121.86 26.23 8.75 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.769 -0.582 . . . . 0.0 111.475 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.09 -60.91 0.57 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.333 -0.854 . . . . 0.0 110.035 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.19 -43.65 1.85 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -59.06 -47.78 89.1 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.05 90.75 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 118.024 0.912 . . . . 0.0 110.221 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.6 -39.37 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -63.96 -43.43 95.8 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.859 -0.525 . . . . 0.0 110.229 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 11' ' ' GLY . 88.5 t -60.76 -42.47 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.662 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.87 -39.76 97.69 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -42.36 96.49 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.085 -0.656 . . . . 0.0 110.228 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.06 -40.08 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 19' ' ' LEU . 3.0 mm? -68.24 -45.15 74.02 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -40.73 89.4 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.949 -0.47 . . . . 0.0 110.496 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -66.05 -37.89 86.99 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.751 -0.593 . . . . 0.0 109.619 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -60.91 -41.76 96.77 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.738 -0.601 . . . . 0.0 110.041 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 p -77.25 155.24 82.16 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.727 -0.608 . . . . 0.0 109.446 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.72 79.75 1.86 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.752 1.396 . . . . 0.0 111.023 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -86.01 -29.12 23.73 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.665 -0.647 . . . . 0.0 111.535 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 59.12 79.65 0.22 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.914 -0.491 . . . . 0.0 109.849 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.13 0 C-N-CA 122.856 0.462 . . . . 0.0 110.584 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ttp . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -133.97 28.28 3.84 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.878 -0.514 . . . . 0.0 111.548 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.64 56.48 7.57 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.668 -0.645 . . . . 0.0 112.318 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -137.66 -45.69 0.54 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.288 -0.882 . . . . 0.0 111.377 179.603 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.91 -11.02 20.1 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.282 -0.886 . . . . 0.0 112.233 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.84 -28.03 67.2 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.078 -1.014 . . . . 0.0 111.871 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.86 -62.11 1.95 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.345 -0.847 . . . . 0.0 110.83 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 m 54.05 -164.64 0.1 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.667 -0.646 . . . . 0.0 110.801 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 14' ' ' PHE . . . -90.9 89.43 7.45 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.919 -1.113 . . . . 0.0 109.282 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.627 ' HA3' ' CB ' ' A' ' 14' ' ' PHE . . . 106.69 -11.82 42.22 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.146 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 12' ' ' ALA . . . 100.48 34.01 4.9 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 119.301 1.551 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . 73.8 -46.49 0.63 Allowed 'General case' 0 N--CA 1.506 2.364 0 CA-C-N 118.084 0.942 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.86 -48.46 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-O 121.331 0.586 . . . . 0.0 109.57 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CB ' ' HA3' ' A' ' 10' ' ' GLY . 47.4 t80 -60.51 -39.27 87.18 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.6 -44.51 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.684 -0.635 . . . . 0.0 109.539 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.49 -38.84 96.95 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tt -64.5 -43.86 92.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.939 -0.742 . . . . 0.0 110.018 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.2 -38.2 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 mt -62.58 -40.62 97.48 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tp -63.07 -25.77 68.53 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 122.129 -0.357 . . . . 0.0 111.191 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.8 m -102.51 -11.12 18.78 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -0.759 . . . . 0.0 111.719 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.61 -44.31 2.55 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.829 -1.169 . . . . 0.0 111.944 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.1 t -89.68 113.01 55.17 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.224 -0.922 . . . . 0.0 111.304 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -77.31 92.1 1.14 Allowed 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.56 1.295 . . . . 0.0 110.266 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -83.11 -49.71 9.23 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.721 -0.612 . . . . 0.0 109.762 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -125.76 69.8 1.19 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 117.543 -1.218 . . . . 0.0 110.58 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.9 ttp . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.01 33.28 4.95 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.927 -0.483 . . . . 0.0 110.944 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -77.96 89.63 4.14 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.438 -0.789 . . . . 0.0 109.769 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -137.83 -63.94 0.56 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.847 -0.533 . . . . 0.0 110.219 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -117.26 25.18 10.64 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.59 -0.693 . . . . 0.0 111.115 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.23 -43.59 7.29 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.29 -0.881 . . . . 0.0 109.563 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.32 -35.93 66.13 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.963 -0.461 . . . . 0.0 109.961 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.1 m -98.73 47.52 0.98 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.716 -0.615 . . . . 0.0 110.312 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.21 -26.23 13.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.34 -0.85 . . . . 0.0 111.236 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.577 ' HA3' ' HB3' ' A' ' 14' ' ' PHE . . . -89.43 31.87 4.98 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.272 -0.892 . . . . 0.0 111.126 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.9 29.82 27.99 Favored Glycine 0 N--CA 1.497 2.762 0 CA-C-N 118.637 1.219 . . . . 0.0 111.544 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.36 14.68 3.87 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 118.463 1.132 . . . . 0.0 111.546 -179.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.7 t -128.29 -58.07 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.577 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 31.7 t80 -55.59 -37.12 67.66 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.271 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.466 HG23 ' HA3' ' A' ' 10' ' ' GLY . 53.5 t -60.61 -43.56 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.247 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.59 -37.18 93.35 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mp -63.86 -39.92 95.35 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.904 -0.763 . . . . 0.0 109.975 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.6 t -61.33 -41.23 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.217 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -37.61 85.59 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.089 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -40.94 82.98 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.13 -0.356 . . . . 0.0 110.213 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -65.28 -25.14 67.51 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.826 -0.546 . . . . 0.0 110.874 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.87 -60.77 3.14 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.551 -0.718 . . . . 0.0 110.495 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.76 96.86 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.229 0 C-N-CA 122.442 0.297 . . . . 0.0 111.537 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.38 134.91 23.52 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.345 1.364 . . . . 0.0 111.2 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -82.1 -46.71 13.49 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.711 -0.618 . . . . 0.0 111.04 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 t80 56.3 45.07 23.66 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.071 0.462 . . . . 0.0 110.83 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.505 2.304 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.458 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpt . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.42 0.628 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -156.71 146.23 20.64 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.799 -0.563 . . . . 0.0 110.258 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.47 43.29 0.19 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.561 -0.712 . . . . 0.0 110.939 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -132.26 -58.03 0.95 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.35 -0.844 . . . . 0.0 110.58 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.5 ttt -114.1 36.05 3.88 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.559 -0.713 . . . . 0.0 110.95 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.02 -39.16 88.71 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.482 -0.761 . . . . 0.0 110.944 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.41 -99.81 0.09 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.564 -0.71 . . . . 0.0 109.247 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.54 17.68 1.73 Allowed 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 119.334 0.97 . . . . 0.0 112.749 179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.7 -42.83 40.06 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.041 -1.037 . . . . 0.0 109.124 179.652 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.27 27.96 16.95 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 179.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.64 -42.79 1.2 Allowed Glycine 0 N--CA 1.496 2.657 0 CA-C-N 118.463 1.132 . . . . 0.0 110.408 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.73 -54.35 47.24 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-N 117.875 0.838 . . . . 0.0 111.15 -179.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.7 t -57.54 -37.9 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.756 -0.59 . . . . 0.0 110.181 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.5 -45.57 86.73 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.88 -0.513 . . . . 0.0 110.3 179.638 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.13 -38.6 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.673 -0.642 . . . . 0.0 109.935 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.54 -43.33 99.44 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.27 -45.95 75.11 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.4 t -61.93 -36.13 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.412 -0.805 . . . . 0.0 109.197 179.457 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.14 -33.67 61.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.608 -0.683 . . . . 0.0 110.661 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.93 -38.37 21.13 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.292 -0.88 . . . . 0.0 110.691 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -87.29 -50.97 6.22 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.635 -0.666 . . . . 0.0 111.026 -179.606 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.8 -47.1 8.88 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.609 -0.682 . . . . 0.0 110.315 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.406 ' HB2' ' CE1' ' A' ' 25' ' ' HIS . 13.6 m 69.2 130.51 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.269 0 C-N-CA 123.301 0.64 . . . . 0.0 111.403 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.39 -16.61 19.27 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.344 1.181 . . . . 0.0 112.24 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.406 ' CE1' ' HB2' ' A' ' 23' ' ' SER . 66.8 m80 55.23 45.71 25.21 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.192 0.52 . . . . 0.0 111.278 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -141.69 140.78 33.27 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.392 -0.818 . . . . 0.0 110.201 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 tptt . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.856 179.827 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -135.55 -57.38 0.79 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.764 -0.585 . . . . 0.0 111.586 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -138.89 -135.84 0.13 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.448 -0.782 . . . . 0.0 109.934 -179.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 60.22 75.6 0.4 Allowed 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 118.84 0.745 . . . . 0.0 109.471 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.3 tpp 56.19 30.3 16.29 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.42 -179.346 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 49.89 36.51 11.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 122.016 -0.428 . . . . 0.0 111.167 -179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 54.35 29.33 10.69 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.964 -0.46 . . . . 0.0 112.091 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.7 m -82.52 81.62 8.26 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 0.0 109.975 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.83 -65.99 0.13 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.504 -0.748 . . . . 0.0 111.034 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.78 -27.28 6.75 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.09 -53.95 42.13 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.3 -26.38 62.95 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 118.183 0.992 . . . . 0.0 111.811 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.96 -37.58 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.333 -0.854 . . . . 0.0 110.566 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -105.48 -52.81 2.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.397 -0.814 . . . . 0.0 110.182 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.02 -47.23 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.4 -40.13 97.17 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.54 -43.12 98.03 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.164 -0.61 . . . . 0.0 110.195 179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.95 -40.42 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.69 -0.631 . . . . 0.0 109.544 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 19' ' ' LEU . 3.0 tt -68.8 -30.67 69.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.737 -0.602 . . . . 0.0 110.585 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 tp -76.71 -31.62 57.3 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.393 -0.817 . . . . 0.0 111.032 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.4 m -65.43 -40.21 93.05 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.586 -0.696 . . . . 0.0 111.416 -179.809 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.36 -7.11 13.98 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.361 -0.837 . . . . 0.0 112.425 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.88 163.04 0.13 Allowed Pre-proline 0 N--CA 1.504 2.239 0 CA-C-N 118.717 0.69 . . . . 0.0 111.487 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.45 68.44 8.31 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.554 1.291 . . . . 0.0 110.031 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 56.43 49.16 15.46 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.235 0.541 . . . . 0.0 110.719 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -96.16 -50.71 4.71 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.526 -0.734 . . . . 0.0 110.117 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.388 179.994 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttp . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 120.811 0.338 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -150.84 172.43 15.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.839 -0.538 . . . . 0.0 110.833 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -106.78 34.46 3.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.493 -0.755 . . . . 0.0 110.931 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.19 -40.93 78.38 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.543 -0.723 . . . . 0.0 110.0 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.97 37.65 0.8 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.86 -0.525 . . . . 0.0 109.742 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.92 -53.68 4.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.605 -0.685 . . . . 0.0 109.571 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.67 116.89 3.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.811 -0.556 . . . . 0.0 110.033 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.2 t -128.47 38.56 3.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.723 -0.611 . . . . 0.0 110.244 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 50.08 63.59 2.13 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.802 -0.561 . . . . 0.0 110.34 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 14' ' ' PHE . . . 56.38 31.05 59.36 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.44 27.98 64.15 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 53.95 26.96 6.78 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 118.362 1.081 . . . . 0.0 110.786 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.1 t -139.81 -57.46 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 25.0 t80 -56.18 -32.06 63.99 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.166 179.36 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 t -56.13 -44.22 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.71 -36.03 74.71 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.296 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -63.66 -44.52 93.55 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 117.854 0.827 . . . . 0.0 110.008 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.3 t -60.48 -42.26 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.53 -35.03 79.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.914 -0.491 . . . . 0.0 109.87 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.66 -45.71 74.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.113 -0.367 . . . . 0.0 110.359 179.808 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.5 m -67.43 -23.47 65.54 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.763 -0.586 . . . . 0.0 110.956 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.55 -53.99 46.45 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.448 -0.783 . . . . 0.0 110.753 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 t -152.1 77.66 6.79 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.633 -0.667 . . . . 0.0 110.628 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.77 71.88 6.81 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.528 1.278 . . . . 0.0 110.356 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.45 65.81 1.4 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.675 0.75 . . . . 0.0 110.702 -179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -86.27 -38.55 17.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.693 -0.63 . . . . 0.0 110.295 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.796 -0.565 . . . . 0.0 110.925 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.43 -50.73 72.8 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.86 -0.525 . . . . 0.0 111.365 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.11 -34.37 68.56 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.954 -0.466 . . . . 0.0 110.881 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -53.4 -55.59 23.81 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -85.05 -31.47 23.4 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.617 -0.677 . . . . 0.0 110.47 179.396 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.6 31.31 9.87 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 51.89 39.94 26.96 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.625 -0.672 . . . . 0.0 112.8 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.3 t -83.74 -59.17 2.51 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.298 -0.876 . . . . 0.0 110.795 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.11 -53.73 8.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.61 -0.681 . . . . 0.0 109.816 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.1 71.75 1.89 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 162.21 -77.77 0.16 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.31 -48.79 80.29 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 122.046 -0.679 . . . . 0.0 111.48 -179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.48 -39.23 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.739 -0.601 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -65.74 -40.67 92.37 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.833 -0.542 . . . . 0.0 110.084 179.548 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 11' ' ' GLY . 83.6 t -62.06 -39.47 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.651 -0.655 . . . . 0.0 109.79 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.84 95.53 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.648 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.34 -43.03 87.25 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.917 -0.755 . . . . 0.0 110.316 179.685 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.3 t -58.95 -39.71 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.88 -39.88 91.08 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.841 -0.537 . . . . 0.0 109.731 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 tt -60.12 -45.05 94.29 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.548 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.552 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 12.6 m -68.83 -36.17 77.87 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.831 -0.543 . . . . 0.0 110.012 179.528 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.36 -40.45 82.29 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.974 -0.454 . . . . 0.0 109.936 179.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.44 144.17 52.87 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.676 -0.64 . . . . 0.0 109.413 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.94 87.34 0.71 Allowed 'Trans proline' 0 N--CA 1.492 1.419 0 O-C-N 123.624 1.328 . . . . 0.0 110.531 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -149.07 60.73 1.05 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.663 -0.648 . . . . 0.0 110.456 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.552 ' CE1' ' HA ' ' A' ' 21' ' ' THR . 11.0 m-85 -132.7 130.45 40.07 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.351 -0.843 . . . . 0.0 110.183 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.819 -0.55 . . . . 0.0 111.506 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptt? . . . . . 0 N--CA 1.5 2.041 0 CA-C-O 120.359 0.123 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 61.57 107.84 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.262 0.553 . . . . 0.0 111.471 179.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 6' ' ' ALA . 0.2 OUTLIER -115.03 91.82 3.74 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.23 -0.918 . . . . 0.0 111.144 -179.817 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 47.36 49.16 15.95 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-O 121.091 0.472 . . . . 0.0 111.013 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.7 mmm 61.18 38.63 16.65 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.092 0.472 . . . . 0.0 110.762 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 3' ' ' ARG . . . -69.8 -41.4 75.11 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.37 -0.831 . . . . 0.0 110.76 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.548 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . . . -167.48 80.07 0.19 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.468 0.651 . . . . 0.0 110.517 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 56.0 p -130.42 121.37 25.77 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.472 -0.767 . . . . 0.0 109.757 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 8' ' ' SER . . . 66.53 -69.35 0.12 Allowed 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.413 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.57 17.73 58.48 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.065 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 7' ' ' ALA . . . -65.14 -50.98 54.4 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.21 80.51 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.196 -0.59 . . . . 0.0 109.814 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.57 -40.97 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.378 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -63.99 -38.75 92.22 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.929 -0.482 . . . . 0.0 110.152 179.479 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 11' ' ' GLY . 85.1 t -58.82 -43.65 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.9 -37.77 93.6 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.179 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.89 -41.99 95.15 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.007 -0.702 . . . . 0.0 109.821 179.483 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.8 t -59.94 -39.8 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.54 -43.44 89.97 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.243 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.09 -34.55 76.62 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.951 -0.468 . . . . 0.0 109.918 179.529 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -68.74 -38.11 79.91 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.9 tt -60.1 -45.44 92.94 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.874 -0.516 . . . . 0.0 109.977 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.88 159.01 83.98 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.613 -0.679 . . . . 0.0 109.757 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.34 56.41 3.25 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.532 1.28 . . . . 0.0 111.975 -179.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -136.26 25.01 3.24 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.366 -0.833 . . . . 0.0 110.13 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -128.43 168.91 14.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.381 -0.824 . . . . 0.0 110.446 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.083 0 CA-C-O 117.598 -1.191 . . . . 0.0 111.33 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpp? . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 120.68 0.276 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 50.34 40.98 23.92 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.498 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 mmt85 58.13 19.33 5.98 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -88.85 -54.64 4.04 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.126 -0.984 . . . . 0.0 109.035 179.605 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.8 mtt -87.04 12.49 11.23 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.877 -0.515 . . . . 0.0 111.24 179.552 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.29 -47.27 7.28 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.206 -0.934 . . . . 0.0 109.926 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.69 -25.6 14.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.83 -0.544 . . . . 0.0 111.251 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -86.34 22.93 1.69 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.275 -0.891 . . . . 0.0 112.072 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.73 21.05 13.01 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.871 -1.143 . . . . 0.0 111.707 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.653 ' HA3' HG23 ' A' ' 15' ' ' VAL . . . -105.95 20.37 36.2 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.942 -1.099 . . . . 0.0 111.472 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.77 28.47 60.36 Favored Glycine 0 N--CA 1.497 2.719 0 CA-C-N 118.421 1.111 . . . . 0.0 112.015 179.675 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.7 12.79 3.89 Favored 'General case' 0 N--CA 1.508 2.425 0 CA-C-N 118.688 1.244 . . . . 0.0 111.989 -179.502 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 89.0 t -126.65 -56.5 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 179.62 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.5 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 29.7 t80 -59.76 -38.27 81.33 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.256 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.653 HG23 ' HA3' ' A' ' 10' ' ' GLY . 60.4 t -59.58 -45.92 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.912 -0.493 . . . . 0.0 109.713 179.532 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.96 -39.65 97.5 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.685 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 tp -67.84 -40.52 83.69 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 117.946 0.873 . . . . 0.0 110.804 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.22 -42.64 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 tt -69.67 -36.28 75.9 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.315 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.46 -42.11 75.33 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 122.242 -0.286 . . . . 0.0 110.606 179.75 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.7 m -71.84 -17.61 62.13 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.744 -0.598 . . . . 0.0 111.291 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -16.3 59.94 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.105 -0.997 . . . . 0.0 111.731 179.908 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.2 m 56.83 70.19 1.49 Allowed Pre-proline 0 N--CA 1.504 2.253 0 CA-C-N 118.704 0.684 . . . . 0.0 110.766 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.17 107.0 1.65 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.704 1.371 . . . . 0.0 109.929 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -125.71 -42.61 1.91 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.748 -0.595 . . . . 0.0 111.448 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 57.29 63.81 1.78 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.384 0.611 . . . . 0.0 110.105 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.7 mttt . . . . . 0 N--CA 1.499 1.99 0 CA-C-O 117.734 -1.126 . . . . 0.0 110.414 -179.808 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 ttp . . . . . 0 N--CA 1.501 2.082 0 CA-C-O 121.342 0.592 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -157.21 -87.61 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.748 -0.595 . . . . 0.0 109.698 -179.952 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -81.07 -32.08 34.13 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.067 -1.021 . . . . 0.0 110.051 179.592 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.61 -28.14 44.39 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 179.857 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -36.19 83.15 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.34 -0.85 . . . . 0.0 110.015 179.673 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.14 -41.26 67.34 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.229 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.98 -8.16 59.65 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.829 -0.545 . . . . 0.0 110.944 179.319 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.541 ' C ' ' HB2' ' A' ' 14' ' ' PHE . 48.0 m 57.6 56.95 4.57 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.652 . . . . 0.0 110.987 -179.878 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.562 ' HB1' ' HB ' ' A' ' 13' ' ' VAL . . . 41.45 60.72 2.03 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.583 0.706 . . . . 0.0 111.785 179.79 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.64 21.43 79.42 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.748 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.55 36.82 72.43 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.825 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.28 -59.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 117.876 0.838 . . . . 0.0 110.352 -179.942 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.562 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 91.5 t -55.07 -31.53 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.818 -0.551 . . . . 0.0 110.471 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.541 ' HB2' ' C ' ' A' ' 8' ' ' SER . 4.5 t80 -70.92 -42.83 69.37 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.587 -0.696 . . . . 0.0 109.492 179.346 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.09 -44.1 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.625 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.86 -39.46 98.04 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.614 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -66.31 -41.39 89.8 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.957 -0.731 . . . . 0.0 110.163 179.659 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.81 -40.34 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.67 -40.88 93.76 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.407 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tt -69.19 -43.93 73.17 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.453 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.4 m -75.29 -11.8 60.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.986 -0.446 . . . . 0.0 111.687 179.988 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.25 48.19 0.88 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.005 -1.059 . . . . 0.0 110.284 179.934 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.09 100.6 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.319 0 O-C-N 121.881 -0.512 . . . . 0.0 111.938 179.737 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.08 179.97 4.9 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.176 1.25 . . . . 0.0 110.68 179.64 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -144.2 41.15 1.37 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.291 -0.881 . . . . 0.0 111.459 -179.839 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -83.14 114.52 21.39 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.099 -1.001 . . . . 0.0 109.435 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.451 -179.636 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tpt . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.415 0.626 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -72.78 164.06 27.15 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.174 0.511 . . . . 0.0 110.403 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.72 -103.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.532 -0.73 . . . . 0.0 109.977 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.47 32.65 16.58 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 119.714 1.143 . . . . 0.0 111.39 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.7 ptm -168.53 -45.84 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.484 -0.76 . . . . 0.0 111.088 179.598 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.56 -53.41 4.32 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.429 -0.794 . . . . 0.0 110.172 179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.26 75.5 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.849 -0.532 . . . . 0.0 110.747 179.772 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 14' ' ' PHE . 65.9 p -75.79 -20.26 58.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.585 -0.697 . . . . 0.0 111.235 179.576 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.87 47.45 0.75 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.271 -0.893 . . . . 0.0 110.829 179.801 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.82 -0.72 56.32 Favored Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.268 -0.895 . . . . 0.0 110.876 179.694 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -5.88 76.07 Favored Glycine 0 N--CA 1.498 2.786 0 CA-C-N 119.089 1.444 . . . . 0.0 111.531 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.58 -49.53 2.01 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.0 1.4 . . . . 0.0 108.948 179.673 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.42 -52.52 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.628 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 8' ' ' SER . 0.2 OUTLIER -66.11 -47.59 73.67 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.607 -0.683 . . . . 0.0 110.453 179.904 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.82 -39.12 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.947 -0.47 . . . . 0.0 109.926 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.0 -43.16 91.89 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.54 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.77 -43.29 96.85 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 117.601 0.701 . . . . 0.0 110.605 179.764 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.2 t -60.17 -42.77 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.581 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tp -65.41 -39.24 91.91 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.168 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.64 -52.68 64.45 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.438 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.2 m -61.22 -34.04 74.47 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.99 -0.444 . . . . 0.0 110.37 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.67 -39.24 93.34 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.832 -0.543 . . . . 0.0 109.721 179.591 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.6 m -73.15 157.68 88.01 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.875 -0.516 . . . . 0.0 109.987 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.55 93.01 0.5 Allowed 'Trans proline' 0 N--CA 1.492 1.434 0 O-C-N 123.896 1.471 . . . . 0.0 111.465 -179.717 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -57.58 -42.0 82.27 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.861 -0.524 . . . . 0.0 110.834 179.764 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -97.12 107.49 20.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.509 -0.744 . . . . 0.0 109.677 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 117.591 -1.195 . . . . 0.0 110.931 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 120.51 0.195 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 62.74 170.69 0.14 Allowed 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.905 0.86 . . . . 0.0 112.378 179.845 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.73 -52.56 0.75 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.642 -0.662 . . . . 0.0 109.485 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.87 -35.3 79.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.829 -0.544 . . . . 0.0 109.774 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.98 14.54 26.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.558 -0.714 . . . . 0.0 111.084 179.55 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.08 -3.34 21.66 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.226 -0.921 . . . . 0.0 112.054 -179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.33 -47.99 4.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.917 -1.114 . . . . 0.0 110.053 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -65.75 -28.35 68.98 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.761 -0.587 . . . . 0.0 111.395 179.791 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.08 -44.75 79.27 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.219 -0.926 . . . . 0.0 110.514 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.27 49.52 2.69 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.888 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -106.12 -77.23 1.08 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 179.725 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.07 98.6 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.196 -0.591 . . . . 0.0 109.775 179.449 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.65 -41.05 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.392 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 18' ' ' VAL . 26.4 t80 -66.2 -41.16 90.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.902 -0.499 . . . . 0.0 109.97 179.534 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.3 t -57.84 -43.13 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.649 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.73 -40.14 90.03 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.4 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 mt -61.08 -38.78 87.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.874 -0.78 . . . . 0.0 110.094 179.637 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 14' ' ' PHE . 83.9 t -66.2 -40.99 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.522 -0.737 . . . . 0.0 109.127 179.636 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tt -70.4 -42.28 71.89 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.378 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -35.34 78.41 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.818 -0.551 . . . . 0.0 109.531 179.431 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -103.1 34.99 2.67 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.718 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 23' ' ' SER . 0.6 OUTLIER -81.12 -24.39 37.7 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.385 -0.822 . . . . 0.0 111.603 -179.973 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 17.0 m 70.14 160.78 0.15 Allowed Pre-proline 0 N--CA 1.507 2.408 0 CA-C-N 118.202 0.455 . . . . 0.0 111.411 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.37 -173.15 1.21 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 O-C-N 123.478 1.251 . . . . 0.0 111.065 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 60.21 57.85 2.81 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.564 0.697 . . . . 0.0 110.744 -179.963 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -134.75 130.11 35.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.436 -0.79 . . . . 0.0 110.634 179.953 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 120.697 0.284 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 55.21 41.93 31.0 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.176 0.512 . . . . 0.0 111.847 179.901 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.3 114.65 28.51 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.384 -0.823 . . . . 0.0 110.347 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -145.32 -76.32 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.852 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 11.8 mtm -126.78 48.07 2.23 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.13 -0.982 . . . . 0.0 110.218 179.616 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.78 -37.88 8.1 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.526 -0.734 . . . . 0.0 110.565 179.92 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.885 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -132.13 67.89 1.51 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.31 -0.869 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.98 -15.31 15.15 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.793 -0.567 . . . . 0.0 112.305 179.926 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' H ' ' HB2' ' A' ' 14' ' ' PHE . . . -95.54 56.59 1.82 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.882 -1.136 . . . . 0.0 108.721 179.573 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.66 14.65 49.3 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.405 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.885 ' HA2' ' HB1' ' A' ' 7' ' ' ALA . . . 57.03 37.52 79.95 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.73 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.46 -60.31 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.193 -0.593 . . . . 0.0 110.77 -179.776 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.86 -37.58 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 O-C-N 121.749 -0.594 . . . . 0.0 110.278 -179.964 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.464 ' HB2' ' H ' ' A' ' 9' ' ' ALA . 1.7 t80 -62.36 -48.64 78.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.95 -0.469 . . . . 0.0 110.271 179.497 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.5 -43.85 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.965 -0.46 . . . . 0.0 110.349 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.15 -40.5 99.04 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.704 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -43.24 96.75 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.014 -0.698 . . . . 0.0 110.27 179.763 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.51 -42.54 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.735 -0.603 . . . . 0.0 109.668 179.702 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.6 -34.63 77.4 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.867 -0.52 . . . . 0.0 110.228 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tp -70.07 -46.3 65.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.781 -0.574 . . . . 0.0 110.226 179.752 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.9 m -67.96 -29.54 68.61 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.979 -0.451 . . . . 0.0 110.897 179.878 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.68 -61.77 1.89 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.593 -0.692 . . . . 0.0 110.434 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.56 109.71 1.34 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.59 -0.693 . . . . 0.0 109.941 -179.976 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.59 144.14 59.44 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 O-C-N 123.577 1.304 . . . . 0.0 110.673 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -107.71 49.38 0.81 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.752 -0.593 . . . . 0.0 110.475 -179.985 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -88.51 143.18 27.13 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.482 -0.761 . . . . 0.0 109.994 179.724 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 118.677 -0.678 . . . . 0.0 110.41 179.891 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.22 -32.46 15.77 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.069 -0.394 . . . . 0.0 110.786 179.961 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.1 mtm105 -102.73 39.71 1.49 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.279 -0.888 . . . . 0.0 110.137 179.635 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -37.14 85.11 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.906 -0.496 . . . . 0.0 110.045 179.664 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.1 ttp -110.77 25.42 11.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.732 -0.605 . . . . 0.0 110.061 179.356 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.07 -55.86 3.18 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.228 -0.92 . . . . 0.0 110.476 179.848 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.28 17.33 2.77 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.624 -0.672 . . . . 0.0 112.455 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m 50.0 39.67 19.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.325 -0.859 . . . . 0.0 111.633 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.528 ' CB ' ' HB ' ' A' ' 13' ' ' VAL . . . 48.74 63.9 1.92 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.8 0.81 . . . . 0.0 110.449 -179.787 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.45 20.22 77.14 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.573 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.59 42.18 66.24 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.39 -54.85 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 O-C-N 122.14 -0.624 . . . . 0.0 109.959 -179.838 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.528 ' HB ' ' CB ' ' A' ' 9' ' ' ALA . 55.7 t -57.4 -34.75 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.778 -0.576 . . . . 0.0 110.243 179.821 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.06 -50.66 71.08 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.564 -0.71 . . . . 0.0 109.6 179.555 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.1 t -59.57 -37.78 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.618 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.09 99.71 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.722 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.23 -42.24 75.93 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.871 -0.781 . . . . 0.0 110.253 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG12 ' CB ' ' A' ' 23' ' ' SER . 66.3 t -64.55 -38.92 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.454 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.438 ' HA ' ' H ' ' A' ' 23' ' ' SER . 2.2 tt -67.45 -36.48 81.28 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.086 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 tt -61.31 -33.07 72.99 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.643 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.4 m -99.9 29.86 3.99 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.717 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 63.68 83.72 0.16 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.05 0.929 . . . . 0.0 111.598 179.794 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.438 ' H ' ' HA ' ' A' ' 19' ' ' LEU . 26.8 t -71.91 141.74 84.71 Favored Pre-proline 0 N--CA 1.501 2.114 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.605 179.816 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -77.19 87.47 1.5 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.562 1.296 . . . . 0.0 110.283 179.846 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.33 -43.65 12.72 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.679 -0.638 . . . . 0.0 110.262 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.3 59.59 0.68 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.701 -0.624 . . . . 0.0 109.793 179.801 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 117.753 -1.118 . . . . 0.0 110.418 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 2.002 0 CA-C-O 120.875 0.369 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.71 174.37 10.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.874 -0.516 . . . . 0.0 110.56 -179.902 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.677 ' HG2' ' HB2' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -113.84 94.72 4.97 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.48 -0.763 . . . . 0.0 110.625 179.985 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -89.13 -58.23 2.61 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.471 -0.768 . . . . 0.0 109.831 179.763 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -39.14 57.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 110.366 179.686 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.677 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . . . 47.57 43.26 15.95 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 122.016 -0.428 . . . . 0.0 111.96 179.741 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 58.98 89.04 0.06 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.578 0.704 . . . . 0.0 109.792 -179.646 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.459 ' C ' ' HB2' ' A' ' 14' ' ' PHE . 1.5 m -93.96 23.64 4.77 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.63 -0.669 . . . . 0.0 112.061 -179.488 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 14' ' ' PHE . . . 43.16 69.06 0.43 Allowed 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.711 0.767 . . . . 0.0 110.79 179.848 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.62 17.04 72.51 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.463 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.15 33.27 60.86 Favored Glycine 0 N--CA 1.498 2.832 0 CA-C-N 118.545 1.173 . . . . 0.0 110.423 -179.626 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.26 -57.22 0.11 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.902 -0.763 . . . . 0.0 109.104 -179.982 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.443 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 75.5 t -57.13 -36.58 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.544 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 5.6 t80 -84.33 -35.02 23.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.486 -0.759 . . . . 0.0 109.806 179.429 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -57.68 -42.14 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.957 -0.464 . . . . 0.0 110.095 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.22 -43.61 96.8 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.687 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -40.75 95.64 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.886 -0.773 . . . . 0.0 110.632 179.786 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.18 -44.39 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.519 -0.738 . . . . 0.0 109.165 179.559 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 tp -65.94 -38.02 87.55 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.298 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -41.34 90.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.3 m -74.0 -31.59 63.02 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.691 -0.631 . . . . 0.0 110.118 179.574 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.94 -36.26 80.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.737 -0.602 . . . . 0.0 110.987 179.972 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.1 p -125.57 73.71 68.88 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.382 -0.824 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -89.99 52.54 1.3 Allowed 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.166 1.244 . . . . 0.0 110.852 179.764 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -162.46 77.57 0.48 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.917 -1.114 . . . . 0.0 110.953 179.982 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 54.49 67.46 1.01 Allowed 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.203 0.525 . . . . 0.0 110.735 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.14 -179.65 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 121.52 0.676 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.7 132.97 37.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.476 -0.765 . . . . 0.0 110.641 -179.795 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -109.93 -8.14 14.9 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.147 -0.346 . . . . 0.0 111.714 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -84.27 -49.65 8.58 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.303 -0.873 . . . . 0.0 109.832 -179.875 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -74.38 -40.86 61.82 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.828 -0.545 . . . . 0.0 110.023 179.692 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 51.67 39.03 24.31 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 122.101 -0.374 . . . . 0.0 111.94 179.92 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 52.9 83.9 0.06 Allowed 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.55 0.69 . . . . 0.0 111.388 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 m -58.85 -33.63 70.66 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.614 -0.679 . . . . 0.0 111.316 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.91 59.03 2.3 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.551 -0.718 . . . . 0.0 110.093 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.95 -70.31 0.31 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -53.79 -41.76 67.3 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.63 89.77 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.168 0.984 . . . . 0.0 110.171 179.694 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.48 -39.78 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.497 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -64.7 -43.16 94.39 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.756 -0.59 . . . . 0.0 109.473 179.304 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 11' ' ' GLY . 77.0 t -59.46 -42.2 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 121.82 -0.55 . . . . 0.0 109.616 179.652 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.31 97.32 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.7 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 tt -64.63 -44.38 90.69 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 122.081 -0.658 . . . . 0.0 109.972 179.586 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.86 -39.71 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.553 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.42 -37.65 88.27 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.103 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.433 HD11 ' NE2' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -66.76 -26.65 67.07 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.68 -0.637 . . . . 0.0 110.292 179.396 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -67.54 -41.28 84.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.461 -0.775 . . . . 0.0 111.0 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.4 tp -104.88 -35.7 7.62 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.57 -0.706 . . . . 0.0 111.954 -179.727 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 m -106.42 95.86 12.55 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 -179.777 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -71.84 178.42 5.85 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 O-C-N 123.561 1.296 . . . . 0.0 111.111 179.786 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.433 ' NE2' HD11 ' A' ' 20' ' ' LEU . 10.2 p80 -152.07 42.3 0.68 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.576 -0.702 . . . . 0.0 110.896 -179.713 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -110.79 139.51 46.02 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.152 -0.967 . . . . 0.0 110.926 -179.907 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.842 179.911 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -130.7 105.29 7.71 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.434 0.635 . . . . 0.0 110.213 -179.515 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -119.19 -168.06 1.5 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.275 -0.891 . . . . 0.0 110.217 -179.885 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 53.58 45.78 27.41 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.913 -0.492 . . . . 0.0 111.22 179.956 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.2 mpp? 53.52 75.51 0.26 Allowed 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.528 0.68 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.7 39.25 1.14 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.679 -0.638 . . . . 0.0 111.054 179.855 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 55.21 96.74 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.539 0.685 . . . . 0.0 111.982 179.715 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.06 27.1 5.16 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.337 -0.852 . . . . 0.0 111.074 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.23 13.89 19.27 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.248 -0.908 . . . . 0.0 111.505 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 14' ' ' PHE . . . -106.84 34.07 5.97 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.911 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.0 31.45 55.85 Favored Glycine 0 N--CA 1.496 2.685 0 CA-C-N 118.184 0.992 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 53.47 29.08 8.42 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-N 118.368 1.084 . . . . 0.0 111.006 -179.455 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -143.37 -58.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.837 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.502 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 26.9 t80 -60.7 -28.09 68.38 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.49 179.354 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -54.67 -48.5 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.742 -0.599 . . . . 0.0 109.7 179.601 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.5 -39.44 96.85 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.42 HD22 ' CE1' ' A' ' 14' ' ' PHE . 1.2 tt -60.71 -41.59 95.56 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 117.616 0.708 . . . . 0.0 109.989 179.572 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.9 t -62.07 -42.83 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.532 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -63.63 -30.05 71.21 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.88 -0.512 . . . . 0.0 109.965 179.359 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -73.56 -46.59 46.49 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.6 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.1 m -67.56 -37.19 82.31 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.61 -0.681 . . . . 0.0 109.7 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.16 47.6 0.87 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.636 -0.665 . . . . 0.0 109.821 179.568 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.5 p -92.47 138.88 23.8 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.301 -0.875 . . . . 0.0 109.985 179.772 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.34 130.95 20.79 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.604 1.318 . . . . 0.0 110.156 179.783 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -146.72 69.65 1.19 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.689 -0.632 . . . . 0.0 110.583 -179.854 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -56.97 -38.48 73.06 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.655 -0.653 . . . . 0.0 110.469 179.835 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mttp . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.643 179.618 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.5 ttm . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.06 -139.38 0.9 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.249 -0.282 . . . . 0.0 110.691 179.947 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -135.7 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.085 -1.01 . . . . 0.0 110.219 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 63.72 10.13 4.87 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.199 -0.938 . . . . 0.0 112.236 -179.731 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.7 ttt -146.99 16.47 1.21 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.106 -0.996 . . . . 0.0 111.385 179.794 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.09 25.57 5.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.976 -1.077 . . . . 0.0 111.038 179.746 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.68 26.19 8.86 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.301 -0.874 . . . . 0.0 110.705 179.924 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.583 ' HB3' ' CB ' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -67.54 108.38 2.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.522 -0.737 . . . . 0.0 109.751 179.99 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' A' ' 14' ' ' PHE . . . 46.77 62.03 2.54 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.658 0.742 . . . . 0.0 109.847 -179.324 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.61 19.31 77.8 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.086 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.62 39.9 76.94 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.562 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.91 -59.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 117.821 0.81 . . . . 0.0 110.931 -179.847 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.31 -28.8 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 121.678 -0.639 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 26.6 t80 -65.2 -44.22 89.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.526 -0.734 . . . . 0.0 109.42 179.444 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.3 t -65.71 -44.93 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.471 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.63 -39.29 97.71 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.451 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.71 -45.3 93.37 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.098 -0.648 . . . . 0.0 109.729 179.591 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.52 -41.48 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.392 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -65.76 -36.76 84.48 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.0 -0.437 . . . . 0.0 110.311 179.449 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.9 tp -63.98 -37.13 86.27 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.69 -0.631 . . . . 0.0 109.769 179.601 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.5 m -68.56 -37.42 79.9 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.114 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 19' ' ' LEU . 35.8 mt -67.46 -38.11 83.94 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.371 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.7 m -63.97 161.26 40.2 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.921 -0.487 . . . . 0.0 109.979 179.731 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.79 73.32 1.39 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 O-C-N 123.869 1.457 . . . . 0.0 111.321 -179.851 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -127.65 -56.42 1.3 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.892 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -92.7 111.98 23.77 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.468 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? . . . . . 0 N--CA 1.498 1.95 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.66 -179.759 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.52 0.676 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.58 175.48 12.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.903 -0.498 . . . . 0.0 110.469 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 60.29 71.46 0.57 Allowed 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.387 0.613 . . . . 0.0 111.24 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.01 -44.14 61.3 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.833 -0.542 . . . . 0.0 110.333 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.3 tpt -61.83 -30.9 71.14 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.704 -0.623 . . . . 0.0 109.953 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.12 -32.85 74.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.67 -0.644 . . . . 0.0 110.496 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.78 -26.23 54.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.654 -0.654 . . . . 0.0 110.64 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.7 t -66.08 166.66 11.28 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.51 -0.744 . . . . 0.0 111.0 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 56.56 29.25 15.19 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 122.056 -0.402 . . . . 0.0 111.945 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.8 56.45 0.23 Allowed Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 163.48 -61.21 0.26 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.12 98.41 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 122.058 -0.672 . . . . 0.0 109.918 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.0 t -59.77 -40.02 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -65.91 -39.12 90.29 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.87 -0.519 . . . . 0.0 109.845 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 11' ' ' GLY . 84.4 t -60.39 -44.41 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.92 -37.62 94.51 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.7 tp -63.67 -43.42 96.76 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 122.074 -0.662 . . . . 0.0 110.016 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.0 t -60.28 -41.29 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tt -67.11 -41.86 85.5 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.882 -0.511 . . . . 0.0 110.089 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.03 -35.62 79.12 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.724 -0.61 . . . . 0.0 110.447 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.8 m -65.88 -36.82 84.48 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.3 -49.29 11.75 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.902 -0.499 . . . . 0.0 110.26 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.42 113.9 1.89 Allowed Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.616 -0.678 . . . . 0.0 110.323 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HD2' ' CE2' ' A' ' 26' ' ' TYR . 50.0 Cg_endo -81.27 25.33 0.65 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.275 1.317 . . . . 0.0 113.369 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 55.04 71.52 0.53 Allowed 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.262 -0.899 . . . . 0.0 111.19 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.427 ' CE2' ' HD2' ' A' ' 24' ' ' PRO . 55.9 m-85 -67.47 155.96 37.77 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.688 -0.633 . . . . 0.0 110.454 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 mttm . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 117.647 -1.168 . . . . 0.0 110.251 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mtp . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.246 0.546 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -97.21 133.57 41.67 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.652 -0.655 . . . . 0.0 110.597 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -161.37 53.76 0.27 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.731 0.777 . . . . 0.0 109.111 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.03 -15.31 8.78 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.679 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 66.4 mtm -132.77 -57.52 0.93 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.4 -0.812 . . . . 0.0 110.179 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.44 34.8 23.74 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 120.971 0.415 . . . . 0.0 111.181 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.72 -44.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.274 -0.892 . . . . 0.0 110.976 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -69.98 86.46 0.53 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.517 0.675 . . . . 0.0 110.274 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.65 -63.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.72 -51.47 0.24 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -59.4 -47.64 89.88 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.87 -43.36 99.01 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 117.972 0.886 . . . . 0.0 109.8 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.31 -36.56 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -72.35 -35.65 68.59 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.734 -0.603 . . . . 0.0 110.051 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 11' ' ' GLY . 64.3 t -59.46 -46.37 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.89 -36.54 93.42 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.2 tp -63.16 -41.93 99.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.086 -0.655 . . . . 0.0 109.884 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.1 t -61.5 -40.76 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -37.1 84.94 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.722 -0.611 . . . . 0.0 109.876 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 tt -62.27 -41.1 98.18 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.591 -0.693 . . . . 0.0 109.556 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.0 m -75.05 -22.37 58.42 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.754 -0.591 . . . . 0.0 110.549 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tt -57.46 -47.47 81.76 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.707 -0.621 . . . . 0.0 111.262 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.84 104.84 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.236 0 CA-C-N 117.813 0.279 . . . . 0.0 111.151 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.86 149.96 83.19 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.983 1.122 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -104.5 -44.46 4.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.057 -0.402 . . . . 0.0 110.947 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -70.5 -44.87 66.72 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.683 -0.636 . . . . 0.0 110.499 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.6 tttt . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 118.582 -0.723 . . . . 0.0 110.082 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 mtm . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 120.691 0.281 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.37 -164.5 0.21 Allowed 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 120.957 0.408 . . . . 0.0 111.611 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.38 -74.23 0.62 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.267 -0.895 . . . . 0.0 110.416 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 52.35 28.46 5.77 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.3 mmt 49.78 65.26 1.47 Allowed 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.598 -0.689 . . . . 0.0 111.347 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.53 13.11 32.31 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.535 -0.728 . . . . 0.0 112.351 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.07 -41.42 74.17 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.087 -1.008 . . . . 0.0 110.377 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -98.14 131.38 44.56 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 56.3 38.78 30.09 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 120.843 0.354 . . . . 0.0 111.107 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.3 -85.92 0.09 OUTLIER Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -59.49 -45.39 95.63 Favored Glycine 0 N--CA 1.501 2.968 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.44 -43.27 97.0 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.105 -0.644 . . . . 0.0 110.059 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.4 t -63.53 -40.9 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.99 -39.66 92.97 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.938 -0.476 . . . . 0.0 110.247 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 11' ' ' GLY . 95.2 t -61.63 -46.33 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.7 -0.625 . . . . 0.0 109.317 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.97 -37.63 87.99 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.8 -45.15 94.0 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 122.188 -0.595 . . . . 0.0 110.171 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.32 -41.17 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 121.764 -0.585 . . . . 0.0 109.449 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.04 -36.73 84.96 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 122.163 -0.336 . . . . 0.0 110.327 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.67 -46.01 73.58 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.78 -0.575 . . . . 0.0 110.143 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.0 m -63.8 -42.41 97.7 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.736 -0.603 . . . . 0.0 109.62 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.8 -36.28 83.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.656 -0.652 . . . . 0.0 110.231 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.82 80.73 41.28 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.533 -0.729 . . . . 0.0 109.513 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.65 77.33 3.92 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.464 1.244 . . . . 0.0 109.999 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 26.9 m80 57.13 21.19 6.21 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 122.15 -0.344 . . . . 0.0 111.551 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -169.46 147.11 3.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.248 -0.907 . . . . 0.0 109.819 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.119 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.898 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.062 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -163.18 -59.61 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.734 -0.604 . . . . 0.0 111.743 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -116.31 -56.51 2.29 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.386 -0.821 . . . . 0.0 111.292 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 59.8 24.4 13.38 Favored 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 122.513 0.325 . . . . 0.0 111.728 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.6 ptm -165.54 -42.19 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.279 -0.888 . . . . 0.0 111.72 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.1 80.52 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.6 -0.688 . . . . 0.0 111.639 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.76 87.72 3.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.556 -0.715 . . . . 0.0 109.951 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 30.5 p -89.44 168.56 12.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.875 -0.515 . . . . 0.0 110.611 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 8' ' ' SER . . . 69.15 0.17 2.72 Favored 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.68 -64.81 0.73 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -56.49 -38.96 83.1 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.52 87.96 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 117.883 0.842 . . . . 0.0 110.67 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.74 -40.42 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 18' ' ' VAL . 32.6 t80 -67.64 -40.76 84.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.728 -0.608 . . . . 0.0 109.893 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 11' ' ' GLY . 76.7 t -60.23 -41.0 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.7 -0.625 . . . . 0.0 109.827 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.07 -39.52 94.73 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 tp -65.79 -41.33 92.08 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.887 -0.773 . . . . 0.0 110.275 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 14' ' ' PHE . 99.3 t -62.48 -40.67 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 tp -66.9 -38.96 87.25 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.796 -0.565 . . . . 0.0 110.056 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 tt -59.88 -41.95 92.67 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.4 m -68.68 -30.87 69.63 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.757 -0.589 . . . . 0.0 109.655 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.4 tp -70.55 -32.39 69.79 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.776 -0.578 . . . . 0.0 110.892 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m 59.18 60.82 4.74 Favored Pre-proline 0 N--CA 1.505 2.29 0 O-C-N 122.064 -0.397 . . . . 0.0 111.606 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.45 139.18 31.15 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.406 1.214 . . . . 0.0 110.641 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -62.26 -30.12 70.89 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.881 -0.512 . . . . 0.0 111.005 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -112.02 149.58 31.82 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.564 -0.71 . . . . 0.0 109.805 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.144 0 CA-C-O 118.886 -0.578 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 N--CA 1.498 1.945 0 CA-C-O 120.98 0.419 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -109.05 28.25 8.67 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.723 -0.611 . . . . 0.0 110.889 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.51 55.03 0.55 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.205 -0.934 . . . . 0.0 110.328 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -118.39 38.46 3.72 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.238 -0.914 . . . . 0.0 110.814 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.4 -62.3 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.73 -0.607 . . . . 0.0 109.863 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.41 -31.06 71.59 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.992 -0.442 . . . . 0.0 111.192 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.04 90.18 1.59 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.472 -0.767 . . . . 0.0 109.647 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.5 t -159.02 -84.72 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.969 -0.457 . . . . 0.0 110.421 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.3 -39.63 4.65 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.46 -0.775 . . . . 0.0 110.657 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.644 ' HA2' ' HB2' ' A' ' 14' ' ' PHE . . . -121.26 13.99 9.5 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.44 -55.16 0.72 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.57 -46.8 4.64 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 117.723 0.762 . . . . 0.0 110.094 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.88 -41.93 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.987 -0.445 . . . . 0.0 111.024 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.644 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 46.6 t80 -63.58 -45.27 91.2 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.44 -0.788 . . . . 0.0 110.907 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.4 -42.77 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.833 -0.542 . . . . 0.0 110.169 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.31 -36.51 91.78 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.26 -36.74 74.63 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.622 -0.928 . . . . 0.0 110.75 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.15 -50.25 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.54 -0.725 . . . . 0.0 109.465 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -31.81 73.22 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.803 -0.561 . . . . 0.0 109.665 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.14 -46.67 87.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.0 m -67.96 -25.01 65.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.041 -0.412 . . . . 0.0 110.37 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tt -61.28 -55.48 31.36 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.776 -0.578 . . . . 0.0 110.843 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.1 m -145.18 75.43 13.9 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.452 -0.78 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -83.22 71.32 6.22 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.613 1.323 . . . . 0.0 110.426 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 50.52 32.71 6.94 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.915 -0.491 . . . . 0.0 111.068 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -161.81 156.83 23.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.566 -0.708 . . . . 0.0 110.114 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 117.571 -1.204 . . . . 0.0 110.177 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 mtm . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -140.15 107.99 5.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.94 -0.475 . . . . 0.0 110.193 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.89 147.46 5.77 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.865 -0.522 . . . . 0.0 110.311 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 54.91 26.3 7.72 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.122 0.487 . . . . 0.0 111.79 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.87 -60.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.323 -0.86 . . . . 0.0 109.537 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 49.37 62.5 2.59 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.481 0.657 . . . . 0.0 110.107 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 62.16 22.42 13.12 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.56 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 51.03 38.53 20.79 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.697 -0.627 . . . . 0.0 110.523 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.6 -45.14 0.12 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.343 -0.848 . . . . 0.0 111.741 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.9 -61.28 7.52 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.55 -37.0 93.45 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.59 -48.85 79.94 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 117.774 0.787 . . . . 0.0 110.423 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.21 -39.46 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.69 -0.631 . . . . 0.0 109.736 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -63.16 -45.52 91.46 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.786 -0.571 . . . . 0.0 110.06 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.41 -42.14 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.675 -0.64 . . . . 0.0 109.847 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.18 -39.82 98.39 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tt -64.68 -41.26 96.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.95 -0.735 . . . . 0.0 109.879 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 21' ' ' THR . 50.9 t -63.06 -34.75 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -73.36 -41.08 63.86 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 tp -71.34 -37.8 71.69 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.733 -0.605 . . . . 0.0 110.348 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -65.36 -24.07 67.15 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.435 -0.791 . . . . 0.0 111.057 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.85 -26.59 59.8 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.387 -0.821 . . . . 0.0 110.696 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.23 68.35 0.83 Allowed Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.89 -0.506 . . . . 0.0 111.287 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -83.12 106.18 1.38 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.222 1.281 . . . . 0.0 110.315 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -136.05 -51.25 0.71 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.629 -0.669 . . . . 0.0 111.119 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 57.92 75.3 0.39 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.473 0.654 . . . . 0.0 110.329 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 1.8 mmpt? . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.52 -0.738 . . . . 0.0 110.713 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 tmm? . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -131.63 -58.58 0.98 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.784 -0.573 . . . . 0.0 111.016 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.45 -79.84 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 122.836 0.454 . . . . 0.0 110.49 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.64 -42.93 81.48 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.195 -0.941 . . . . 0.0 109.421 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -71.03 -24.21 62.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.839 -0.538 . . . . 0.0 110.861 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.17 -18.0 24.11 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.517 -0.739 . . . . 0.0 111.857 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.06 -44.4 3.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.33 -0.856 . . . . 0.0 111.43 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 t -77.22 82.74 3.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.33 -0.856 . . . . 0.0 110.568 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.88 -64.74 0.28 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.797 -0.564 . . . . 0.0 110.191 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.42 -48.73 0.96 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -56.6 -47.64 82.93 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.42 92.62 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 117.717 0.759 . . . . 0.0 110.37 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.27 -39.34 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -64.31 -42.16 96.47 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.799 -0.563 . . . . 0.0 109.865 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 11' ' ' GLY . 73.9 t -59.51 -39.66 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.57 -42.49 97.39 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -69.38 -41.73 76.09 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.989 -0.712 . . . . 0.0 109.632 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.5 t -60.46 -45.37 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tp -64.75 -38.42 90.93 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -42.51 98.51 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.747 -0.596 . . . . 0.0 110.004 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -64.85 -36.39 84.2 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.654 -0.654 . . . . 0.0 109.593 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.452 ' HA ' HD13 ' A' ' 22' ' ' LEU . 2.5 mm? -70.22 -49.14 53.19 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.688 -0.632 . . . . 0.0 109.823 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.6 p -130.95 89.25 43.22 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.875 -0.516 . . . . 0.0 109.657 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.25 144.13 55.72 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.477 1.251 . . . . 0.0 110.938 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -113.31 53.22 0.77 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.476 0.655 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -104.22 167.89 9.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.606 -0.684 . . . . 0.0 110.215 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 117.668 -1.158 . . . . 0.0 110.295 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.499 1.979 0 CA-C-O 121.009 0.433 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 21.7 m-20 -103.64 -167.17 1.34 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.764 -0.585 . . . . 0.0 110.182 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -162.83 130.35 3.69 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.318 -0.863 . . . . 0.0 110.961 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 52.34 48.23 23.06 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 121.846 0.832 . . . . 0.0 111.617 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.71 -35.06 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.942 -0.474 . . . . 0.0 111.034 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 2' ' ' ASP . . . -67.67 -60.35 2.61 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.628 -0.67 . . . . 0.0 110.859 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -161.03 31.28 0.14 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.377 -0.827 . . . . 0.0 112.649 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.0 p -127.84 35.6 4.46 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.929 -1.107 . . . . 0.0 111.497 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.44 7.71 45.82 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.544 -0.722 . . . . 0.0 110.619 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.47 -38.72 2.99 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -73.42 -50.82 10.88 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.83 98.79 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.947 -0.737 . . . . 0.0 109.928 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.31 -39.35 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -65.14 -40.19 94.06 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.883 -0.51 . . . . 0.0 109.941 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 11' ' ' GLY . 97.1 t -59.66 -44.39 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.15 -37.43 94.54 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.05 -39.1 86.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.835 -0.803 . . . . 0.0 110.385 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.68 -40.25 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -38.66 87.2 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tp -72.82 -38.64 67.09 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.943 -0.473 . . . . 0.0 110.122 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.4 m -65.73 -25.02 67.1 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.709 -0.619 . . . . 0.0 110.413 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.484 HD11 ' CE1' ' A' ' 26' ' ' TYR . 1.4 tm? -63.84 -57.53 9.58 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.417 -0.802 . . . . 0.0 110.46 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 67.36 150.45 0.12 Allowed Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -72.45 157.17 53.48 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.301 1.334 . . . . 0.0 110.614 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 55.14 50.84 14.38 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.247 0.546 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' CE1' HD11 ' A' ' 22' ' ' LEU . 2.4 p90 -105.19 -18.44 14.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.62 -0.675 . . . . 0.0 111.992 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 27' ' ' LYS . 3.6 tppt? . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.322 -0.861 . . . . 0.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttm . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -133.18 158.36 43.03 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.721 -0.612 . . . . 0.0 110.489 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.1 mtm-85 -74.55 -51.86 13.46 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.778 -0.577 . . . . 0.0 110.605 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 49.99 36.99 12.94 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.0 mtt 52.12 49.47 20.56 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.864 -0.523 . . . . 0.0 111.835 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.5 -41.31 12.12 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.479 -0.763 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.51 -58.75 2.0 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.412 -0.805 . . . . 0.0 110.969 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.2 m 50.11 41.95 24.36 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.051 -0.406 . . . . 0.0 111.283 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.14 58.37 5.62 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 121.33 0.586 . . . . 0.0 111.962 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.19 15.14 72.01 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -103.05 -30.59 5.37 Favored Glycine 0 N--CA 1.495 2.577 0 CA-C-N 118.54 1.17 . . . . 0.0 110.248 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.64 94.19 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 118.053 0.927 . . . . 0.0 110.598 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.5 t -63.72 -46.47 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.22 -49.71 66.33 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.735 -0.603 . . . . 0.0 109.717 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.28 -39.2 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.48 -43.94 98.31 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -43.23 99.3 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.822 -0.811 . . . . 0.0 109.871 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -59.92 -40.23 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.501 -0.749 . . . . 0.0 109.474 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.576 ' O ' HD12 ' A' ' 22' ' ' LEU . 6.6 tt -72.84 -37.73 67.35 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.949 -0.47 . . . . 0.0 110.576 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.54 -37.7 42.21 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.72 -0.613 . . . . 0.0 111.327 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.2 m -73.88 -4.35 34.45 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.533 -0.729 . . . . 0.0 112.289 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 23' ' ' SER . 0.0 OUTLIER -55.59 -19.16 9.32 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 120.805 -1.185 . . . . 0.0 112.595 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.745 ' N ' HD13 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -59.28 129.73 86.75 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.332 -0.855 . . . . 0.0 110.746 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.53 158.75 56.13 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.6 1.316 . . . . 0.0 110.175 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -104.87 51.51 0.76 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.497 0.665 . . . . 0.0 109.863 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -93.26 168.58 10.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.618 -0.676 . . . . 0.0 110.413 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 117.715 -1.136 . . . . 0.0 109.932 179.801 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -155.16 -45.87 0.08 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.932 -0.48 . . . . 0.0 111.443 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.6 mtt-85 60.69 69.21 0.7 Allowed 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.455 0.645 . . . . 0.0 110.796 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.07 -34.55 73.6 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.724 -0.61 . . . . 0.0 110.469 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.3 mtm -120.8 -70.73 0.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.573 -0.705 . . . . 0.0 109.321 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 7' ' ' ALA . . . 40.89 51.98 3.22 Favored 'General case' 0 N--CA 1.506 2.358 0 C-N-CA 122.688 0.395 . . . . 0.0 111.438 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.458 ' O ' ' HA3' ' A' ' 11' ' ' GLY . . . 63.92 100.21 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.488 0.661 . . . . 0.0 109.885 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 m -96.11 -51.46 4.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.458 -0.776 . . . . 0.0 109.885 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.79 -49.53 77.14 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.72 31.61 8.18 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -105.3 -45.07 1.39 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.27 -48.23 62.28 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 118.198 0.999 . . . . 0.0 111.298 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.48 -43.88 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.701 -0.625 . . . . 0.0 109.331 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -69.88 -39.02 76.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.873 -0.517 . . . . 0.0 110.313 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 11' ' ' GLY . 41.2 t -58.55 -40.81 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.795 -0.566 . . . . 0.0 109.685 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.25 -45.63 96.1 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.39 -42.73 87.46 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.98 -0.718 . . . . 0.0 109.433 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.06 -42.06 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -39.99 95.85 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.798 -0.564 . . . . 0.0 109.819 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.24 -36.73 78.41 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.949 -0.47 . . . . 0.0 109.862 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.6 m -81.61 -45.84 15.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.647 -0.658 . . . . 0.0 109.526 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.65 -42.89 97.91 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 122.081 -0.387 . . . . 0.0 110.347 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.4 m -112.87 89.92 14.43 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.709 -0.619 . . . . 0.0 109.869 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.17 90.12 1.01 Allowed 'Trans proline' 0 N--CA 1.489 1.233 0 O-C-N 123.771 1.406 . . . . 0.0 110.081 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -128.26 31.74 4.99 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.756 -0.59 . . . . 0.0 111.068 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.02 87.78 2.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.3 -0.875 . . . . 0.0 109.622 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.998 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -133.06 118.73 19.12 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.935 -0.478 . . . . 0.0 110.425 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.5 mtt-85 -77.46 -31.85 54.03 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.931 -0.481 . . . . 0.0 111.401 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -55.87 -43.93 77.64 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.896 -0.502 . . . . 0.0 110.433 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -88.26 -73.85 0.48 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.629 -0.669 . . . . 0.0 109.202 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.67 18.51 3.72 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.22 2.63 5.18 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.914 -1.116 . . . . 0.0 112.168 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.613 ' CB ' HG23 ' A' ' 13' ' ' VAL . 56.9 m -106.12 33.86 3.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.933 -1.104 . . . . 0.0 110.901 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.72 21.22 2.56 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.69 43.0 53.31 Favored Glycine 0 N--CA 1.502 3.05 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.08 -49.09 0.02 OUTLIER Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.49 -44.52 46.13 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-N 117.795 0.797 . . . . 0.0 111.244 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.613 HG23 ' CB ' ' A' ' 8' ' ' SER . 19.8 t -56.27 -42.08 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.986 -0.446 . . . . 0.0 109.993 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -67.91 -41.35 82.78 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.762 -0.586 . . . . 0.0 109.863 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.17 -41.02 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.724 -0.61 . . . . 0.0 109.596 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.01 -37.96 94.88 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -41.47 89.92 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.965 -0.726 . . . . 0.0 110.25 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.73 -38.92 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.33 -39.65 94.32 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.83 -29.87 68.29 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.893 -0.504 . . . . 0.0 110.089 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 m -100.1 39.65 1.32 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.635 -0.666 . . . . 0.0 109.455 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tp -119.81 -78.73 0.59 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.147 -0.971 . . . . 0.0 109.893 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 p -167.62 139.46 2.55 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.387 -0.821 . . . . 0.0 110.853 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.52 89.89 1.24 Allowed 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 123.844 1.444 . . . . 0.0 110.157 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -64.67 -43.85 92.26 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.729 -0.607 . . . . 0.0 110.751 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -149.27 159.75 43.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.675 -0.641 . . . . 0.0 110.716 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 tptt . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.108 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 120.831 0.348 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.37 175.54 7.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.843 -0.536 . . . . 0.0 110.83 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.15 -167.9 2.58 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.99 19.06 5.57 Favored 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.1 tpt -129.37 -39.7 1.49 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.85 -1.156 . . . . 0.0 111.105 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.28 -36.9 33.45 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.784 -0.572 . . . . 0.0 112.318 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.53 -45.16 10.13 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.305 -0.872 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 p -66.01 -34.63 78.53 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.447 -0.783 . . . . 0.0 111.229 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.38 69.89 4.29 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.193 -0.942 . . . . 0.0 109.844 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.8 -65.48 0.51 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.08 87.07 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.04 -37.13 78.91 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 117.847 0.824 . . . . 0.0 110.68 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.1 t -66.01 -46.08 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.11 -48.7 67.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.635 -0.666 . . . . 0.0 109.807 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.32 -37.7 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.49 -40.32 98.53 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 tt -67.19 -46.08 74.98 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 122.012 -0.699 . . . . 0.0 109.664 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -62.17 -41.53 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tt -65.61 -40.21 92.38 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -37.29 78.95 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 122.02 -0.425 . . . . 0.0 110.187 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -72.86 -33.01 65.82 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.554 -0.716 . . . . 0.0 109.745 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.74 -63.0 1.21 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.61 -0.682 . . . . 0.0 109.72 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.9 m 55.17 93.59 0.05 OUTLIER Pre-proline 0 N--CA 1.504 2.233 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.21 82.5 2.03 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 O-C-N 123.425 1.224 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -106.18 -51.12 3.02 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -92.16 -45.25 8.36 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.8 pttt . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.813 179.593 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mmt . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 t70 65.18 -76.36 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 122.81 0.444 . . . . 0.0 111.176 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.63 66.94 9.9 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.372 -0.83 . . . . 0.0 109.542 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -158.06 -59.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.0 ptm -50.7 -29.13 10.5 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.09 -48.05 77.67 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.529 -0.732 . . . . 0.0 111.002 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.81 -54.77 2.32 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.598 -0.689 . . . . 0.0 110.479 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -76.42 -171.92 1.97 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.703 -0.623 . . . . 0.0 110.324 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 8' ' ' SER . . . 74.76 -52.36 0.68 Allowed 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.063 0.545 . . . . 0.0 112.081 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.68 -53.43 25.57 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.66 -40.94 99.44 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.0 -33.42 74.3 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.986 -0.714 . . . . 0.0 110.673 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 9' ' ' ALA . 80.0 t -67.83 -45.91 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.461 -0.774 . . . . 0.0 109.273 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -69.23 -47.22 65.35 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.545 -0.722 . . . . 0.0 109.914 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.7 t -64.95 -43.24 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.52 -38.89 97.0 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -43.39 98.95 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 117.652 0.726 . . . . 0.0 109.679 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.55 -40.26 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.506 ' HA ' HD12 ' A' ' 22' ' ' LEU . 3.2 mm? -68.73 -42.08 78.12 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.876 -0.515 . . . . 0.0 109.813 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 20' ' ' LEU . 13.2 tp -62.03 -35.65 79.21 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.047 -0.408 . . . . 0.0 110.403 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 54.8 m -68.87 -31.17 69.91 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.592 -0.692 . . . . 0.0 109.782 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 19' ' ' LEU . 17.0 mt -68.85 -55.64 10.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.637 -0.665 . . . . 0.0 110.171 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.68 99.88 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.251 0 O-C-N 122.236 -0.29 . . . . 0.0 111.394 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.22 60.78 7.53 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 O-C-N 123.368 1.194 . . . . 0.0 110.054 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.1 m80 56.37 40.77 29.64 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 121.309 0.576 . . . . 0.0 110.568 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.54 92.34 3.72 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 109.782 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.138 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ttt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.586 0.707 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -154.62 141.7 19.34 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.732 -0.605 . . . . 0.0 109.879 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -117.77 176.03 5.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.487 -0.758 . . . . 0.0 111.135 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 60.55 19.98 9.8 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.8 mtt -139.06 -64.58 0.5 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.78 88.27 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.0 -23.52 28.64 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.833 -0.542 . . . . 0.0 110.557 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -72.13 -49.41 36.18 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.249 -0.907 . . . . 0.0 109.865 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.18 -50.66 6.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.884 -0.51 . . . . 0.0 110.134 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.3 51.28 1.62 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.66 -86.94 0.06 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.28 -46.85 86.91 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 117.814 0.807 . . . . 0.0 111.309 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.46 -40.77 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -61.58 -51.26 69.25 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.893 -0.505 . . . . 0.0 109.753 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.21 -43.01 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.98 98.56 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -42.13 98.79 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 117.715 0.757 . . . . 0.0 110.313 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.37 -42.02 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.38 -41.29 69.85 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 tp -60.53 -33.57 72.85 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.946 -0.471 . . . . 0.0 110.922 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 m -62.24 -38.88 90.94 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.502 -0.749 . . . . 0.0 110.083 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.57 50.55 1.17 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.596 -0.69 . . . . 0.0 109.801 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 t -106.41 118.42 54.7 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.23 -0.919 . . . . 0.0 110.757 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -79.46 93.54 1.08 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.795 1.418 . . . . 0.0 109.747 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -113.49 25.68 11.07 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.508 -0.745 . . . . 0.0 111.507 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -99.38 78.85 2.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.064 -1.022 . . . . 0.0 109.606 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.1 tptt . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 117.293 -1.337 . . . . 0.0 110.841 -179.88 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtm . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 120.951 0.405 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.04 169.26 18.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.786 -0.571 . . . . 0.0 110.459 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -90.99 -90.16 0.16 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.633 -0.667 . . . . 0.0 110.209 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 48.83 32.5 3.74 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 118.871 0.759 . . . . 0.0 112.235 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.39 29.48 15.25 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.685 -0.635 . . . . 0.0 111.278 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.27 -57.48 2.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.362 -0.836 . . . . 0.0 109.894 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.423 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . . . -102.73 87.86 3.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.624 -0.673 . . . . 0.0 109.505 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.5 m -123.02 124.71 43.73 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.546 ' O ' HG23 ' A' ' 13' ' ' VAL . . . 65.42 -73.16 0.06 Allowed 'General case' 0 N--CA 1.506 2.358 0 C-N-CA 122.804 0.442 . . . . 0.0 110.455 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.16 -50.42 28.08 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 7' ' ' ALA . . . -66.93 -35.24 89.2 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.47 -38.04 73.87 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 117.858 0.829 . . . . 0.0 110.448 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 9' ' ' ALA . 84.5 t -59.54 -38.72 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -74.88 -32.02 61.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.684 -0.635 . . . . 0.0 110.112 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.84 -44.46 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.0 -38.65 94.31 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.36 -45.56 93.05 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 122.02 -0.694 . . . . 0.0 109.266 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.05 -38.63 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.867 ' HA ' HD12 ' A' ' 22' ' ' LEU . 13.5 tp -61.69 -27.01 68.39 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.702 -0.624 . . . . 0.0 109.95 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.48 -38.86 23.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.903 -0.498 . . . . 0.0 110.222 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.89 -15.72 61.58 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.657 -0.652 . . . . 0.0 111.912 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.867 HD12 ' HA ' ' A' ' 19' ' ' LEU . 11.8 mt -58.77 -55.07 39.85 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.458 -0.776 . . . . 0.0 110.898 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 m 62.09 90.9 0.08 OUTLIER Pre-proline 0 N--CA 1.503 2.195 0 C-N-CA 122.459 0.304 . . . . 0.0 110.618 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -69.75 -28.99 24.62 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 O-C-N 123.498 1.262 . . . . 0.0 111.516 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -129.65 -65.75 0.83 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -158.23 142.3 15.73 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 110.352 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 118.586 -0.721 . . . . 0.0 109.82 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.16 152.51 38.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.742 -0.599 . . . . 0.0 110.345 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -157.34 -174.54 4.94 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.712 -0.618 . . . . 0.0 110.311 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 59.13 22.93 11.13 Favored 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.856 -0.528 . . . . 0.0 111.976 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.78 -45.77 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.575 -0.703 . . . . 0.0 109.947 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.15 43.85 1.15 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.361 -0.837 . . . . 0.0 109.908 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -118.44 -53.47 2.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -108.36 -49.21 3.21 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.26 80.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.924 -0.485 . . . . 0.0 111.138 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.92 69.31 1.92 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.53 -86.8 0.06 OUTLIER Glycine 0 N--CA 1.498 2.786 0 CA-C-N 118.284 1.042 . . . . 0.0 111.058 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.45 79.93 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 122.104 -0.645 . . . . 0.0 111.267 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.02 -42.89 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -65.4 -40.89 93.99 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.112 -0.367 . . . . 0.0 110.062 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.5 t -60.58 -42.2 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 O-C-N 121.613 -0.68 . . . . 0.0 109.278 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.5 -40.35 96.14 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.0 mt -62.73 -46.59 87.36 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.034 -0.686 . . . . 0.0 109.756 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.2 t -52.79 -40.6 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.648 -0.658 . . . . 0.0 109.591 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.58 -46.6 21.71 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.977 -0.452 . . . . 0.0 109.865 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -45.49 90.73 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.849 -0.532 . . . . 0.0 109.669 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.7 m -66.91 -34.5 77.91 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -38.25 76.88 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.916 -0.49 . . . . 0.0 110.293 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.18 116.58 66.63 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.883 -0.51 . . . . 0.0 110.007 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.16 136.0 26.05 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.597 1.314 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -99.4 -55.66 2.62 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.699 -0.626 . . . . 0.0 109.878 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -134.67 102.28 5.23 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt . . . . . 0 N--CA 1.503 2.191 0 CA-C-O 117.272 -1.347 . . . . 0.0 110.569 -179.485 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.52 -60.85 0.1 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.878 -0.514 . . . . 0.0 110.903 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 56.8 68.23 0.89 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.182 0.515 . . . . 0.0 111.706 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -93.82 -60.33 1.78 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.253 -0.904 . . . . 0.0 109.779 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -145.4 67.81 1.22 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.778 0.799 . . . . 0.0 109.97 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.89 -45.1 8.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.705 -0.622 . . . . 0.0 109.725 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 13' ' ' VAL . . . -156.88 112.95 2.96 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.005 -0.434 . . . . 0.0 109.938 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.541 ' HB2' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER 59.74 -162.46 0.25 Allowed 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.841 -0.537 . . . . 0.0 111.193 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.99 39.82 0.91 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.965 -1.084 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.2 38.12 88.89 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.6 -54.64 0.01 OUTLIER Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.27 -50.54 71.09 Favored 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 118.065 0.933 . . . . 0.0 111.007 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.61 HG21 ' HB1' ' A' ' 7' ' ' ALA . 12.1 t -65.74 -32.44 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.666 -0.646 . . . . 0.0 110.247 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -71.94 -42.37 66.7 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.53 -0.731 . . . . 0.0 110.235 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -56.65 -45.33 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.749 -0.594 . . . . 0.0 109.443 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.11 -33.86 88.38 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 tp -77.39 -35.81 54.02 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.68 -0.894 . . . . 0.0 110.171 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.41 -45.6 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.578 -0.701 . . . . 0.0 109.648 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -36.1 82.94 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.775 -0.578 . . . . 0.0 109.834 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tp -77.32 -35.5 54.8 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.74 -0.6 . . . . 0.0 110.344 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -64.5 -23.94 67.45 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.78 -0.575 . . . . 0.0 110.9 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -75.27 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.393 -0.817 . . . . 0.0 110.086 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.452 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 54.91 -172.55 0.01 OUTLIER Pre-proline 0 N--CA 1.507 2.386 0 CA-C-N 118.656 0.662 . . . . 0.0 111.004 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 23' ' ' SER . 50.6 Cg_endo -75.76 68.87 6.27 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.411 0.741 . . . . 0.0 110.729 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -109.32 -50.88 2.94 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.34 -0.85 . . . . 0.0 110.261 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -83.47 75.28 10.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.61 -0.682 . . . . 0.0 109.762 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 117.268 -1.349 . . . . 0.0 111.373 -179.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mtp . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 t70 66.66 -65.65 0.2 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 122.963 0.505 . . . . 0.0 111.766 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.97 -6.28 48.77 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.408 -0.808 . . . . 0.0 111.388 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.15 -45.35 87.56 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.293 -0.88 . . . . 0.0 109.912 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.02 -32.31 63.3 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.829 -0.544 . . . . 0.0 109.846 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.85 -28.92 69.19 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.903 -0.498 . . . . 0.0 111.016 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.19 80.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.657 -0.652 . . . . 0.0 110.209 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 m -94.43 28.42 2.59 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.537 -0.727 . . . . 0.0 110.95 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 13' ' ' VAL . . . -65.66 -39.46 91.41 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.155 -0.965 . . . . 0.0 110.45 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.42 85.24 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -64.13 -40.88 98.48 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.61 91.53 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 117.795 0.798 . . . . 0.0 110.054 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 9' ' ' ALA . 77.7 t -61.29 -40.78 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.21 -40.23 93.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.961 -0.462 . . . . 0.0 109.957 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 11' ' ' GLY . 90.9 t -62.19 -43.77 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.02 -37.34 94.13 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.9 -44.29 93.44 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.967 -0.725 . . . . 0.0 110.012 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.6 t -58.67 -43.63 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.92 -39.44 93.53 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -60.59 -41.78 95.41 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.9 -0.5 . . . . 0.0 109.99 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 49.5 m -69.31 -29.16 66.95 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.66 -0.65 . . . . 0.0 110.526 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.62 -29.02 62.11 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.471 -0.768 . . . . 0.0 110.563 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.36 73.69 0.53 Allowed Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.927 -0.483 . . . . 0.0 110.708 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.82 69.5 6.86 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.464 1.244 . . . . 0.0 109.974 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -118.41 -35.3 3.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.758 -0.589 . . . . 0.0 111.054 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 61.16 -168.19 0.18 Allowed 'General case' 0 N--CA 1.505 2.314 0 CA-C-N 118.2 0.455 . . . . 0.0 110.693 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.379 0 C-N-CA 123.082 0.553 . . . . 0.0 111.286 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ptp . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.073 0.463 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -133.38 -54.82 0.9 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.65 -0.656 . . . . 0.0 110.334 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 16.5 mtm105 -72.49 106.19 4.48 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.478 -0.764 . . . . 0.0 109.224 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -96.03 -55.49 2.95 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.999 -0.438 . . . . 0.0 109.984 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.1 -42.52 17.31 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.528 -0.732 . . . . 0.0 110.089 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.48 82.67 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.799 -0.563 . . . . 0.0 111.139 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 3' ' ' ARG . . . -91.63 23.81 3.37 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.498 -0.751 . . . . 0.0 111.745 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.4 t -87.3 61.68 6.8 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.07 -1.019 . . . . 0.0 109.958 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 15' ' ' VAL . . . 39.75 83.82 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 C-N-CA 122.927 0.491 . . . . 0.0 111.177 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.58 -65.42 4.02 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 12' ' ' ALA . . . 149.94 51.74 0.02 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . 75.45 -47.96 0.61 Allowed 'General case' 0 N--CA 1.511 2.591 0 CA-C-N 117.886 0.843 . . . . 0.0 110.688 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.2 -44.9 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 9' ' ' ALA . 12.8 t80 -75.67 -32.43 60.15 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.137 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.81 HG22 ' HB3' ' A' ' 9' ' ' ALA . 72.6 t -60.45 -44.43 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.661 -0.65 . . . . 0.0 110.049 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.02 97.88 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.76 -44.97 79.99 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.809 -0.818 . . . . 0.0 110.111 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.96 -42.0 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.02 -33.27 70.55 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.921 -0.487 . . . . 0.0 109.7 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tt -71.39 -44.8 64.27 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.9 -0.5 . . . . 0.0 109.826 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.0 m -75.11 -29.59 60.62 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.668 -0.645 . . . . 0.0 110.889 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.08 62.35 0.88 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.888 0.852 . . . . 0.0 108.99 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.0 t -117.07 78.07 9.57 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.786 -0.571 . . . . 0.0 110.561 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -86.11 70.51 4.48 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 121.256 1.304 . . . . 0.0 109.475 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 57.52 57.65 4.22 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.649 0.738 . . . . 0.0 109.982 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -121.35 162.18 20.79 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.464 -0.773 . . . . 0.0 110.965 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt . . . . . 0 N--CA 1.499 2.007 0 CA-C-O 117.701 -1.143 . . . . 0.0 110.115 179.761 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -110.57 38.72 2.39 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.537 0.684 . . . . 0.0 110.463 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.51 -47.28 2.45 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 0.3 OUTLIER -92.34 -38.14 12.21 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.9 mtm -92.04 19.0 7.2 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.64 -0.662 . . . . 0.0 111.771 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.7 -66.9 0.87 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.152 -0.968 . . . . 0.0 109.118 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.79 21.37 0.79 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.729 -0.607 . . . . 0.0 111.494 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 4' ' ' GLU . 6.1 p -107.24 -50.57 3.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.329 -0.857 . . . . 0.0 110.377 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.83 73.1 5.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.175 -0.953 . . . . 0.0 110.009 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.36 -82.3 0.05 OUTLIER Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.872 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.14 -47.89 84.11 Favored Glycine 0 N--CA 1.503 3.156 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.51 75.95 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 122.049 -0.677 . . . . 0.0 110.654 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.58 -44.97 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.76 -0.588 . . . . 0.0 109.743 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.74 -48.41 66.53 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.65 -0.656 . . . . 0.0 110.424 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.3 t -67.33 -40.13 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.776 -0.577 . . . . 0.0 109.79 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.55 99.24 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -45.22 94.36 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 117.752 0.776 . . . . 0.0 109.825 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.522 ' O ' HG22 ' A' ' 21' ' ' THR . 66.5 t -63.98 -41.76 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tp -65.57 -33.29 75.56 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.61 -0.681 . . . . 0.0 109.665 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -36.52 74.04 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.567 -0.708 . . . . 0.0 110.326 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -69.69 -24.12 63.54 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.347 -0.845 . . . . 0.0 111.367 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.47 -32.83 8.35 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.363 -0.835 . . . . 0.0 111.008 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.67 167.24 0.12 Allowed Pre-proline 0 N--CA 1.504 2.262 0 C-N-CA 122.749 0.42 . . . . 0.0 111.276 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.76 63.46 4.55 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.202 1.268 . . . . 0.0 109.556 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 52.12 46.16 27.1 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.291 0.567 . . . . 0.0 110.637 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -126.92 124.95 40.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.414 -0.803 . . . . 0.0 110.854 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 tptp . . . . . 0 N--CA 1.505 2.292 0 CA-C-O 119.028 -0.51 . . . . 0.0 111.2 179.909 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 120.639 0.257 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -89.84 -47.59 7.79 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.242 -0.912 . . . . 0.0 109.459 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -103.17 -14.98 16.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.746 -0.596 . . . . 0.0 111.07 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.7 -48.06 42.07 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.361 -0.837 . . . . 0.0 110.99 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.6 ttm -76.59 -45.4 30.47 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.716 -0.615 . . . . 0.0 110.894 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.59 36.03 19.56 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.966 -0.459 . . . . 0.0 111.883 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 51.79 44.57 29.21 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.709 -0.619 . . . . 0.0 112.546 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -92.85 0.66 57.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.45 -0.781 . . . . 0.0 111.167 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 14' ' ' PHE . . . 52.94 56.57 7.38 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.375 -0.828 . . . . 0.0 109.266 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 14' ' ' PHE . . . 80.35 -63.18 4.2 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.548 ' O ' ' HB3' ' A' ' 12' ' ' ALA . . . 146.63 50.39 0.03 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . 75.48 -48.44 0.61 Allowed 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 123.494 0.718 . . . . 0.0 110.27 -179.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.41 -45.38 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.837 -0.539 . . . . 0.0 109.571 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.46 ' CB ' ' HA3' ' A' ' 10' ' ' GLY . 20.7 t80 -67.0 -35.15 79.31 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.109 -0.369 . . . . 0.0 110.842 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.43 -46.63 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.46 -37.94 86.19 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -43.29 96.92 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 122.021 -0.694 . . . . 0.0 109.751 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.2 t -59.7 -40.75 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.81 -42.96 97.57 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.9 tt -59.58 -45.69 91.13 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.925 -0.484 . . . . 0.0 109.985 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 51.5 m -64.22 -34.04 77.18 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.899 -0.501 . . . . 0.0 109.929 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -63.52 -33.76 76.28 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.702 -0.624 . . . . 0.0 109.652 179.348 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -82.06 118.85 73.56 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.47 132.54 22.4 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.232 1.288 . . . . 0.0 111.445 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -143.91 64.4 1.32 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.557 -0.714 . . . . 0.0 110.679 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -103.93 70.2 0.99 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.199 -0.938 . . . . 0.0 110.697 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.224 0 O-C-N 121.453 -0.78 . . . . 0.0 111.255 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 120.886 0.374 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -105.38 148.74 26.78 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.729 -0.607 . . . . 0.0 110.042 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 58.88 -94.61 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 122.477 0.311 . . . . 0.0 111.336 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 55.67 18.34 2.79 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-N 118.984 0.811 . . . . 0.0 112.793 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.79 -60.43 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.079 -1.013 . . . . 0.0 109.391 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 57.03 33.58 23.57 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.193 0.52 . . . . 0.0 111.057 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.613 ' CA ' HG21 ' A' ' 15' ' ' VAL . . . -152.2 -76.64 0.13 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.527 -0.733 . . . . 0.0 109.358 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.6 m 57.33 -76.62 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.58 -40.84 28.73 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.679 -0.638 . . . . 0.0 112.638 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA3' HG23 ' A' ' 15' ' ' VAL . . . -89.75 34.48 4.04 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 52.88 30.19 36.2 Favored Glycine 0 N--CA 1.497 2.738 0 CA-C-N 118.52 1.16 . . . . 0.0 110.483 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.417 ' HA ' ' CB ' ' A' ' 7' ' ' ALA . . . 53.94 26.94 6.73 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 118.045 0.923 . . . . 0.0 110.935 -179.205 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.1 t -142.56 -60.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.463 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 51.9 t80 -55.05 -32.8 62.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.613 HG21 ' CA ' ' A' ' 7' ' ' ALA . 17.8 t -56.36 -43.23 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.93 -40.59 97.31 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -40.92 98.13 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.93 -0.747 . . . . 0.0 109.602 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 14' ' ' PHE . 71.9 t -60.27 -40.48 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.482 ' HA ' HD13 ' A' ' 19' ' ' LEU . 2.0 mm? -63.31 -40.69 98.03 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.6 tt -63.55 -36.65 84.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.038 -0.414 . . . . 0.0 110.111 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.5 m -68.08 -32.23 72.42 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.515 -0.741 . . . . 0.0 109.943 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -79.11 -63.94 1.3 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.631 -0.668 . . . . 0.0 110.142 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.6 p -165.9 95.11 0.8 Allowed Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.674 -0.642 . . . . 0.0 110.848 -179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -84.53 96.46 0.69 Allowed 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 121.293 1.329 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -109.55 -35.96 6.09 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.396 -0.815 . . . . 0.0 111.102 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.57 147.31 50.92 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.504 -0.748 . . . . 0.0 110.619 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 117.724 -1.131 . . . . 0.0 110.39 -179.931 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptp . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 120.707 0.289 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -79.39 161.71 26.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.533 -0.729 . . . . 0.0 110.611 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.8 ttm-85 51.78 47.8 24.08 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.086 0.47 . . . . 0.0 111.473 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.92 -39.54 14.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.453 -0.779 . . . . 0.0 109.853 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 11.9 ttm -106.62 -21.1 13.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.789 -0.569 . . . . 0.0 110.854 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.35 -50.48 63.4 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.202 -0.936 . . . . 0.0 110.727 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.33 74.64 1.12 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.625 0.726 . . . . 0.0 109.741 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.8 p -121.86 26.23 8.75 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.769 -0.582 . . . . 0.0 111.475 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.09 -60.91 0.57 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.333 -0.854 . . . . 0.0 110.035 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.19 -43.65 1.85 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -59.06 -47.78 89.1 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.05 90.75 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 118.024 0.912 . . . . 0.0 110.221 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.6 -39.37 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -63.96 -43.43 95.8 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.859 -0.525 . . . . 0.0 110.229 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 11' ' ' GLY . 88.5 t -60.76 -42.47 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.87 -39.76 97.69 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -42.36 96.49 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.085 -0.656 . . . . 0.0 110.228 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.06 -40.08 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 19' ' ' LEU . 3.0 mm? -68.24 -45.15 74.02 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -40.73 89.4 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.949 -0.47 . . . . 0.0 110.496 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -66.05 -37.89 86.99 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.751 -0.593 . . . . 0.0 109.619 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -60.91 -41.76 96.77 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.738 -0.601 . . . . 0.0 110.041 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 p -77.25 155.24 82.16 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.727 -0.608 . . . . 0.0 109.446 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.72 79.75 1.86 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 O-C-N 123.752 1.396 . . . . 0.0 111.023 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -86.01 -29.12 23.73 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.665 -0.647 . . . . 0.0 111.535 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 59.12 79.65 0.22 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.914 -0.491 . . . . 0.0 109.849 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.13 0 C-N-CA 122.856 0.462 . . . . 0.0 110.584 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ttp . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -133.97 28.28 3.84 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.878 -0.514 . . . . 0.0 111.548 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.64 56.48 7.57 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.668 -0.645 . . . . 0.0 112.318 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -137.66 -45.69 0.54 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.288 -0.882 . . . . 0.0 111.377 179.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.91 -11.02 20.1 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.282 -0.886 . . . . 0.0 112.233 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.84 -28.03 67.2 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.078 -1.014 . . . . 0.0 111.871 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.86 -62.11 1.95 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.345 -0.847 . . . . 0.0 110.83 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 m 54.05 -164.64 0.1 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.667 -0.646 . . . . 0.0 110.801 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 14' ' ' PHE . . . -90.9 89.43 7.45 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.919 -1.113 . . . . 0.0 109.282 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.627 ' HA3' ' CB ' ' A' ' 14' ' ' PHE . . . 106.69 -11.82 42.22 Favored Glycine 0 N--CA 1.5 2.959 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.146 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 12' ' ' ALA . . . 100.48 34.01 4.9 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 119.301 1.551 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . 73.8 -46.49 0.63 Allowed 'General case' 0 N--CA 1.506 2.364 0 CA-C-N 118.084 0.942 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.86 -48.46 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-O 121.331 0.586 . . . . 0.0 109.57 179.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.627 ' CB ' ' HA3' ' A' ' 10' ' ' GLY . 47.4 t80 -60.51 -39.27 87.18 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.6 -44.51 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.684 -0.635 . . . . 0.0 109.539 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.49 -38.84 96.95 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tt -64.5 -43.86 92.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.939 -0.742 . . . . 0.0 110.018 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.2 -38.2 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 mt -62.58 -40.62 97.48 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tp -63.07 -25.77 68.53 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 122.129 -0.357 . . . . 0.0 111.191 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.8 m -102.51 -11.12 18.78 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -0.759 . . . . 0.0 111.719 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.61 -44.31 2.55 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.829 -1.169 . . . . 0.0 111.944 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.1 t -89.68 113.01 55.17 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.224 -0.922 . . . . 0.0 111.304 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -77.31 92.1 1.14 Allowed 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.56 1.295 . . . . 0.0 110.266 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -83.11 -49.71 9.23 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.721 -0.612 . . . . 0.0 109.762 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -125.76 69.8 1.19 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 117.543 -1.218 . . . . 0.0 110.58 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.9 ttp . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.01 33.28 4.95 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.927 -0.483 . . . . 0.0 110.944 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -77.96 89.63 4.14 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.438 -0.789 . . . . 0.0 109.769 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -137.83 -63.94 0.56 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.847 -0.533 . . . . 0.0 110.219 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -117.26 25.18 10.64 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.59 -0.693 . . . . 0.0 111.115 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.23 -43.59 7.29 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.29 -0.881 . . . . 0.0 109.563 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.32 -35.93 66.13 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.963 -0.461 . . . . 0.0 109.961 179.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.1 m -98.73 47.52 0.98 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.716 -0.615 . . . . 0.0 110.312 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.21 -26.23 13.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.34 -0.85 . . . . 0.0 111.236 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.577 ' HA3' ' HB3' ' A' ' 14' ' ' PHE . . . -89.43 31.87 4.98 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 121.272 -0.892 . . . . 0.0 111.126 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.9 29.82 27.99 Favored Glycine 0 N--CA 1.497 2.762 0 CA-C-N 118.637 1.219 . . . . 0.0 111.544 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.36 14.68 3.87 Favored 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 118.463 1.132 . . . . 0.0 111.546 -179.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.7 t -128.29 -58.07 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.577 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 31.7 t80 -55.59 -37.12 67.66 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.271 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.466 HG23 ' HA3' ' A' ' 10' ' ' GLY . 53.5 t -60.61 -43.56 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.247 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.59 -37.18 93.35 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mp -63.86 -39.92 95.35 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.904 -0.763 . . . . 0.0 109.975 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.6 t -61.33 -41.23 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -37.61 85.59 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -40.94 82.98 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.13 -0.356 . . . . 0.0 110.213 179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -65.28 -25.14 67.51 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.826 -0.546 . . . . 0.0 110.874 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.87 -60.77 3.14 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.551 -0.718 . . . . 0.0 110.495 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.76 96.86 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.229 0 C-N-CA 122.442 0.297 . . . . 0.0 111.537 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.38 134.91 23.52 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.345 1.364 . . . . 0.0 111.2 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -82.1 -46.71 13.49 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.711 -0.618 . . . . 0.0 111.04 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 t80 56.3 45.07 23.66 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.071 0.462 . . . . 0.0 110.83 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.505 2.304 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.458 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpt . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.42 0.628 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -156.71 146.23 20.64 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.799 -0.563 . . . . 0.0 110.258 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.47 43.29 0.19 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.561 -0.712 . . . . 0.0 110.939 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -132.26 -58.03 0.95 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.35 -0.844 . . . . 0.0 110.58 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.5 ttt -114.1 36.05 3.88 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.559 -0.713 . . . . 0.0 110.95 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.02 -39.16 88.71 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.482 -0.761 . . . . 0.0 110.944 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.41 -99.81 0.09 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.564 -0.71 . . . . 0.0 109.247 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.54 17.68 1.73 Allowed 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 119.334 0.97 . . . . 0.0 112.749 179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.7 -42.83 40.06 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.041 -1.037 . . . . 0.0 109.124 179.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.27 27.96 16.95 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 179.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.64 -42.79 1.2 Allowed Glycine 0 N--CA 1.496 2.657 0 CA-C-N 118.463 1.132 . . . . 0.0 110.408 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.73 -54.35 47.24 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-N 117.875 0.838 . . . . 0.0 111.15 -179.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 88.7 t -57.54 -37.9 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.756 -0.59 . . . . 0.0 110.181 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.5 -45.57 86.73 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.88 -0.513 . . . . 0.0 110.3 179.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.13 -38.6 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.673 -0.642 . . . . 0.0 109.935 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.54 -43.33 99.44 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.27 -45.95 75.11 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.4 t -61.93 -36.13 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.412 -0.805 . . . . 0.0 109.197 179.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.14 -33.67 61.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.608 -0.683 . . . . 0.0 110.661 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.93 -38.37 21.13 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.292 -0.88 . . . . 0.0 110.691 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -87.29 -50.97 6.22 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.635 -0.666 . . . . 0.0 111.026 -179.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.8 -47.1 8.88 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.609 -0.682 . . . . 0.0 110.315 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.406 ' HB2' ' CE1' ' A' ' 25' ' ' HIS . 13.6 m 69.2 130.51 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.269 0 C-N-CA 123.301 0.64 . . . . 0.0 111.403 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.39 -16.61 19.27 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.344 1.181 . . . . 0.0 112.24 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.406 ' CE1' ' HB2' ' A' ' 23' ' ' SER . 66.8 m80 55.23 45.71 25.21 Favored 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.192 0.52 . . . . 0.0 111.278 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -141.69 140.78 33.27 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.392 -0.818 . . . . 0.0 110.201 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 tptt . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.856 179.827 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -135.55 -57.38 0.79 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.764 -0.585 . . . . 0.0 111.586 -179.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -138.89 -135.84 0.13 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.448 -0.782 . . . . 0.0 109.934 -179.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 60.22 75.6 0.4 Allowed 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 118.84 0.745 . . . . 0.0 109.471 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.3 tpp 56.19 30.3 16.29 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.42 -179.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 49.89 36.51 11.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 122.016 -0.428 . . . . 0.0 111.167 -179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 54.35 29.33 10.69 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.964 -0.46 . . . . 0.0 112.091 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.7 m -82.52 81.62 8.26 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.393 -0.817 . . . . 0.0 109.975 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.83 -65.99 0.13 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.504 -0.748 . . . . 0.0 111.034 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.78 -27.28 6.75 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.09 -53.95 42.13 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.3 -26.38 62.95 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 118.183 0.992 . . . . 0.0 111.811 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.96 -37.58 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.333 -0.854 . . . . 0.0 110.566 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -105.48 -52.81 2.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.397 -0.814 . . . . 0.0 110.182 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.02 -47.23 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.4 -40.13 97.17 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.54 -43.12 98.03 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.164 -0.61 . . . . 0.0 110.195 179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.95 -40.42 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.69 -0.631 . . . . 0.0 109.544 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 19' ' ' LEU . 3.0 tt -68.8 -30.67 69.29 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.737 -0.602 . . . . 0.0 110.585 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 tp -76.71 -31.62 57.3 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.393 -0.817 . . . . 0.0 111.032 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.4 m -65.43 -40.21 93.05 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.586 -0.696 . . . . 0.0 111.416 -179.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.36 -7.11 13.98 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.361 -0.837 . . . . 0.0 112.425 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.88 163.04 0.13 Allowed Pre-proline 0 N--CA 1.504 2.239 0 CA-C-N 118.717 0.69 . . . . 0.0 111.487 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.45 68.44 8.31 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.554 1.291 . . . . 0.0 110.031 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 56.43 49.16 15.46 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.235 0.541 . . . . 0.0 110.719 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -96.16 -50.71 4.71 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.526 -0.734 . . . . 0.0 110.117 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.388 179.994 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttp . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 120.811 0.338 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -150.84 172.43 15.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.839 -0.538 . . . . 0.0 110.833 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -106.78 34.46 3.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.493 -0.755 . . . . 0.0 110.931 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.19 -40.93 78.38 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.543 -0.723 . . . . 0.0 110.0 179.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.97 37.65 0.8 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.86 -0.525 . . . . 0.0 109.742 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.92 -53.68 4.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.605 -0.685 . . . . 0.0 109.571 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.67 116.89 3.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.811 -0.556 . . . . 0.0 110.033 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.2 t -128.47 38.56 3.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.723 -0.611 . . . . 0.0 110.244 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 50.08 63.59 2.13 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.802 -0.561 . . . . 0.0 110.34 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 14' ' ' PHE . . . 56.38 31.05 59.36 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.44 27.98 64.15 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 53.95 26.96 6.78 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 118.362 1.081 . . . . 0.0 110.786 -179.242 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.1 t -139.81 -57.46 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 25.0 t80 -56.18 -32.06 63.99 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.166 179.36 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 t -56.13 -44.22 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.71 -36.03 74.71 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -63.66 -44.52 93.55 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 117.854 0.827 . . . . 0.0 110.008 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.3 t -60.48 -42.26 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.53 -35.03 79.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.914 -0.491 . . . . 0.0 109.87 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.66 -45.71 74.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.113 -0.367 . . . . 0.0 110.359 179.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.5 m -67.43 -23.47 65.54 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.763 -0.586 . . . . 0.0 110.956 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.55 -53.99 46.45 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.448 -0.783 . . . . 0.0 110.753 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 t -152.1 77.66 6.79 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.633 -0.667 . . . . 0.0 110.628 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.77 71.88 6.81 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.528 1.278 . . . . 0.0 110.356 179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.45 65.81 1.4 Allowed 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.675 0.75 . . . . 0.0 110.702 -179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -86.27 -38.55 17.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.693 -0.63 . . . . 0.0 110.295 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.796 -0.565 . . . . 0.0 110.925 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.43 -50.73 72.8 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.86 -0.525 . . . . 0.0 111.365 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.11 -34.37 68.56 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.954 -0.466 . . . . 0.0 110.881 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -53.4 -55.59 23.81 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -85.05 -31.47 23.4 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.617 -0.677 . . . . 0.0 110.47 179.396 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.6 31.31 9.87 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 51.89 39.94 26.96 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.625 -0.672 . . . . 0.0 112.8 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.3 t -83.74 -59.17 2.51 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.298 -0.876 . . . . 0.0 110.795 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.11 -53.73 8.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.61 -0.681 . . . . 0.0 109.816 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.1 71.75 1.89 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 162.21 -77.77 0.16 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.31 -48.79 80.29 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 122.046 -0.679 . . . . 0.0 111.48 -179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.48 -39.23 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.739 -0.601 . . . . 0.0 109.465 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -65.74 -40.67 92.37 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.833 -0.542 . . . . 0.0 110.084 179.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 11' ' ' GLY . 83.6 t -62.06 -39.47 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.651 -0.655 . . . . 0.0 109.79 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.84 95.53 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.34 -43.03 87.25 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.917 -0.755 . . . . 0.0 110.316 179.685 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.3 t -58.95 -39.71 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.88 -39.88 91.08 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.841 -0.537 . . . . 0.0 109.731 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 tt -60.12 -45.05 94.29 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.552 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 12.6 m -68.83 -36.17 77.87 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.831 -0.543 . . . . 0.0 110.012 179.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 tp -58.36 -40.45 82.29 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.974 -0.454 . . . . 0.0 109.936 179.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.44 144.17 52.87 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.676 -0.64 . . . . 0.0 109.413 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.94 87.34 0.71 Allowed 'Trans proline' 0 N--CA 1.492 1.419 0 O-C-N 123.624 1.328 . . . . 0.0 110.531 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -149.07 60.73 1.05 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.663 -0.648 . . . . 0.0 110.456 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.552 ' CE1' ' HA ' ' A' ' 21' ' ' THR . 11.0 m-85 -132.7 130.45 40.07 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.351 -0.843 . . . . 0.0 110.183 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.819 -0.55 . . . . 0.0 111.506 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptt? . . . . . 0 N--CA 1.5 2.041 0 CA-C-O 120.359 0.123 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 61.57 107.84 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.262 0.553 . . . . 0.0 111.471 179.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 6' ' ' ALA . 0.2 OUTLIER -115.03 91.82 3.74 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.23 -0.918 . . . . 0.0 111.144 -179.817 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 47.36 49.16 15.95 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-O 121.091 0.472 . . . . 0.0 111.013 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.7 mmm 61.18 38.63 16.65 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.092 0.472 . . . . 0.0 110.762 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 3' ' ' ARG . . . -69.8 -41.4 75.11 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.37 -0.831 . . . . 0.0 110.76 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.548 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . . . -167.48 80.07 0.19 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.468 0.651 . . . . 0.0 110.517 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 56.0 p -130.42 121.37 25.77 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.472 -0.767 . . . . 0.0 109.757 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 8' ' ' SER . . . 66.53 -69.35 0.12 Allowed 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.413 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.57 17.73 58.48 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.065 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 7' ' ' ALA . . . -65.14 -50.98 54.4 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.21 80.51 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 122.196 -0.59 . . . . 0.0 109.814 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.3 t -61.57 -40.97 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.378 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -63.99 -38.75 92.22 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.929 -0.482 . . . . 0.0 110.152 179.479 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 11' ' ' GLY . 85.1 t -58.82 -43.65 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.9 -37.77 93.6 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.179 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.89 -41.99 95.15 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.007 -0.702 . . . . 0.0 109.821 179.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.8 t -59.94 -39.8 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.54 -43.44 89.97 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.09 -34.55 76.62 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.951 -0.468 . . . . 0.0 109.918 179.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -68.74 -38.11 79.91 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.9 tt -60.1 -45.44 92.94 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.874 -0.516 . . . . 0.0 109.977 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.88 159.01 83.98 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.613 -0.679 . . . . 0.0 109.757 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.34 56.41 3.25 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 O-C-N 123.532 1.28 . . . . 0.0 111.975 -179.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -136.26 25.01 3.24 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.366 -0.833 . . . . 0.0 110.13 179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -128.43 168.91 14.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.381 -0.824 . . . . 0.0 110.446 -179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.083 0 CA-C-O 117.598 -1.191 . . . . 0.0 111.33 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpp? . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 120.68 0.276 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 50.34 40.98 23.92 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.498 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 mmt85 58.13 19.33 5.98 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -88.85 -54.64 4.04 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.126 -0.984 . . . . 0.0 109.035 179.605 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.8 mtt -87.04 12.49 11.23 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.877 -0.515 . . . . 0.0 111.24 179.552 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.29 -47.27 7.28 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.206 -0.934 . . . . 0.0 109.926 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.69 -25.6 14.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.83 -0.544 . . . . 0.0 111.251 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -86.34 22.93 1.69 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.275 -0.891 . . . . 0.0 112.072 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.73 21.05 13.01 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.871 -1.143 . . . . 0.0 111.707 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.653 ' HA3' HG23 ' A' ' 15' ' ' VAL . . . -105.95 20.37 36.2 Favored Glycine 0 N--CA 1.5 2.927 0 O-C-N 120.942 -1.099 . . . . 0.0 111.472 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.77 28.47 60.36 Favored Glycine 0 N--CA 1.497 2.719 0 CA-C-N 118.421 1.111 . . . . 0.0 112.015 179.675 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.7 12.79 3.89 Favored 'General case' 0 N--CA 1.508 2.425 0 CA-C-N 118.688 1.244 . . . . 0.0 111.989 -179.502 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 89.0 t -126.65 -56.5 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 179.62 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.5 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 29.7 t80 -59.76 -38.27 81.33 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.256 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.653 HG23 ' HA3' ' A' ' 10' ' ' GLY . 60.4 t -59.58 -45.92 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.912 -0.493 . . . . 0.0 109.713 179.532 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.96 -39.65 97.5 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.685 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 tp -67.84 -40.52 83.69 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 117.946 0.873 . . . . 0.0 110.804 179.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.22 -42.64 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 tt -69.67 -36.28 75.9 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.315 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.46 -42.11 75.33 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 122.242 -0.286 . . . . 0.0 110.606 179.75 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.7 m -71.84 -17.61 62.13 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.744 -0.598 . . . . 0.0 111.291 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.09 -16.3 59.94 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.105 -0.997 . . . . 0.0 111.731 179.908 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.2 m 56.83 70.19 1.49 Allowed Pre-proline 0 N--CA 1.504 2.253 0 CA-C-N 118.704 0.684 . . . . 0.0 110.766 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.17 107.0 1.65 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.704 1.371 . . . . 0.0 109.929 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -125.71 -42.61 1.91 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.748 -0.595 . . . . 0.0 111.448 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 57.29 63.81 1.78 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.384 0.611 . . . . 0.0 110.105 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.7 mttt . . . . . 0 N--CA 1.499 1.99 0 CA-C-O 117.734 -1.126 . . . . 0.0 110.414 -179.808 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 ttp . . . . . 0 N--CA 1.501 2.082 0 CA-C-O 121.342 0.592 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -157.21 -87.61 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.748 -0.595 . . . . 0.0 109.698 -179.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -81.07 -32.08 34.13 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.067 -1.021 . . . . 0.0 110.051 179.592 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.61 -28.14 44.39 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 179.857 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -36.19 83.15 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.34 -0.85 . . . . 0.0 110.015 179.673 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.14 -41.26 67.34 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.229 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.98 -8.16 59.65 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.829 -0.545 . . . . 0.0 110.944 179.319 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.541 ' C ' ' HB2' ' A' ' 14' ' ' PHE . 48.0 m 57.6 56.95 4.57 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.656 -0.652 . . . . 0.0 110.987 -179.878 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.562 ' HB1' ' HB ' ' A' ' 13' ' ' VAL . . . 41.45 60.72 2.03 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.583 0.706 . . . . 0.0 111.785 179.79 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.64 21.43 79.42 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.748 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.55 36.82 72.43 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.825 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.28 -59.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 117.876 0.838 . . . . 0.0 110.352 -179.942 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.562 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 91.5 t -55.07 -31.53 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.818 -0.551 . . . . 0.0 110.471 179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.541 ' HB2' ' C ' ' A' ' 8' ' ' SER . 4.5 t80 -70.92 -42.83 69.37 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.587 -0.696 . . . . 0.0 109.492 179.346 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.09 -44.1 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.625 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.86 -39.46 98.04 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.614 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -66.31 -41.39 89.8 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.957 -0.731 . . . . 0.0 110.163 179.659 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.81 -40.34 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.534 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.67 -40.88 93.76 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.407 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tt -69.19 -43.93 73.17 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.453 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.4 m -75.29 -11.8 60.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.986 -0.446 . . . . 0.0 111.687 179.988 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.25 48.19 0.88 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.005 -1.059 . . . . 0.0 110.284 179.934 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.09 100.6 0.04 OUTLIER Pre-proline 0 N--CA 1.505 2.319 0 O-C-N 121.881 -0.512 . . . . 0.0 111.938 179.737 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.08 179.97 4.9 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.176 1.25 . . . . 0.0 110.68 179.64 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -144.2 41.15 1.37 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.291 -0.881 . . . . 0.0 111.459 -179.839 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -83.14 114.52 21.39 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.099 -1.001 . . . . 0.0 109.435 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.451 -179.636 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tpt . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.415 0.626 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -72.78 164.06 27.15 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.174 0.511 . . . . 0.0 110.403 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.72 -103.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.532 -0.73 . . . . 0.0 109.977 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.47 32.65 16.58 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 119.714 1.143 . . . . 0.0 111.39 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.7 ptm -168.53 -45.84 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.484 -0.76 . . . . 0.0 111.088 179.598 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.56 -53.41 4.32 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.429 -0.794 . . . . 0.0 110.172 179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.26 75.5 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.849 -0.532 . . . . 0.0 110.747 179.772 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 14' ' ' PHE . 65.9 p -75.79 -20.26 58.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.585 -0.697 . . . . 0.0 111.235 179.576 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.87 47.45 0.75 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.271 -0.893 . . . . 0.0 110.829 179.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.82 -0.72 56.32 Favored Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.268 -0.895 . . . . 0.0 110.876 179.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -5.88 76.07 Favored Glycine 0 N--CA 1.498 2.786 0 CA-C-N 119.089 1.444 . . . . 0.0 111.531 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.58 -49.53 2.01 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.0 1.4 . . . . 0.0 108.948 179.673 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.42 -52.52 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.628 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 8' ' ' SER . 0.2 OUTLIER -66.11 -47.59 73.67 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.607 -0.683 . . . . 0.0 110.453 179.904 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.82 -39.12 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.947 -0.47 . . . . 0.0 109.926 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.0 -43.16 91.89 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.54 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.77 -43.29 96.85 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 117.601 0.701 . . . . 0.0 110.605 179.764 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.2 t -60.17 -42.77 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.581 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tp -65.41 -39.24 91.91 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.168 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.64 -52.68 64.45 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.438 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.2 m -61.22 -34.04 74.47 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.99 -0.444 . . . . 0.0 110.37 179.511 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 mp -64.67 -39.24 93.34 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.832 -0.543 . . . . 0.0 109.721 179.591 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.6 m -73.15 157.68 88.01 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.875 -0.516 . . . . 0.0 109.987 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.55 93.01 0.5 Allowed 'Trans proline' 0 N--CA 1.492 1.434 0 O-C-N 123.896 1.471 . . . . 0.0 111.465 -179.717 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -57.58 -42.0 82.27 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.861 -0.524 . . . . 0.0 110.834 179.764 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -97.12 107.49 20.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.509 -0.744 . . . . 0.0 109.677 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 117.591 -1.195 . . . . 0.0 110.931 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 120.51 0.195 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 62.74 170.69 0.14 Allowed 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.905 0.86 . . . . 0.0 112.378 179.845 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.73 -52.56 0.75 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.642 -0.662 . . . . 0.0 109.485 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.87 -35.3 79.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.829 -0.544 . . . . 0.0 109.774 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.98 14.54 26.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.558 -0.714 . . . . 0.0 111.084 179.55 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.08 -3.34 21.66 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.226 -0.921 . . . . 0.0 112.054 -179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.33 -47.99 4.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.917 -1.114 . . . . 0.0 110.053 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.4 t -65.75 -28.35 68.98 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.761 -0.587 . . . . 0.0 111.395 179.791 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.08 -44.75 79.27 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.219 -0.926 . . . . 0.0 110.514 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.27 49.52 2.69 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.888 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -106.12 -77.23 1.08 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 179.725 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.07 98.6 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.196 -0.591 . . . . 0.0 109.775 179.449 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 67.9 t -58.65 -41.05 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.392 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 18' ' ' VAL . 26.4 t80 -66.2 -41.16 90.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.902 -0.499 . . . . 0.0 109.97 179.534 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.3 t -57.84 -43.13 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.649 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.73 -40.14 90.03 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.4 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.0 mt -61.08 -38.78 87.48 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.874 -0.78 . . . . 0.0 110.094 179.637 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 14' ' ' PHE . 83.9 t -66.2 -40.99 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.522 -0.737 . . . . 0.0 109.127 179.636 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tt -70.4 -42.28 71.89 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.378 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -35.34 78.41 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.818 -0.551 . . . . 0.0 109.531 179.431 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -103.1 34.99 2.67 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.718 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 23' ' ' SER . 0.6 OUTLIER -81.12 -24.39 37.7 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.385 -0.822 . . . . 0.0 111.603 -179.973 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 17.0 m 70.14 160.78 0.15 Allowed Pre-proline 0 N--CA 1.507 2.408 0 CA-C-N 118.202 0.455 . . . . 0.0 111.411 -179.926 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.37 -173.15 1.21 Allowed 'Trans proline' 0 N--CA 1.493 1.444 0 O-C-N 123.478 1.251 . . . . 0.0 111.065 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 60.21 57.85 2.81 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.564 0.697 . . . . 0.0 110.744 -179.963 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -134.75 130.11 35.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.436 -0.79 . . . . 0.0 110.634 179.953 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.538 179.753 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 120.697 0.284 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 55.21 41.93 31.0 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.176 0.512 . . . . 0.0 111.847 179.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.3 114.65 28.51 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.384 -0.823 . . . . 0.0 110.347 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -145.32 -76.32 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 11.8 mtm -126.78 48.07 2.23 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.13 -0.982 . . . . 0.0 110.218 179.616 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.78 -37.88 8.1 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.526 -0.734 . . . . 0.0 110.565 179.92 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.885 ' HB1' ' HA2' ' A' ' 11' ' ' GLY . . . -132.13 67.89 1.51 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.31 -0.869 . . . . 0.0 110.332 -179.885 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.98 -15.31 15.15 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.793 -0.567 . . . . 0.0 112.305 179.926 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' H ' ' HB2' ' A' ' 14' ' ' PHE . . . -95.54 56.59 1.82 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.882 -1.136 . . . . 0.0 108.721 179.573 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.66 14.65 49.3 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.405 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.885 ' HA2' ' HB1' ' A' ' 7' ' ' ALA . . . 57.03 37.52 79.95 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.73 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.46 -60.31 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.193 -0.593 . . . . 0.0 110.77 -179.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.86 -37.58 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 O-C-N 121.749 -0.594 . . . . 0.0 110.278 -179.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.464 ' HB2' ' H ' ' A' ' 9' ' ' ALA . 1.7 t80 -62.36 -48.64 78.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.95 -0.469 . . . . 0.0 110.271 179.497 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.5 -43.85 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.965 -0.46 . . . . 0.0 110.349 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.15 -40.5 99.04 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.704 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -43.24 96.75 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.014 -0.698 . . . . 0.0 110.27 179.763 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.51 -42.54 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.735 -0.603 . . . . 0.0 109.668 179.702 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.6 -34.63 77.4 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.867 -0.52 . . . . 0.0 110.228 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tp -70.07 -46.3 65.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.781 -0.574 . . . . 0.0 110.226 179.752 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.9 m -67.96 -29.54 68.61 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.979 -0.451 . . . . 0.0 110.897 179.878 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.68 -61.77 1.89 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.593 -0.692 . . . . 0.0 110.434 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.56 109.71 1.34 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.59 -0.693 . . . . 0.0 109.941 -179.976 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.59 144.14 59.44 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 O-C-N 123.577 1.304 . . . . 0.0 110.673 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -107.71 49.38 0.81 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.752 -0.593 . . . . 0.0 110.475 -179.985 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -88.51 143.18 27.13 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.482 -0.761 . . . . 0.0 109.994 179.724 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 118.677 -0.678 . . . . 0.0 110.41 179.891 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.22 -32.46 15.77 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.069 -0.394 . . . . 0.0 110.786 179.961 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.1 mtm105 -102.73 39.71 1.49 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.279 -0.888 . . . . 0.0 110.137 179.635 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -37.14 85.11 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.906 -0.496 . . . . 0.0 110.045 179.664 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.1 ttp -110.77 25.42 11.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.732 -0.605 . . . . 0.0 110.061 179.356 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.07 -55.86 3.18 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.228 -0.92 . . . . 0.0 110.476 179.848 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.28 17.33 2.77 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.624 -0.672 . . . . 0.0 112.455 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m 50.0 39.67 19.41 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.325 -0.859 . . . . 0.0 111.633 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.528 ' CB ' ' HB ' ' A' ' 13' ' ' VAL . . . 48.74 63.9 1.92 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.8 0.81 . . . . 0.0 110.449 -179.787 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.45 20.22 77.14 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.573 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.59 42.18 66.24 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.39 -54.85 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 O-C-N 122.14 -0.624 . . . . 0.0 109.959 -179.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.528 ' HB ' ' CB ' ' A' ' 9' ' ' ALA . 55.7 t -57.4 -34.75 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.778 -0.576 . . . . 0.0 110.243 179.821 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.06 -50.66 71.08 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.564 -0.71 . . . . 0.0 109.6 179.555 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.1 t -59.57 -37.78 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.618 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.09 99.71 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.722 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.23 -42.24 75.93 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.871 -0.781 . . . . 0.0 110.253 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG12 ' CB ' ' A' ' 23' ' ' SER . 66.3 t -64.55 -38.92 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.454 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.438 ' HA ' ' H ' ' A' ' 23' ' ' SER . 2.2 tt -67.45 -36.48 81.28 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.086 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 tt -61.31 -33.07 72.99 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.643 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.4 m -99.9 29.86 3.99 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.717 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 63.68 83.72 0.16 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.05 0.929 . . . . 0.0 111.598 179.794 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.438 ' H ' ' HA ' ' A' ' 19' ' ' LEU . 26.8 t -71.91 141.74 84.71 Favored Pre-proline 0 N--CA 1.501 2.114 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.605 179.816 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -77.19 87.47 1.5 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.562 1.296 . . . . 0.0 110.283 179.846 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.33 -43.65 12.72 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.679 -0.638 . . . . 0.0 110.262 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.3 59.59 0.68 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.701 -0.624 . . . . 0.0 109.793 179.801 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 117.753 -1.118 . . . . 0.0 110.418 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 2.002 0 CA-C-O 120.875 0.369 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.71 174.37 10.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.874 -0.516 . . . . 0.0 110.56 -179.902 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.677 ' HG2' ' HB2' ' A' ' 6' ' ' ALA . 0.3 OUTLIER -113.84 94.72 4.97 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.48 -0.763 . . . . 0.0 110.625 179.985 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -89.13 -58.23 2.61 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.471 -0.768 . . . . 0.0 109.831 179.763 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -39.14 57.47 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 110.366 179.686 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.677 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . . . 47.57 43.26 15.95 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 122.016 -0.428 . . . . 0.0 111.96 179.741 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 58.98 89.04 0.06 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.578 0.704 . . . . 0.0 109.792 -179.646 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.459 ' C ' ' HB2' ' A' ' 14' ' ' PHE . 1.5 m -93.96 23.64 4.77 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.63 -0.669 . . . . 0.0 112.061 -179.488 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 14' ' ' PHE . . . 43.16 69.06 0.43 Allowed 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.711 0.767 . . . . 0.0 110.79 179.848 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.62 17.04 72.51 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.15 33.27 60.86 Favored Glycine 0 N--CA 1.498 2.832 0 CA-C-N 118.545 1.173 . . . . 0.0 110.423 -179.626 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.26 -57.22 0.11 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.902 -0.763 . . . . 0.0 109.104 -179.982 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.443 ' HB ' ' HB1' ' A' ' 9' ' ' ALA . 75.5 t -57.13 -36.58 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.544 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 5.6 t80 -84.33 -35.02 23.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.486 -0.759 . . . . 0.0 109.806 179.429 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -57.68 -42.14 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.957 -0.464 . . . . 0.0 110.095 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.22 -43.61 96.8 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.687 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -40.75 95.64 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.886 -0.773 . . . . 0.0 110.632 179.786 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.18 -44.39 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.519 -0.738 . . . . 0.0 109.165 179.559 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 tp -65.94 -38.02 87.55 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.298 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -41.34 90.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.3 m -74.0 -31.59 63.02 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.691 -0.631 . . . . 0.0 110.118 179.574 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.94 -36.26 80.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.737 -0.602 . . . . 0.0 110.987 179.972 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.1 p -125.57 73.71 68.88 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.382 -0.824 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -89.99 52.54 1.3 Allowed 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.166 1.244 . . . . 0.0 110.852 179.764 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -162.46 77.57 0.48 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.917 -1.114 . . . . 0.0 110.953 179.982 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 54.49 67.46 1.01 Allowed 'General case' 0 N--CA 1.506 2.373 0 CA-C-O 121.203 0.525 . . . . 0.0 110.735 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.14 -179.65 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 121.52 0.676 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.7 132.97 37.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.476 -0.765 . . . . 0.0 110.641 -179.795 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 66.1 mtm180 -109.93 -8.14 14.9 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.147 -0.346 . . . . 0.0 111.714 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -84.27 -49.65 8.58 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.303 -0.873 . . . . 0.0 109.832 -179.875 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -74.38 -40.86 61.82 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.828 -0.545 . . . . 0.0 110.023 179.692 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 51.67 39.03 24.31 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 122.101 -0.374 . . . . 0.0 111.94 179.92 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 52.9 83.9 0.06 Allowed 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.55 0.69 . . . . 0.0 111.388 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 m -58.85 -33.63 70.66 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.614 -0.679 . . . . 0.0 111.316 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.91 59.03 2.3 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.551 -0.718 . . . . 0.0 110.093 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.95 -70.31 0.31 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.861 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -53.79 -41.76 67.3 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.63 89.77 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-N 118.168 0.984 . . . . 0.0 110.171 179.694 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.48 -39.78 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.497 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -64.7 -43.16 94.39 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.756 -0.59 . . . . 0.0 109.473 179.304 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 11' ' ' GLY . 77.0 t -59.46 -42.2 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 121.82 -0.55 . . . . 0.0 109.616 179.652 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.31 97.32 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.7 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 tt -64.63 -44.38 90.69 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 122.081 -0.658 . . . . 0.0 109.972 179.586 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.86 -39.71 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.553 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.42 -37.65 88.27 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.103 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.433 HD11 ' NE2' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -66.76 -26.65 67.07 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.68 -0.637 . . . . 0.0 110.292 179.396 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -67.54 -41.28 84.55 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.461 -0.775 . . . . 0.0 111.0 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.4 tp -104.88 -35.7 7.62 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.57 -0.706 . . . . 0.0 111.954 -179.727 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.0 m -106.42 95.86 12.55 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 -179.777 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -71.84 178.42 5.85 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 O-C-N 123.561 1.296 . . . . 0.0 111.111 179.786 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.433 ' NE2' HD11 ' A' ' 20' ' ' LEU . 10.2 p80 -152.07 42.3 0.68 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.576 -0.702 . . . . 0.0 110.896 -179.713 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -110.79 139.51 46.02 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.152 -0.967 . . . . 0.0 110.926 -179.907 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.842 179.911 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -130.7 105.29 7.71 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.434 0.635 . . . . 0.0 110.213 -179.515 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -119.19 -168.06 1.5 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.275 -0.891 . . . . 0.0 110.217 -179.885 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 53.58 45.78 27.41 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.913 -0.492 . . . . 0.0 111.22 179.956 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.2 mpp? 53.52 75.51 0.26 Allowed 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.528 0.68 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.7 39.25 1.14 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.679 -0.638 . . . . 0.0 111.054 179.855 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 55.21 96.74 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.539 0.685 . . . . 0.0 111.982 179.715 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.06 27.1 5.16 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.337 -0.852 . . . . 0.0 111.074 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.23 13.89 19.27 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.248 -0.908 . . . . 0.0 111.505 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 14' ' ' PHE . . . -106.84 34.07 5.97 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.911 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.0 31.45 55.85 Favored Glycine 0 N--CA 1.496 2.685 0 CA-C-N 118.184 0.992 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 53.47 29.08 8.42 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-N 118.368 1.084 . . . . 0.0 111.006 -179.455 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -143.37 -58.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.837 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.502 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 26.9 t80 -60.7 -28.09 68.38 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.49 179.354 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -54.67 -48.5 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.742 -0.599 . . . . 0.0 109.7 179.601 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.5 -39.44 96.85 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.42 HD22 ' CE1' ' A' ' 14' ' ' PHE . 1.2 tt -60.71 -41.59 95.56 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 117.616 0.708 . . . . 0.0 109.989 179.572 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.9 t -62.07 -42.83 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.532 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -63.63 -30.05 71.21 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.88 -0.512 . . . . 0.0 109.965 179.359 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -73.56 -46.59 46.49 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.6 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.1 m -67.56 -37.19 82.31 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.61 -0.681 . . . . 0.0 109.7 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.16 47.6 0.87 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.636 -0.665 . . . . 0.0 109.821 179.568 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.5 p -92.47 138.88 23.8 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.301 -0.875 . . . . 0.0 109.985 179.772 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.34 130.95 20.79 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.604 1.318 . . . . 0.0 110.156 179.783 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -146.72 69.65 1.19 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.689 -0.632 . . . . 0.0 110.583 -179.854 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -56.97 -38.48 73.06 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.655 -0.653 . . . . 0.0 110.469 179.835 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mttp . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.643 179.618 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.5 ttm . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.06 -139.38 0.9 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.249 -0.282 . . . . 0.0 110.691 179.947 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -135.7 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.085 -1.01 . . . . 0.0 110.219 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 63.72 10.13 4.87 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.199 -0.938 . . . . 0.0 112.236 -179.731 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.7 ttt -146.99 16.47 1.21 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.106 -0.996 . . . . 0.0 111.385 179.794 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.09 25.57 5.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.976 -1.077 . . . . 0.0 111.038 179.746 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.68 26.19 8.86 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.301 -0.874 . . . . 0.0 110.705 179.924 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.583 ' HB3' ' CB ' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -67.54 108.38 2.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.522 -0.737 . . . . 0.0 109.751 179.99 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' A' ' 14' ' ' PHE . . . 46.77 62.03 2.54 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.658 0.742 . . . . 0.0 109.847 -179.324 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.61 19.31 77.8 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.086 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.62 39.9 76.94 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.562 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.91 -59.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 117.821 0.81 . . . . 0.0 110.931 -179.847 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.31 -28.8 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 121.678 -0.639 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 26.6 t80 -65.2 -44.22 89.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.526 -0.734 . . . . 0.0 109.42 179.444 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.3 t -65.71 -44.93 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.471 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.63 -39.29 97.71 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.451 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.71 -45.3 93.37 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.098 -0.648 . . . . 0.0 109.729 179.591 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.52 -41.48 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.392 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -65.76 -36.76 84.48 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.0 -0.437 . . . . 0.0 110.311 179.449 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.9 tp -63.98 -37.13 86.27 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.69 -0.631 . . . . 0.0 109.769 179.601 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.5 m -68.56 -37.42 79.9 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.114 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 19' ' ' LEU . 35.8 mt -67.46 -38.11 83.94 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.371 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.7 m -63.97 161.26 40.2 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.921 -0.487 . . . . 0.0 109.979 179.731 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.79 73.32 1.39 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 O-C-N 123.869 1.457 . . . . 0.0 111.321 -179.851 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -127.65 -56.42 1.3 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.892 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -92.7 111.98 23.77 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.468 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? . . . . . 0 N--CA 1.498 1.95 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.66 -179.759 . . . . . . . . 0 0 . 1 stop_ save_